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Abstract 
Disorders of dopaminergic neurons in the midbrain are associated with various brain 
diseases such as Parkinson’s disease (PD), for which there are no effective treatments. 
Pluripotent stem cells (PSCs) offer a remarkable potential for finding new therapeutic 
strategies because they are self-renewable and capable to differentiate into all cell types. 
However, biomedical applications of PSCs require knowledge of the molecular mechanisms 
directing PSCs into midbrain dopaminergic (mDA) cell fate. 
During development the generation of mDA neurons is induced by the extrinsic molecules 
SHH, FGF8 and WNT1 in the caudal region of the Otx2 positive domain, which marks the 
presumptive fore- and midbrain, and rostrally to the future hindbrain expressing Gbx2.  
In this study I have further investigated the role of FGF signalling in the generation of mDA 
neurons. Here, I have used mouse epiblast stem cells (EpiSCs). Based on their 
developmentally primed pluripotent state, we assumed that they represent a more suitable 
system when compared with mouse embryonic stem cells. I validated neural differentiation 
of EpiSCs as an alternative model to study neural development in vitro. I found that inhibition 
of the FGF/ERK activity at the onset of EpiSC differentiation initiated expression of Wnt and 
Shh and further induced ventral midbrain progenitor markers, accompanied by suppressing 
caudalisation as well as forebrain induction. To maintain ventral midbrain progenitor fate, 
cells required a period of endogeneous FGF/ERK signalling. Subsequent treatment of FGF8 
and SHH, which restricts progenitors from adopting alternative fates, led to highly efficient 
production of authentic mDA neurons. These neurons exhibited functional, neuron-like 
properties and when implanted into the striatum of mouse PD model strongly restored 
parkinsonian features without any signs of overgrowth.  
In conclusion, a temporally controlled modulation of FGF/ERK activity during neural 
differentiation from PSCs is crucial for reliable and highly efficient generation of functional 
authentic mDA neurons.   
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1 Introduction 
 
In the nervous system dopaminergic (DA) neurons exist in different regions including the 
olfactory bulb, retina, hypothalamus and the ventral midbrain. DA neurons are usually 
identified by their expression of tyrosine hydroxylase (TH), the rate-limiting enzyme in the 
synthesis of dopamine. The ventral midbrain contains two cores of DA neurons, the 
substantia nigra (SN) and the ventral tegmental area (VTA). The SN is a part of the 
nigrostrial system and regulates motor function whilst the VTA belongs to the mesolimbic 
system and is involved in emotional behaviour. Disorders involving neurons of the VTA are 
linked to Schizophrenia and depression whereas the preferential degeneration of DA 
neurons in the SN is believed to be the primary cause of Parkinson’s disease (PD) (Hirsch, 
Graybiel et al. 1988; Sesack and Carr 2002; Dailly, Chenu et al. 2004). 
Stem cell-based transplantation is a promising approach for the treatment of PD. The 
generation of patient-specific induced pluripotent stem cells offers further, perhaps more 
realistic in shorter term, biomedical applications of stem cells in disease modelling and drug 
development. However, realising the potential of stem cells requires in depth understanding 
of the mechanisms that control the generation of mDA neurons during development. 
 
1.1 Pluripotent stem cells 
1.1.1 Stem Cells 
Stem cells have the potential to self-renew for indefinite periods in culture and to give rise to 
one or more specialised cell types along the developmental path. There are many kinds of 
stem cells that can be distinguished by their capacity to differentiate.  
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The zygote and the first blastomeres, derived from the first division of the zygote, are 
totipotent stem cells (Tarkowski 1959; Gardner 1998). They are capable of forming the entire 
embryo including the extra-embryonic tissue. As the blastomeres continue to cleave and 
divide, they form the trophoblast and the inner cell mass (ICM). The ICM further develops 
into the hypoblast and epiblast. Cells from the epiblast are pluripotent as they contribute to 
all cell lineages and can form a chimera when transplanted into another blastocyst (Gardner, 
1998). Through the subsequent process of gastrulation, cells of the epiblast give rise to the 
three germ layers: mesoderm, ectoderm, and endoderm. Cells of the mesoderm, ectoderm, 
and endoderm are considered to be multipotent as they are the progenitor cells of only one 
germ layer and terminally differentiate into a somatic cell type specific to that germlayer. 
1.1.2 Characteristics of pluripotency 
Pluripotency is defined as the ability of a single cell to generate all cell lineages of an 
organism. Stable pluripotent stem cell (PSC) lines can be derived from the epiblast and 
teratomas under specific culture conditions or generated from somatic cells by introduction 
of specific transcription factors. 
The functional pluripotency of a cell can be determined by three independent experiments: 
1) the spontaneous differentiation of PSCs in culture, 2) the formation of teratomas and 
teratocarcinomas by injection of PSCs into an immune compromised adult animal, and 3) 
chimera incorporation and germline transmission when PSCs are injected into a pre-
implantation blastocyst.  
1.1.3 Pluripotent stem cell lines 
Embryonic stem cells  
Embryonic stem cells (ESCs) are pluripotent cells derived from the epiblast of the pre-
implantation embryo (Kaufman et al., 1983). These cells are defined by their expression of 
the key pluripotency markers Nanog, Oct4, Sox2, Klf4, Rex1, and Stella (Avilion et al., 2003; 
Guo et al., 2009; Mitsui et al., 2003; Okamoto et al., 1990; Payer et al., 2003; Ramalho-
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Santos et al., 2002; Rogers et al., 1991). Furthermore female ESCs exist in a pre-X-
inactivation state maintaining two active X-chromosomes (Nichols and Smith, 2009).  
Initially, mouse ESCs were maintained on mitotically inactivated mouse embryonic fibroblast 
cells in the presence of fetal bovine serum (Evans and Kaufman, 1981). Later studies 
identified the leukemia inhibitory factor (LIF) as an important component to maintain 
pluripotency by activating the transcription factor STAT3 (Matsuda et al., 1999; Niwa et al., 
1998; Stewart et al., 1992). LIF in combination with the bone morphogenetic protein (BMP) 
were able to suppress differentiation and allowed the propagation of ESCs in a feeder layer 
free condition (Ying et al., 2003a). However, ESCs expanded in fully defined medium 
containing LIF and the two small molecules that inhibit mitogen-activated protein kinase 
(MAPK) signalling and glycogen synthase kinase-3 ß (GSK3ß) showed an upregulation of 
Nanog and Oct4 positive cells representing the so called ground state of pluripotency 
(Nichols and Smith, 2009; Silva et al., 2008a). 
Epiblast stem cells 
The generation of a stable PSC line from the epiblast of a postimplantation embryo has been 
first reported 2007 (Brons et al., 2007; Tesar et al., 2007). These cells are consequently 
called epiblast stem cells (EpiSCs). The maintenance of their pluripotent state requires 
Activin A and fibroblast growth factor 2 (FGF2) (Tesar et al., 2007). Using the same 
condition, EpiSCs can also be produced from ESCs (Guo et al., 2009). Though EpiSCs 
express the core pluripotent markers Nanog, Oct4, and Sox2, they are distinct from ESCs 
(Chenoweth and Tesar, 2010; Eggan, 2007). Unlike ESCs, EpiSCs display a high 
expression level of genes that mark the postimplantation epiblast such as Fgf5, Brachyury, 
Gata6, Nodal, Foxa2, and Otx2 (Brons et al., 2007; Tesar et al., 2007). In addition, these 
cells grow as flat compact colonies and need cell-cell interaction to survive (Brons et al., 
2007). Studies on EpiSCs further observed that one copy of the X chromosome is 
epigenetically silenced in female cells (Guo et al., 2009). Although EpiSCs can form 
teratomas, they have very limited capacity to contribute to blastocyst chimeras (Brons et al., 
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2007; Rossant, 2008; Tesar et al., 2007). EpiSCs are therefore thought to be more 
advanced in their development when compared to ESCs and thus they are also called 
primed PSCs (Nichols and Smith, 2009).  
Induced pluripotent stem cells 
Reprogramming of somatic cells to become induced pluripotent stem cells (iPSCs) by 
overexpressing the key transcription factors for pluripotency, Oct4, Sox2, Klf4 and c-Myc, 
was first reported in 2006 by Takahashi and Yamanaka (Takahashi and Yamanaka, 2006). 
Since then it has been demonstrated that iPSCs can also be derived from a variety of mouse 
tissues (Aoi et al., 2008; Eminli et al., 2008; Kim et al., 2008; Stadtfeld et al., 2008). These 
cells functionally resemble ESCs as they differentiate in vitro into the cell types of all three 
germ layers, form teratomas and contribute to chimeras and germline transmission (Maherali 
and Hochedlinger 2008, Okita et al 2007, Wernig et al 2007). Genome-wide microarray 
analyses further revealed that the global expression pattern of iPSCs is more similar to 
ESCs than the somatic cells from which they were derived, and that a majority of genes 
specific for ESCs are reactivated in iPSCs (Okita et al., 2007; Wernig et al., 2007). 
Additionally, during reprogramming of female somatic cells the silenced X-chromosome is 
again activated (Maherali et al., 2007) as it is the case for ESCs.  
After successful reprogramming of mouse somatic cells, scientists demonstrated 
reprogramming of various human somatic cells (Aasen et al., 2008; Giorgetti et al., 2009; 
Park et al., 2008; Takahashi et al., 2007; Yu et al., 2007) as well as the generation of 
disease-specific iPSC lines (Carvajal-Vergara et al., 2010; Ebert et al., 2009; Lee et al., 
2009; Marchetto et al., 2010; Park et al., 2008; Raya et al., 2009; Soldner et al., 2009). 
These disease-specific iPSCs provide a powerful tool for disease modelling in vitro and drug 
development. Once technical limitations are eliminated, iPSCs represent an alternative 
source for cellular replacement therapies because patient–specific iPSCs for cell or tissue 
grafts will not lead to immunological rejection. 
 
5 
 
Human embryonic stem cells 
In 1998, human ESCs were derived from pre-implantation stage embryos that were donated 
for research after being targeted for disposal either because they were surplus embryos or 
because they were of poor quality. These cells are considered to be pluripotent because 
they express the core genes of pluripotency Nanog, Oct4 and Sox2 (Adachi et al., 2010; Hay 
et al., 2004; Matin et al., 2004; Xu et al., 2009; Xu et al., 2008; Zaehres et al., 2005), 
differentiate into cells of all three germ layers (Hoffman and Carpenter, 2005), and form 
teratomas after injection into an immune-deficient animal (Thomson et al., 1998). Human 
ESCs share several features with mouse EpiSCs forming cell colonies with a flat 
morphology, reduced tolerance to passaging as single cells, dependence on FGF2 and 
Activin signalling (Xu et al., 2008), and the tendency towards X chromosome inactivation in 
female cell lines (Silva et al., 2008b). Consequently, they display more a primed pluripotent 
state than the ground state of mouse ESCs.  
1.1.4 Pluripotent stem cells as model to study neural development 
PSCs can be stimulated to differentiate into many different neuronal subtypes by use of 
in vitro models mimicking underlying molecular and cellular mechanisms of in vivo 
developmental processes (Lee et al., 2000b; Li et al., 2005; Perrier et al., 2004; Watanabe et 
al., 2005; Wichterle et al., 2002; Ying et al., 2003b). Conversely, insights into the 
mechanisms that direct stem cells into a specific neural fate may provide an improved 
understanding of the mechanism of neural differentiation in vivo, particularly for early human 
development. Therefore, the approach of hESC and disease-specific hiPSC allows us to 
dissect the complex mechanism of normal and pathological neurodevelopment.  
 
1.2 Midbrain dopaminergic development  
1.2.1 Neural induction 
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The first insights into the understanding of how cells of the ectoderm become neural tissue 
came from the pioneering work of Spemann and Mangold nearly 100 years ago (Spemann 
and Mangold, 1923). Using differently pigmented species of amphibians to distinguish the 
cells of donor and host, they transplanted a small piece of the dorsal blastopore lip of the 
gastrulating embryo, now known as Spemann’s ‘‘organizer’’, into the ventral side of another 
embryo at gastrula stage. They found that the cells of host tissue formed a secondary axis 
composed of a neural tube, notochord and paraxial muscles demonstrating the capability of 
the organiser to induce neural fate in vertebrate embryos. Equivalent organizing regions 
were found in zebrafish (shield), chick (Henson’s node), and mouse (node) embryos 
(Beddington, 1994; Boettger et al., 2001; Shih and Fraser, 1996). Each of these organisers 
induces a neural plate not only within the same species but also when transplants are 
carried out across classes (Blum et al., 1992; Hatta and Takahashi, 1996; Kintner and Dodd, 
1991), suggesting an evolutional conserved strategy for neural induction. 
Experiments showed that explants from the frog ectoderm, a region fated to become 
epidermis and neural tissue, gave rise to epidermal cells when cultured without the addition 
of growth factors. In contrast, when the ectodermal explants were dissociated into single 
cells, the cells became neural (Godsave and Slack, 1989; Grunz and Tacke, 1989). A 
number of BMP antagonists secreted by the organizer have been identified as essential 
molecules in neural induction such as Noggin (Furthauer et al., 1999; Lamb et al., 1993; 
Smith and Harland, 1992; Smith et al., 1993; Zimmerman et al., 1996), Chordin (Piccolo et 
al., 1996; Sasai et al., 1995; Sasai et al., 1994), Follistatin (Fainsod et al., 1997; Hemmati-
Brivanlou et al., 1994), Cerberus (Bouwmeester et al., 1996; Piccolo et al., 1999), XNr3 
(Hansen et al., 1997; Smith et al., 1995), Gremlin/Drm and Dan (Dionne et al., 2001; Eimon 
and Harland, 2001; Hsu et al., 1998; Khokha et al., 2003; Pearce et al., 1999). Based on the 
findings in amphibians, the phenomenon of neural induction was explained by the ‘default 
model’ which proposes that ectodermal cells convert into neural plate in the absence of 
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extrinsic signals, while BMP activity directs them to become epidermis (Munoz-Sanjuan and 
Brivanlou, 2002). 
Recent observations in chick and mice indicate that the process of neural induction is more 
complex than can be explained by the default model alone. In chick, mis-expression of BMP 
antagonists in the extra-embryonic or non-neural ectoderm does not induce the expression 
neural markers (Streit et al., 1998; Streit and Stern, 1999a, b) and grafted protein sources of 
BMP do not prevent neural development in the future neural plate (Streit et al., 1998), 
assuming that inhibition of BMP signalling alone is not sufficient for the specification of 
neural tissue. In support to this data, mouse mutants lacking the endogenous BMP 
antagonists Cerberus, Noggin and/or Chordin still develop a nervous system (Bachiller et al., 
2000; Belo et al., 2000; McMahon et al., 1998; Mukhopadhyay et al., 2001). It is worth noting 
that the loss of BMP signalling in mouse mutants missing the BMP receptor 1a (Bmpr1a) 
resulted in an early neural differentiation, implicating a role of BMP signalling in timing of 
neural induction (Di-Gregorio et al., 2007). The outcome of this study also suggests that 
neural induction appears earlier in development than thought. Indeed, gene expression 
analysis in chick embryos revealed that neural induction seems to be already activated 
before gastrulation as Erni, a marker for neural induction, is expressed before the organizer 
region has formed (Streit et al., 2000). 
BMP antagonists appeared not to be sufficient to induce neural cells, indicating that signals 
distinct from BMP antagonists are required for induction of neural fate. It has been proposed 
that FGFs and WNTs are involved in this process. Indeed, recent studies demonstrated that 
both FGF and WNT signalling can regulate BMP signalling (Baker et al., 1999; Eivers et al., 
2008; Gomez-Skarmeta et al., 2001; Pera et al., 2003). Whether these pathways have 
independent functions in neural induction, beside their effects on BMP signalling, remains 
elusive. 
Several studies indicated that the organiser itself is not required for neural induction because 
Foxa2 mouse mutants lacking the node are still able to form a neural plate (Ang and 
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Rossant, 1994; Episkopou et al., 2001; Klingensmith et al., 1999). Reinforcing this 
hypothesis; a neural plate is still formed after the gastrula organizer is surgically removed in 
chick, frog, zebrafish and mouse embryos (Davidson et al., 1999; Shih and Fraser, 1996; 
Smith and Schoenwolf, 1989). It has been proposed that the embryo possesses more than 
one organizer. Indeed, the anterior visceral endoderm (AVE) might be involved in the 
formation of neural tissue as it exists at the right time to induce neural tissue, being present 
shortly after implantation (Thomas et al., 1998). Recent results show that the AVE plays 
mainly a role in the formation of the anterior neural tissue, since embryos where the AVE is 
removed display a dramatic loss of anterior neural tissue (Martinez-Barbera and Beddington, 
2001; Thomas and Beddington, 1996). However, anterior neural induction is still initiated in 
Nodal mutants in the absence of the AVE (Camus et al., 2006) suggesting the AVE might 
not always be required for anterior neural induction and is likely to play an indirect or 
secondary role. 
1.2.2 Neural patterning – regionalisation and specification of midbrain 
dopaminergic neurons 
After initial neural induction, the neural plate folds and fuses at the midline to generate the 
neural tube. During this process of neurulation, cells of the neuroectoderm become 
patterned along the anterior-posterior and dorsal-ventral axis. The major mechanism 
underlying patterning is based on the actions of inductive signals that direct the fate of 
neural progenitors in a concentration dependent manner. There are three local signalling 
centres which establish the antero-posterior axis: the anterior neural ridge (ANR) at the 
anterior end of the neural plate (Houart et al., 1998; Shimamura and Rubenstein, 1997), the 
zona limitans intrathalamica (ZLI) in the middle of the diencephalon (Echevarria et al., 2003; 
Kiecker and Lumsden, 2004; Vieira et al., 2005) and the isthmic organiser (IsO) at the 
midbrain hindbrain border (MHB) (Martinez et al., 1991). These domains are characterised 
by their complex expression of sonic hedgehog (Shh, in ZLI), the fibroblast growth factor 8 
(Fgf8, in ANR, ZLI, and IsO), the BMP antagonists Chordin and Noggin (in ANR), and Wnt1 
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(in IsO) (Figure 1.1). As a result of their combined actions, the most anterior end of the 
neural tube gives rise to the forebrain, while more posterior regions form the midbrain, the 
hindbrain and the spinal cord.  
The establishment of the dorsal-ventral axis is a consequence of the antagonistic interaction 
between the ventralising factor, SHH, emanating from the notochord and the ventral midline 
of the neural tube and the dorsalising factors WNT and BMP from the roof plate (Chizhikov 
and Millen, 2005; Lee et al., 2000a; Lee and Jessell, 1999). Cells along the dorsal-ventral 
axis are subdivided into the floor plate at the ventral side, the basal plate, the alar plate, and 
the roof plate in the dorsal most region of the neural tube by their expression of specific 
genes. 
DA neurons of the midbrain arise ventrally and rostrally to the midbrain-hindbrain border 
(MHB) as consequence of the morphogenetic gradient between SHH and FGF8. SHH 
secreted from the ventral midline cells of the floorplate induces mDA neurons in the ventral 
region of the neural tube, whereas the isthmic secretion of FGF8 determines the position 
and size of the mDA neuron field along the anterior-posterior axis (Figure 1.1) (Burbach and 
Smidt, 2006; Prakash and Wurst, 2006; Ye et al., 1998). Additionally, members of the WNT 
family of secreted glycoproteins are expressed in the midbrain close to the MHB and may 
indirectly enhance the production or the survival of mDA neurons (Figure 1.1) (Castelo-
Branco et al., 2003; Danielian and McMahon, 1996; Smidt and Burbach, 2007). The 
induction and positioning of mDA progenitors in the neural tube occur between embryonic 
days (E) 7.5 and E9 of mouse development (Gale and Li, 2008). 
As cell proliferation and differentiation progress during the formation of the brain, the 
developing ventral midbrain becomes thicker and layered into a ventricular zone, an 
intermediate zone, and a marginal zone based on their regional traits and expression of 
combinations of specific genes. In the ventricular zone, the cells are marked by the 
expression of Lmx1a, Lmx1b, Ngn2, Msx1, Fox2a, and Dmrt5 (Andersson et al., 2006a; 
Andersson et al., 2006b; Ferri et al., 2007; Gennet et al., 2011; Kele et al., 2006; Smidt et 
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al., 2000). These cells retain their proliferative neural stem cell properties. As soon as the 
cells become part of the intermediate zone, they exit the cell cycle and start the post-mitotic 
differentiation into mDA neurons (E11.5-15). As they differentiate, the cells migrate ventrally 
into the mantle zone and then laterally. In contrast to mDA progenitors, these cells express 
the mDA neuronal markers Nurr1, Pitx3, and TH (Maxwell et al., 2005; Saucedo-Cardenas 
et al., 1998; Smidt et al., 1997; Zetterstrom et al., 1997). 
1.2.3 Isthmus assiociated factors 
The IsO is located at the border between the expression domains of the transcription factors 
Otx2, expressed in the presumptive fore- and midbrain, and Gbx2, expressed in the 
presumptive hindbrain and spinal cord (Joyner et al., 2000). This organizer is required for the 
specification of all cells in the posterior midbrain and in the anterior hindbrain. When the IsO 
was transplanted into naive diencephalic tissue then these presumptive forebrain cells 
differentiated into midbrain cells (Martinez et al., 1991) whereas the transplantation of IsO 
into the posterior hindbrain resulted in the formation of an ectopic cerebellum (Marin and 
Puelles, 1994). Based on these observations the IsO was identified as signaling centre.  
OTX2 
OTX2 is a homeodomain-containing transcription factor. At E6, it is detected in the visceral 
endoderm, the presumptive AVE implicated in the formation of anterior neural tissue, and the 
entire epiblast (Ang et al., 1994; Simeone et al., 1993). As gastrulation proceeds, Otx2 
expression becomes restricted to the anterior end of the embryo covering all three germ 
layers (Ang et al., 1994; Simeone et al., 1993; Simeone et al., 1995). In the neuroectoderm, 
it is later confined to the presumptive forebrain and midbrain with a sharp boundary at the 
MHB (Acampora et al., 1995; Ang et al., 1994; Millet et al., 1996; Simeone et al., 1992). 
The evidence that OTX2 has an important role in anterior neural patterning derives from 
studies on mice lacking Otx2. These embryos die early during embryogenesis having lost 
the anterior neuroectoderm (Acampora et al., 1995; Ang et al., 1996; Matsuo et al., 1995). In 
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addition, mouse mutant embryos where Otx2 was replaced by the lacZ reporter gene 
displayed a loss of lacZ expression in the epiblast indicating that Otx2 itself is required for its 
induction in the epiblast (Acampora et al., 1995). Moreover, OTX2 seems to be involved in 
anteriorising the visceral endoderm as it remained to the distal region in these mutant 
embryos (Acampora et al., 1995). Chimeric embryos containing Otx2–/– epiblast and wild-
type visceral endoderm rescued the induction of the early anterior neural plate in the mutant 
embryos, but failed to develop fore- and midbrain tissue (Rhinn et al., 1998). Altogether, the 
results of these experiments emphasise the necessity of OTX2 for the induction and 
regionalization of the anterior neuroectoderm. 
As early as E7.5, Gbx2 is expressed in the anterior hindbrain adjacent to the posterior end of 
the Otx2 expression domain. The border of these mutually exclusive expression domains 
marks the prospective midbrain hindbrain border where the IsO is located (Joyner et al., 
2000). An important function of OTX2 is to control proper positioning of the MHB as well as 
the IsO. In vivo studies revealed that ectopic expression of Gbx2 or reduced Otx2 
expression in the midbrain shifts the IsO to a more anterior position and subsequently 
ablates the midbrain section of mDA neurons (Acampora et al., 1997; Millet et al., 1999; 
Puelles et al., 2003); whereas overexpression of Otx2 or loss of Gbx2 in the hindbrain 
results in an expansion of the midbrain caused by the caudal shift of the IsO (Broccoli et al., 
1999; Sunmonu et al., 2011; Wassarman et al., 1997). 
It was demonstrated that in the ventral midbrain (E11.5) Otx2 is a direct downstream target 
of WNT1/β-catenin signalling as Chip-qPCR analysis uncovered a direct association of the 
β-catenin complex to the Otx2 promotor (Chung et al., 2009). Additionally, detailed analysis 
of mouse embryos at E11.5 in that Otx2 was inserted into the gene locus of Engrailed 1 
(En1, En1+/Otx2), which is expressed in the midbrain region from E8, showed an expansion of 
the Wnt1 expression domain while lack of Otx2 in En1+/Cre; Otx2flox/flox embryos (E12.5) 
resulted in a loss of Wnt1 expression in the ventral midbrain (Prakash et al., 2006) indicating 
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a positive regulatory feedback loop between OTX2 and WNT1 to maintain their expression in 
the ventral midbrain.  
OTX2 may also play a role during neurogenesis of mDA neurons. Mouse mutants in which 
Otx2 was conditionally inactivated by Cre recombinase under the transcriptional control of 
En1 (En1+/Cre; Otx2flox/flox) showed a reduced number of TH positive cells in the midbrain 
(Puelles et al., 2004). Consistent to this finding, mouse mutants overexpressing (ov) Otx2 by 
En1-Cre activity (En1+/Cre; Otx2ov/+) displayed an increased number of TH positive cells 
throughout the ventral midbrain due to an enhanced proliferation of mDA progenitor cells 
(Omodei et al., 2008). Moreover, OTX2 controls the identity and fate of neural mDA 
progenitors by suppressing the expression of the transcription factor Nkx2.2 which has been 
shown to be sufficient to repress the mDA neuronal fate and to induce serotonergic 5HT 
positive neurons in the ventral midbrain (Prakash et al., 2006; Puelles et al., 2004).  
Recent findings demonstrated a specific role for OTX2 in a subtype of mDA neurons as in 
the adult mouse brain OTX2 is restricted to the VTA neurons and excluded from SN neurons 
(Di Salvio et al., 2010a; Di Salvio et al., 2010b). Two VTA specific functions of OTX2 have 
been uncovered: firstly, OTX2 reduces the DA uptake in VTA neurons and, secondly, it 
antagonizes vulnerability to the Parkinsonian toxin MPTP (1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine) (Di Salvio et al., 2010a; Di Salvio et al., 2010b). 
FGF8 
The fibroblast growth factor 8 (FGF8) is an important diffusible signalling molecule of the 
IsO. FGF8 containing beads can mimic the isthmic transplant’s ability to induce midbrain and 
cerebellum characteristics in the diencephalon or cerebellum properties in the posterior 
hindbrain (Crossley and Martin, 1995; Crossley et al., 1996; Irving and Mason, 2000; 
Martinez et al., 1999). From E8.5, Fgf8 is expressed in the caudal, Gbx2-positive expression 
domain of the MHB, a region that will form the isthmus and anterior hindbrain (Crossley and 
Martin, 1995). Genetic studies in mice have demonstrated the crucial role of Fgf8 in the 
development of the midbrain as homozygous Fgf8 mouse mutants lack the posterior 
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midbrain where mDA neurons arise (Meyers et al., 1998). Fgf8 is in a cross-regulatory 
network with Wnt1, En1, En2, Pax2, and Pax5 which establishes and maintains the IsO 
(Wurst and Bally-Cuif, 2001; Ye et al., 2001). FGF8 is required to maintain the expression of 
these early midbrain-hindbrain regulatory factors and additionally stable expression of Fgf8 
is controlled by the correct expression of Wnt1, En1, En2, Pax2, and Pax5 (Lee et al., 1997; 
Lun and Brand, 1998; McMahon et al., 1992; Meyers et al., 1998; Reifers et al., 1998; 
Schwarz et al., 1997; Wurst et al., 1994; Wurst and Bally-Cuif, 2001; Ye et al., 2001; Ye et 
al., 1998).  
FGF8 has further been suggested to stimulate cell proliferation in the midbrain and play a 
role in mDA development. In embryos where Fgf8 was ectopically expressed under the 
control of the Wnt1 enhancer the midbrain expanded in size. The self-renewability of mDA 
neural progenitors was supported in vitro by addition of FGF8 (Chung et al., 2011; Lee et al., 
1997). Additionally, mDA neurons in E9 midbrain explants are only generated in the 
presence of FGF8 indicating a requirement of FGF8 in the specification mDA neurons (Ye et 
al., 1998). 
WNTs 
Members of the WNT family are secreted palmitoylated glycoproteins (Willert et al., 2003). In 
the nervous system, they are involved in cell proliferation (Castelo-Branco et al., 2003; 
Chenn and Walsh, 2002; Megason and McMahon, 2002; Taipale and Beachy, 2001), fate 
decision (Baker et al., 1999; Castelo-Branco et al., 2003; Dorsky et al., 1998; Wilson et al., 
2001), neuronal differentiation (Hall et al., 2000; Krylova et al., 2002; Patapoutian and 
Reichardt, 2000), and neuroprotection (Alvarez et al., 2004; De Ferrari et al., 2003; 
Fuentealba et al., 2004; L'Episcopo et al., 2011; Zhang and Carthew, 1998). So far, 19 Wnt 
ligands have been identified in the mouse genome. Thirteen of these were shown to be 
expressed in the developing midbrain (Rawal et al., 2006). Among them, Wnt1 and Wnt5a 
have been demonstrated to play an important role in the development of mDA neurons 
(Castelo-Branco et al., 2006; Castelo-Branco et al., 2003; Prakash et al., 2006; Schulte et 
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al., 2005). WNT proteins have been postulated to activate three different pathways: the 
canonical WNT pathway, ß-catenin mediated, the non-canonical WNT pathway and the 
WNT/Ca2+ pathway. Much work has been done to understand WNT/β-catenin signalling 
(Barker, 2008; Logan and Nusse, 2004). Briefly, WNT ligand binds to the receptor protein 
Frizzled (FZD) and the co-receptor low-density lipoprotein receptor related protein 5/6 
(LRP5/6) (Figure 1.3 B). The formation of this complex leads to the intracellular 
phosphorylation of LRP5/6 and thus mediates the WNT signal into the cell which activates 
Dishevelled (DVL) by phosphorylation and subsequently inactivates glycogen-synthase-
kinase-3β (GSK3β), a key modulator of this pathway. In the absence of WNT signals, 
GSK3β forms a complex with Axin, adenomatous polyposis coli (APC) and Diversin resulting 
in the phosphorylation and degradation of β-catenin. When cells receive WNT signals, the 
degradation of β-catenin is inhibited by physically displacing GSK3β from the destruction 
complex. Stabilised β-catenin enters the nucleus and interacts with T-cell factor/lymphoid 
enhancer binding factor (TCF/LEF) to affect transcription of WNT target genes such as 
Cyclin D1, Axin2, and Myc.  
Wnt1 is detected as early as E8.5 in the mouse embryo rostral and adjacent to the Fgf8 
expression domain at the MHB (Davis and Joyner, 1988; Wilkinson et al., 1987). In the 
midbrain, its expression continues until E14 and becomes restricted to the roofplate, the 
dorsal midline, and the floorplate (Davis and Joyner, 1988; Parr et al., 1993; Wilkinson et al., 
1987). Wnt1 is crucial for the establishment of the MHB as mouse embryos homozygous for 
Wnt1 null alleles display a loss of the midbrain and anterior hindbrain by E9.5 (Bally-Cuif et 
al., 1995; McMahon and Bradley, 1990; McMahon et al., 1992; Thomas and Capecchi, 
1990). In this context it is worth noting that Wnt1 is not required to induce Fgf8 expression 
because in mice lacking Wnt1, Fgf8 expression is initially induced and later lost (McMahon 
and Bradley, 1990; McMahon et al., 1992). In addition, the expression pattern of Fgf8 is not 
changed in embryos where Wnt1 is expressed under the control of the endogenous En1 
promotor, a gene which is expressed in the midbrain and hindbrain domain from E8 
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(Panhuysen et al., 2004). More likely, Wnt1 plays an important role in stabilising and 
maintaining Fgf8 expression at the MHB as it was shown in chick embryos (Canning et al., 
2007).  
WNT1 signalling is also important in maintaining En1 expression as in Wnt1-null mutant 
mice its expression is lost (Danielian and McMahon, 1996; McMahon et al., 1992). Since 
En1 and En1/2 knock-outs display a similar phenotype to the Wnt1-null in mice (Simon et al., 
2001; Wurst et al., 1994) and overexpression of En1 in Wnt-/- mice rescued the mid–
hindbrain phenotype (Danielian and McMahon, 1996), En1 is thought to be a target of Wnt1.  
WNT1 is generally considered a canonical WNT as it co-localizes with β-catenin in the 
ventral midbrain (Castelo-Branco et al., 2003). Reinforcing this link, inhibition of GSK3β or 
overexpression of β-catenin, which are downstream targets of the canonical WNT pathway, 
resulted in similar phenotypes in the ventral midbrain as Wnt1 activation (Castelo-Branco et 
al., 2004; Castelo-Branco et al., 2003; Danielian and McMahon, 1996; Prakash et al., 2006; 
Tang et al., 2010). In the development of mDA neurons, WNT1 appears to have multiple 
roles. WNT1 regulates the expression of Lmx1a, a key transcription factor of mDA neurons, 
(Chung et al., 2009) and activates Otx2 that in turn inhibits Nkx2.2 expression, a suppressor 
of the DA lineage (Prakash et al., 2006). Several independent studies further demonstrated 
a role of WNT1 in the proliferation of DA neural precursors (Castelo-Branco et al., 2003; 
Megason and McMahon, 2002; Panhuysen et al., 2004; Rimerman et al., 2000). Treatment 
of neural stem cells with WNT1 yields an increase of proliferating NURR1 positive 
precursors and an upregulation of Cyclin D1 and D3 which are involved in regulating cell 
cycle progression (Castelo-Branco et al., 2003). Confirming the importance of WNT1 in the 
proliferation of mDA precursors in vivo, mouse embryos display an expansion of the caudal 
midbrain when Wnt1 is ectopically expressed in the En1 expression domain (Panhuysen et 
al., 2004). 
At E9.5, Wnt5 is detected in the floor plate and basal plate of the developing midbrain 
(Andersson et al., 2008; Blakely et al., 2011; Yamaguchi et al., 1999). From E12.5 until 
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E14.5, Wnt5a expression is extended from the ventricular zone into the intermediate and 
marginal zone of the ventral midbrain (Andersson et al., 2008; Blakely et al., 2011). Later on, 
in the postnatal mouse, Wnt5 expression is lost in SN neurons while neurons of the VTA still 
show a low expression of Wnt5a (Andersson et al., 2008).  
Several studies investigated the molecular mechanism of WNT5a in the cells of the 
developing ventral midbrain and they found that WNT5a activates specific components of 
the non-canonical WNT pathway: Casein kinase 1, DVL and the small GTPase RAC1 
(Andersson et al., 2008; Blakely et al., 2011; Bryja et al., 2007; Schulte et al., 2005). WNT5A 
plays an important role in the terminal differentiation of mDA neurons as it increases the 
number of TH positive neurons by promoting DA differentiation of NURR1 positive 
precursors (Andersson et al., 2008; Bryja et al., 2007; Castelo-Branco et al., 2003). 
Moreover, when ventral midbrain explants were exposed to WNT5a, the axons of DA 
neurons were significantly elongated whereas mice lacking Wnt5a showed a reduced length 
of mDA neurites (Blakely et al., 2011) demonstrating the importance of WNT5a in axon 
outgrowth of DA neurons.  
Engrailed genes 
Engrailed 1 and 2 (EN1/2) are homeobox transcription factors. They are expressed across 
the MHB in the caudal midbrain and rostral hindbrain during early neural development from 
about E8 (Davidson et al., 1988; Davis and Joyner, 1988; Davis et al., 1988; McMahon et 
al., 1992; Wurst et al., 1994). The expression of both genes is maintained in adult SN and 
VTA (Davis and Joyner, 1988; Davis et al., 1988; Sgado et al., 2006; Simon et al., 2001). 
Mutant mice homozygous null for En1/2 (En1-/-; En2-/-) completely lack the mid-hindbrain 
region, a region where mDA neurons arise. Interestingly, neither single mutants show a 
completely loss of the mid-hindbrain region (Liu and Joyner, 2001; Simon et al., 2001) 
implying a functional compensation for each other. EN1/2 have at least two distinct functions 
during the development of mDA neurons. Firstly, they take part in the regionalisation of the 
MHB as they are essential to maintain the expression of the isthmic related factors Wnt1 and 
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Fgf8 (Liu and Joyner, 2001). Secondly, as development progresses, EN1/2 are required for 
the survival of mDA neurons. These neurons are initially generated in En1/2 double mutant 
mice but soon thereafter die through an activation of Caspase-3, a crucial factor of apoptosis 
(Alberi et al., 2004; Sgado et al., 2006; Simon et al., 2001). In this context it was recently 
reported that infusion of EN1/2 into the SN of mice treated with MPTP, a mitochondrial 
complex I toxin which is commonly used for PD models, resulted in a rescue of mDA 
neurons against cell death through upregulation of translation of the two mitochondrial 
complex I proteins NDUFS1 and NDUFS3 (Alvarez-Fischer et al., 2011).  
LMX1B 
Ever since the LIM homeodomain transcription factor LMX1B was detected in DA neurons of 
the adult SN and VTA as well as in mDA progenitors (Guo et al., 2008; Smidt et al., 2000), 
LMX1B has been suggested to be required for mDA development. At E8.5, Lmx1b is 
expressed at the MHB (Guo et al., 2007). Mouse embryos lacking Lmx1b show a loss of 
Fgf8 expression and isthmus regulatory genes Wnt1, En1/2, Pax2, and Gbx2 revealing a 
role for Lmx1b in the development of the IsO (Guo et al., 2007). In these mouse mutant 
embryos, all mDA neurons are lost by E15.5. This phenotype is most likely caused by an 
increased cell death (Guo et al., 2007) as a consequence of abolished En1/2 expression. 
However, conditional knock-out of Lmx1b in DA neurons (using TH-Cre mice) has no effect 
on terminal differentiation and survival of mDA neurons. It is worth noting that Lmx1a, 
another member of the LIM homeodomain transcription factor family, is also expressed in 
mDA neurons (Andersson et al., 2006b) and might compensate the loss of Lmx1b at later 
stages (Nakatani et al., 2010; Yan et al., 2011).  
1.2.4 Floorplate associated factors 
SHH  
In the early stages of development, Shh is expressed in the notochord and the floor plate of 
the neural tube. It is one of the first factors involved in inducing the ventral cell types, 
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including DA neurons (Bayly et al., 2007; Blaess et al., 2006; Fedtsova and Turner, 2001; 
Hynes et al., 1995; Ye et al., 1998). Mechanisms underlying SHH signal transduction have 
not been fully elucidated. Broadly, secreted SHH binds to the twelve-pass membrane 
hedgehog receptor patched (PTC) to relieve inhibition of the seven-membrane spanning G-
protein smoothened (SMO) by PTC (Figure 1.3 C). As soon as SMO inhibition is relieved, 
the GLI zinc finger transcription factors are modified so that GLI2 and GLI1 are activated 
while GLI3 is inactivated (Blaess et al., 2006; Fuccillo et al., 2006). 
Analysis of Shh-null mutant mice revealed a defect in the developing midbrain and forebrain 
by E11.5 (Chiang et al., 1996), confirming its requirement. In the absence of Shh, floor plate 
cells were not present, suggesting that Shh is required for the induction of the floor plate 
(Chiang et al., 1996). Several studies have postulated an antagonistic effect between the 
canonical WNT signalling and the SHH pathway in mDA development. Shh expression is 
maintained in the ventral midbrain when ß-catenin was conditionally abolished by Shh-Cre 
(Joksimovic et al., 2009) whereas in mouse embryos with Shh-Cre-mediated expression of 
stabilized ß-catenin resulted in a reduction of Shh and its target genes (Tang et al., 2010). In 
contrast, Chung et al (2009) recently reported that overexpression of the WNT and SHH 
target genes Oxt2, Lmx1a, and Foxa2 significantly promoted the generation of mDA neurons 
during in vitro differentiation assuming a synergistic interaction of the SHH and WNT 
pathways (Chung et al., 2009).  
FOXA2 
FOXA2 is a forkhead/winged helix transcription factor. During embryonic development, it is 
expressed within the central nervous system in the node, the notochord and floor plate 
(Sasaki and Hogan, 1993). The expression of Foxa2 can be induced by SHH via activation 
of GLI1 (Hynes et al., 1997; Ruiz i Altaba, 1998; Sasaki and Hogan, 1994; Sasaki et al., 
1997). Mouse embryos where Foxa2 expression is abolished show an absence of the node 
and notochord (Ang and Rossant, 1994; Weinstein et al., 1994). As a consequence of the 
missing notochord, the SHH signalling is absent therefore the floor plate is not formed (Ang 
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and Rossant, 1994). Two independent studies on conditional Foxa1 and Foxa2 double 
mutant mouse embryos have demonstrated that Foxa1/2 regulate the expression of 
midbrain-specific developmental factors such as Lmx1a/b, Nurr1, TH, and Ngn2 (Ferri et al., 
2007; Lin et al., 2009). Moreover, it was reported that forced expression of Foxa2 in 
differentiating mouse ES cells and NPCs resulted in a significant increase of TH positive 
neurons (Kittappa et al., 2007; Lee et al., 2010). Together, these data suggest a central role 
of FOXA2 in mDA development.  
1.2.5 Genes regulating midbrain dopaminergic development 
LMX1A 
LMX1A is a member of the LIM homeodomain transcription factor family. The expression of 
Lmx1a is initiated at around E9.5 and maintained in differentiated NURR1 and LMX1B 
double positive DA neurons (Andersson et al., 2006b). In the chick, Lmx1a appears to be 
crucial for mDA development, as knock-down of Lmx1a using siRNA reduces the number of 
postmitotic NURR1/LMX1B double positive DA neurons (Andersson et al., 2006b). In 
contrast, loss of Lmx1a in mice results in only minor mDA defects (Ono et al., 2007). 
Additionally, forced expression of Lmx1a in stably transformed mouse ES cells increases the 
number of mDA neurons during in vitro differentiation shown by the mDA neuronal identity 
seen in 75-95% of the derived neurons (Friling et al., 2009).  
SHH appeared to be an inducer of Lmx1a since chick midbrain explants exposed to SHH 
show an increase of LMX1A positive cells (Andersson et al., 2006b). However, a recent 
study reported an induction of Lmx1a by WNT signalling, independent of SHH signalling 
(Chung et al., 2009).  
LMX1A induces the expression of Msx1 which inhibits expression of negative regulators of 
neurogenesis, such as Nkx6.1, and induces the neurogenic factor, Ngn2 (Andersson et al., 
2006b). Notably, the same study showed that Msx1 is neither necessary nor sufficient for 
mDA generation. Additional pathways may function downstream of LMX1A. Indeed, Chung 
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et al. (2009) showed a direct regulation of Otx2, Pitx3, and Nurr1 by LMX1A (Chung et al., 
2009). 
NURR1 
NURR1 is an orphan nuclear receptor which belongs to the conserved family of ligand-
activated transcription factors (Aranda and Pascual, 2001; Giguere, 1999; Perlmann and 
Wallen-Mackenzie, 2004). At E10.5, it is expressed in the ventral midbrain before the onset 
expression of the DA marker TH (E11.5). Its expression continues into adulthood in mDA 
neurons (Saucedo-Cardenas et al., 1998; Smidt et al., 1997; Wallen et al., 1999; Zetterstrom 
et al., 1997). Analysis of Nurr1 knock-out mice revealed that NURR1 has multiple roles 
during mDA development.  
Firstly, it regulates the transcription of genes involved in maintenance and survival of mDA 
neurons such as the receptor tyrosine kinase (Ret) which in turn responds to trophic factors 
such as glial cell line-derived neurotrophic factor (GDNF) (Galleguillos et al., 2010; 
Kadkhodaei et al., 2009; Perlmann and Wallen-Mackenzie, 2004; Saucedo-Cardenas et al., 
1998; Smits et al., 2003; Zetterstrom et al., 1997). Secondly, it regulates the transcription of 
the genes which determine the DA neuron transmitter phenotype such as TH, the vesicular 
dopamine transporter 2 (Vmat2), and the DA transporter (Dat). In this context, 
overexpression of Nurr1 in immortalized neural stem cells and in ESCs during differentiation 
specifies cells towards DA lineage (Chung et al., 2002; Kim et al., 2002; Kim et al., 2003; 
Lee et al., 2010; Sakurada et al., 1999). This leads to the suggestion that other factors are 
required to direct the DA precursor cells into mature mDA neurons. 
PITX3 
The paired-like homeodomain transcription factor Pitx3 has a tightly regulated expression in 
the SN and VTA in the brain where it is first detected at E11.5 (Smidt et al., 1997). 
Furthermore, DA cells in the SN express PITX3 prior to TH, whilst it sequence is reversed for 
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DA cells of the VTA (Maxwell et al., 2005). Accordingly, Pitx3 deficiency resulted in the 
preferential loss of SN TH positive neurons during foetal development (Smidt et al., 2004). 
 
1.3 Strategies for neural differentiation in vitro of pluripotent stem 
cells 
 
So far, there are three types of protocols being used for differentiating ES cells towards a 
neuronal fate. These protocols are typically used to initiate a general differentiation 
programme and in recent years have been modified to include instructive factors that direct 
more lineage-specific neuronal differentiation, including the DA phenotype. 
1.3.1 Embryoid body differentiation 
This approach is based on the formation of embryoid bodies (EB) that are similar to the ICM 
of a blastocyst as it consists of an outer hypoblast-like layer and an epiblast-like core which 
is capable of differentiation into tissue of all three germlayers (Coucouvanis and Martin, 
1995; Keller, 2005; Keller, 1995). The EB differentiation protocol can be divided into four 
main steps: 1) Differentiation of ES cells into EBs containing all three germ layers. 2) 
Enrichment of the neuroectodermal fate by inhibiting mesodermal cells using selection 
medium. 3) Expansion and maintenance of neural precursor cells in the presence of FGF2 
followed by an induction of DA neural cell fate using Ascorbic acid and the two morphogens 
SHH and FGF8. 4) Induction of neuronal differentiation in serum free medium. It has been 
demonstrated that over 30% of neurons express TH (Lee et al., 2000b). However, it is still 
unclear to what extent these cells represent a midbrain DA phenotype.  
1.3.2 Stromal co-culture system 
Neural differentiation of ESCs has been shown to be induced by the stromal derived 
inducing activity (SDIA). This method involves the use of the skull bone marrow derived 
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stromal cell line PA6 (Kodama et al., 1986) that efficiently induces neuronal differentiation of 
ESCs with a high proportion of TH positive neurons (Kawasaki et al., 2000). About 30 % 
neurons were TH positive of which only 10-15% displayed a midbrain DA phenotype 
(Kawasaki et al., 2000; Kawasaki et al., 2002; Zhao et al., 2004). The nature of SDIA is still 
not known. It was suggested that SDIA may be a secreted factor that is secondarily bound to 
the cell surface, as treatment with Heparin removes the neural inducing activity and neural 
differentiation is still induced in the absence of physical contact to ESC.  
1.3.3 Monolayer differentiation 
In this method, undifferentiated ES cells are dissociated and plated at a low density onto 
gelatinised culture plates in chemical-defined N2B27 medium (Ying and Smith, 2003; Ying et 
al., 2003b). Through this method, it was demonstrated that about 75% cells express the 
neuroepithelial marker SOX1 by day 3 and 4 (Ying and Smith, 2003; Ying et al., 2003b). 
Only few TH positive cells are generated but the number of DA neurons can be significantly 
increased by the addition of SHH and FGF8 (Ying and Smith, 2003; Ying et al., 2003b). The 
serum-free chemical-defined condition of this protocol allows studies of the role of signalling 
molecules in neural differentiation. 
 
1.4 FGF pathway 
 
Fibroblast growth factor ligands and receptors are involved in diverse processes of early 
brain development including antero-posterior patterning, cell proliferation, survival and 
migration (Oki et al., 2010; Partanen, 2007; Sun et al., 1999).  
1.4.1 FGF ligands 
Fibroblast growth factors (FGF) are secreted glycoproteins. They are structurally related as 
they share a central core of ~120 amino acids and a high affinity for Heparin and Heparan 
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sulphate proteoglycans (Itoh and Ornitz, 2004; Ornitz and Itoh, 2001). The family includes 23 
members (FGF1-23) of which FGF19 has not been identified in mouse yet (Itoh and Ornitz, 
2004; Ornitz, 2000; Ornitz and Itoh, 2001). FGFs can be divided into 7 groups by 
phylogenetic and gene-location analysis (Table 1). In terms of their manner of action, they 
can be further sorted into hormone-like (FGF19: FGF19/21/23), intracellular (FGF11: 
FGF11-14) and canonical FGFs (FGF1: FGF1-2; FGF4: FGF4-6; FGF7: FGF3/7/22; FGF9: 
FGF9/16/20; FGF8: FGF8/17/18) whereby the canonical FGFs mediate the signal into the 
cell by binding Fibroblast growth factor receptors (FGFR) (Itoh and Ornitz, 2004, 2008).  
1.4.2 FGF receptors 
The FGFRs are single transmembrane proteins. The extracellular region contains the Ig-like 
domain that is required for binding the FGF ligands. The intracellular domain of FGFRs holds 
the domain responsible for the tyrosine kinase activity. There are five FGFRs (FGFR1-5). It 
is worth noting that FGFR5 does not have a tyrosine kinase domain and therefore might be 
involved in other processes (Wiedemann and Trueb, 2000). The FGFRs undergo alternative 
splicing in their extracellular domain in order to achieve a large variety of receptors with 
diverse affinities and specificities for their ligands (Powers et al., 2000; Zhang et al., 2006). 
After receptor-ligand binding, the receptors dimerise and mediate the signal into the cell by 
structural alterations that in turn activate the intracellular kinase domain and result in 
phosphorylated tyrosine residues inducing downstream signalling pathways such as 
Mitogen-activated protein kinases (MAPK/ERK), Phosphatidylinositol-3 kinase (PI3K) and 
Phospholipase C gamma (PLC-γ) (Figure 1.3 A) (Beenken and Mohammadi, 2009; 
Eswarakumar et al., 2005; Powers et al., 2000; Turner and Grose, 2010). 
1.4.3 FGF signalling 
The PLC-γ pathway is induced when phospholipase C-γ binds to the intracellular 
phosphorylated domain of FGFR (Burgess et al., 1990; Mohammadi et al., 1992; 
Mohammadi et al., 1991; Peters et al., 1992). Activated PLC-γ then hydrolyses 
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Phosphatidyl-inositol-4,5-bisphosphate to inositol trisphosphate (IP3) and Diacylglycerol 
(DAG) (Klint and Claesson-Welsh, 1999). IP3 cause the release of calcium from the 
endoplasmic reticulum, while DAG stimulates protein kinase C (PKC). In Xenopus, this 
pathway has been suggested to be involved in the caudalization of neural tissue by fgfr4 
(Umbhauer et al., 2000). 
Before activation of PI3K, FGFR substrate 2 (FRS2 also known as SNT1) binds to the 
phosphorylated FGFR allowing the phosphorylation of FRS2 (Hadari et al., 2001; Xu et al., 
1998). As a consequence, Growth factor receptor-bound 2 (GRB2) recognise the 
phosphorylated sites of FRS2 and forms a complex in order to recruit the GRB2 associated 
binding protein 1 (GAB1) and subsequently induces the PI3K pathway (Hadari et al., 2001; 
Kim et al., 1994; Kim et al., 1998; Kouhara et al., 1997; Ong et al., 2000; Ong et al., 2001; 
Rodrigues et al., 2000; Xu et al., 1998). Activated PI3K leads to the generation of 
Phosphatidylinositol -3, 4, 5-tripphosphate (PIP3) via phosphorylation of 
Phosphatindylinositol-4,5-diphosphate (PIP2) (Denley et al., 2009; Rodriguez-Escudero et 
al., 2005; Whitman et al., 1988; Whitman et al., 1987). PIP3 mediates the translocation of 
the serine/threonine kinase AKT1 (also called protein kinase B) to its membrane-bound 
activator, the Phosphoinositide-dependent kinase (PDK1) (Fayard et al., 2010; Rodriguez-
Escudero et al., 2005).  
The MAPK/ERK pathway also requires the activation of the multi-protein complex FGFR-
FRS2-GRB2. To induce the GTP binding protein RAS, GRB2 binds the adopter protein Son 
of sevenless (SOS) which drives the exchange of GDP for GTP in RAS (Clark et al., 1992; 
Kouhara et al., 1997; Lowenstein et al., 1992; Schlessinger, 1994). RAS then stimulates the 
MAPK/ERK pathway consisting of RAF1, RAC1, MEKKs (also called MAPKKK), MEK (also 
known as MAPKK), and ERK1/2 (extra-cellular signal-regulated kinases, alias MAPK) 
(Gardner et al., 1994; Kouhara et al., 1997; Marshall, 1995). This cascade controls the 
phosphorylation of target transcription factors which initiate expression of genes such as c-
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Myc or Cyclin D1 (Balmanno and Cook, 1999; Chuang and Ng, 1994; Lavoie et al., 1996; 
Sears et al., 1999; Terada et al., 1999). 
1.4.4 FGF modulation 
Initial studies in Zebrafish and Xenopus identified several Fgf target genes that share the 
same expression pattern as Fgf activity and are supposed to be in a negative feedback loop 
with FGF signalling (Gawantka et al., 1998; Kudoh et al., 2001): Sprouty (spry1-4) 
(Furthauer et al., 2001; Kramer et al., 1999), Sprouty related EVH1 domain proteins 
(spreds1-3) (Wakioka et al., 2001), Map kinase phosphatase 3 (mkp3) (Groom et al., 1996), 
sef (Furthauer et al., 2002; Lin et al., 2002; Tsang et al., 2002) and Fibronectin-leucine-rich 
transmembrane protein 3 (flrt3) (Bottcher et al., 2004). 
Gain of function studies in mouse showed an antagonistic role of Spry in FGF signalling 
(Mailleux et al., 2001; Minowada et al., 1999). It was shown that SPRY is able to interfere 
with the FGF signalling in two different ways: 1) Inactivation of GRB2 (Hanafusa et al., 2002) 
or 2) Inhibition of RAF and consequently preventing the activation of the MAPK/ERK 
pathway (Sasaki et al., 2003).  
SPRY and SPRED proteins share a cisteine-rich domain at the C terminus (Kato et al., 
2003; Wakioka et al., 2001). However, the mechanism of SPREDs in inhibition of FGF 
signalling has not been identified yet. Most likely SPRED proteins interfere with FGF activity 
by binding RAF and/or RAS (Sasaki et al., 2003; Wakioka et al., 2001). 
In agreement with the initial results for fgf target genes in Zebrafish and Xenopus, studies in 
mouse confirmed that MPK3 (also called PYST1 or DUSP6) also has an antagonistic role in 
FGF signalling (Urness et al., 2008). Moreover, it has been demonstrated that MKP3 inhibits 
the MAPK/ERK pathway via inactivation of ERK1/2 (Urness et al., 2008). Its expression 
pattern is very similar to that of the Fgf8 indicating a regulatory effect of FGF8 on Mkp3 
expression (Eblaghie et al., 2003; Kawakami et al., 2003; Vieira and Martinez, 2005). 
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The transmembrane protein SEF, one of the other feedback regulators of FGF originally 
identified in zebrafish, prevents FGF signalling via FGFR1 as overexpression of Sef resulted 
in a reduced phosphorylation of FGFR1 (Kovalenko et al., 2006; Kovalenko et al., 2003). 
 
1.4.5 Multiple roles of the FGF pathway during neural development 
FGF signalling has been shown to be involved in neural induction (Alvarez et al., 1998; 
Hudson and Lemaire, 2001; Inazawa et al., 1998; Kengaku and Okamoto, 1995; Kudoh et 
al., 2004; Lamb and Harland, 1995; Rodriguez-Gallardo et al., 1997; Storey et al., 1998) but 
whether FGF signalling is necessary to initiate the neuroepithelium fate is still controversial 
((Alvarez et al., 1998; Kengaku and Okamoto, 1995; Lamb and Harland, 1995; Storey et al., 
1998; Streit et al., 2000) vs (Ribisi et al., 2000; Wills et al., 2010)). In the stem cell model, a 
blockade of FGF signalling via the MAPK/ERK pathway is required for maintaining mESCs in 
a pluripotent state (Silva et al., 2008a; Ying et al., 2008) and thus activation of this pathway 
drives ESCs into differentiation (Kunath et al., 2007; Stavridis et al., 2007). In this context, 
Kunath et al. (Kunath et al., 2007) suggest that ERK dependent FGF signalling is required 
for the exit from an ICM-like state toward epiblast ectoderm, whereas Stavridis et al. (2007, 
2010) argue that this signalling acts in the transition of epiblast-like cells to neural 
progenitors. Additionally, other studies demonstrated that FGF signalling modulates BMP 
signalling which in turn promotes neural induction (Marchal et al., 2009; Pera et al., 2003; 
Stuhlmiller and Garcia-Castro, 2011). However, beyond the controversial role of FGF 
signalling in neural induction, a consensus is emerging that FGF signalling does play an 
important role during the induction of the posterior nervous system (Cox and Hemmati-
Brivanlou, 1995; Doniach, 1995; Holowacz and Sokol, 1999; Kengaku and Okamoto, 1995; 
Lamb and Harland, 1995; Rentzsch et al., 2004; Ribisi et al., 2000; Wills et al., 2010). 
Several independent studies demonstrated that, FGF2 or FGF8 induce hindbrain 
characteristics in explants of forebrain tissue (Cox and Hemmati-Brivanlou, 1995; Crossley 
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and Martin, 1995; Crossley et al., 1996; Irving and Mason, 2000; Kengaku and Okamoto, 
1995; Lamb and Harland, 1995; Martinez et al., 1999). Reinforcing the link that FGF 
signalling is involved in caudalisation of the neuroectoderm, mouse embryos at E~7.5 
lacking Fgf8 or exposed to small molecules blocking FGF signalling show an increase of the 
anterior tissue markers Otx2 and Six3 and a reduction of the hindbrain marker Gbx2 (Oki et 
al., 2010; Sun et al., 1999).  
Analysis of the spatial and temporal patterns of phosphorylated ERK during early mouse 
development uncovered an activation of ERK midbrain-hindbrain boundary at E8.5-10.5 
which coincides with the expression of Fgf8 (Crossley and Martin, 1995). When the embryos 
were exposed to FGFR specific inhibitors the phosphorylated ERK domain at the MHB was 
lost (Corson et al., 2003) implying that FGF acts via the MAPK/ERK pathway in mDA 
development.  
So far only five FGF ligands have been shown to be expressed in embryos at gastrulation: 
FGF3 (Niswander and Martin, 1992; Wilkinson et al., 1988); FGF4 (Hebert et al., 1990; 
Niswander and Martin, 1992); FGF5 (Goldfarb et al., 1991; Haub and Goldfarb, 1991; Hebert 
et al., 1991); FGF8 (Crossley and Martin, 1995; Mahmood et al., 1995) and FGF17 
(Maruoka et al., 1998). Of these ligands, Fgf3, Fgf5, and Fgf17 null mutant mice are viable 
and fertile (Hebert et al., 1994; Mansour et al., 1993; Xu et al., 2000) whereas homozygous 
Fgf4 mutant mouse embryos die shortly before gastrulation starts (Feldman et al., 1995). 
Mouse embryos lacking Fgf8 are also not viable and die around E9.5 (Sun et al., 1999). As 
already mentioned above, besides the defects in the mesoderm and endoderm, Fgf8 null 
embryos display an expansion of factors that are expressed in the anterior region of the 
developing embryo such as Otx2 and Six3 and a reduction of Gbx2, a marker for the 
presumptive hindbrain (Sun et al., 1999). 
Furthermore, Fgfr1 and Fgfr2 are expressed and required at gastrulation stage shown by the 
death of gastrulating embryos lacking one of these genes (Arman et al., 1998; Deng et al., 
1994; Orr-Urtreger et al., 1991; Yamaguchi et al., 1992; Yamaguchi et al., 1994). As the 
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phenotypes of Fgf8 and Fgfr1 mutants are similar, FGFR1 is considered to be the receptor 
of FGF8.  
 
1.5 Hypthesis and aims 
 
Effective induction of mDA neurons from stem cells is fundamental for realising their 
potential in biomedical applications for neurodegenerative diseases such as PD. This thesis 
focuses on the temporal actions of FGF signalling in mDA neuron fate specification of mouse 
PSCs. During early stages of neural development, FGF is involved in the formation of the 
hindbrain and forebrain. Therefore we supposed that inhibition of FGF activity guides PSCs 
into midbrain fate including the cell population from where mDA neurons arise. To study the 
effects of FGF blockade during DA neuron differentiation in vitro, I used mouse EpiSCs. I 
supposed that these cells potentially offer a better and more synchronised in vitro 
differentiation model than mouse ESCs. Therefore, I firstly validated mouse EpiSCs as an 
alternative model to study neural differentiation in vitro. Secondly, I investigated the effects 
of FGF/ERK inhibition during mDA neural differentiation of EpiSCs. Lastly, I demonstrate the 
functional capability of mouse EpiSC-derived mDA neurons in vitro and in vivo.   
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Figure 1.1 Schematic illustration of the signalling centres which establish the antero-
posterior axis.  
These centres are characterised by their complex expression of Shh, marked in blue, Fgf8, 
labelled in red, the BMP antagonists Chordin and Noggin (in ANR, not shown), and Wnt1, 
displayed in green. (Echevarria et al., 2003) 
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Figure 1.2 Drawing of midbrain DA neural development 
(A) Cell lineage specification into the three germlayers takes place during gastrulation from 
E~6.5. From E8.5-11, patterning factors such as FGF8, WNT1, and SHH are essential to 
induce the gene expression of transcription factors that guide the cells into mDA neurons. 
First mDA neurons are born around E11.5 when TH expression is initiated. (B) Timescale 
showing the expression of factors related to development of mDA neurons. Dashed lines for 
Dmrt5 indicate that this gene isnot expressed in cells becoming mDA neurons.   
sagittal section 
of the midbrain 
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Figure 1.3 Schematic illustration of the pathways implicated in the generation of mDA 
neurons. 
(A) FGF pathway. (B) WNT/ß-catenin pathway. (C) SHH pathway. PD0325901, PD173074 
and CHIR99021 are small molecules that modulate the pathways by specific inhibition of the 
indicated enzymes.  
  
A) 
B) 
C) 
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Table 1.1 The 23 members of the FGF family can be divided into 7 groups according 
their evolutionary relationship and and gene-location analysis. 
Family Members 
FGF1 FGF1, FGF2 
FGF4 FGF4, FGF5, FGF6 
FGF7 FGF3, FGF7, FGF22 
FGF9 FGF9, FGF16, FGF20 
FGF8 FGF8, FGF17, FGF18 
FGF19 FGF19, FGF21, FGF23 
FGF11 FGF11, FGF12, FGF13, FGF14 
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2 Materials and Methods 
2.1 Cell Culture 
 
Unless stated otherwise reagents and materials for tissue culture were purchased from 
Invitrogen, Nunc, or Sigma.  
All steps were carried out inside a laminar flow sterile hood (Nuaire) to avoid contamination. 
Cells were incubated at 37°C with 5% CO2 in a humidified incubator (Sanyo). 
2.1.1 Routine ESC and iPSC culture  
Culture dishes were coated for at least 30 min with 0.1% Gelatine in PBS at room 
temperature. ESCs and iPSCs were propagated on gelatinized culture dishes in 1x Glasgow 
minimum essential medium (GMEM) supplemented with 10% (v/v) foetal calf serum (FCS), 
1 mM sodium pyruvate, 1x non-essential amino acid (NEAA), 2 mM l-glutamine, 0.1 mM 
ß-mercaptoethanol, and 100 units/ml leukaemia inhibitory factor (LIF) which was prepared in 
house by transfecting COS-7 cells with a human LIF expression plasmid. The culture was 
passaged every 2 to 3 days.  
ESCs and iPSCs used in this thesis can be found in Table 2.1.  
2.1.2 Derivation of EpiSC from ESC 
ESCs were plated at three different cell densities on gelatinized culture dishes in ESC 
medium (1x104, 1x105, and 1x106 cells/cm²). The day after, ESCs were washed twice with 
PBS and cultured in retinol-free N2B27 medium with 10 ng/ml FGF2 (Peprotech) and 
20 ng/ml Activin A (R&D). The composition of N2B27 was 50% DMEM/F12 and 50% 
Neurobasal supplemeted with 1:200 N2 and 1:100 B27 supplements. Cells were passaged 
every 2-3 days as EpiSCs. After ~5 passages, cultures should become more homogenous 
and EpiSC-like.  
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2.1.3 Routine EpiSC culture  
EpiSCs were routinely passaged every 2 days. Cells were incubated in PBS without 
magnesium and calcium for ~3 min at room temperature. PBS was then gently replaced by 
retinol-free N2B27 medium with 10 ng/ml FGF2 (Peprotech) and 20 ng/ml Activin A (R&D). 
EpiSCs were mechanically dissociated and seeded into plates which were coated either with 
FCS or 15 µg/ml Fibronectin (Millipore) for 30 min at 37°C and washed twice with PBS. After 
2 days in culture, the surviving EpiSCs formed large compact, flattened colonies. 
2.1.4 Freezing ESCs, iPSCs and EpiSCs 
Cells in tissue culture dishes were harvested as described above and centrifuged for 5 min 
at 1000 rpm. Cells were resuspended in freezing medium consisting of 10% dimethyl 
sulphoxide (DMSO) and culture medium and transferred into a cryotube. Tubes were placed 
in a styropor box at -20°C for ~3 hours and then at -80°C for overnight. The next day, cells 
were transferred to a liquid nitrogen cell bank. 
2.1.5 Thawing ESCs, iPSCs and EpiSCs 
Frozen cryotubes were retrieved from liquid nitrogen storage and placed immediately into 
37°C water bath. Once the cells were thawed, they were transferred into 9.5 ml warm media 
to dilute out the DMSO. The cell suspension was then centrifuged for 5 min at 1000 rpm and 
the cells were gently resuspended in the appropriate media and transferred to suitable 
culture plates. The media was then refreshed about 10 hours later to remove any dead cells 
and dilute out the remaining DMSO.  
2.2 Neural differentiation 
 
Monolayer differentiations (MD) from ESCs and iPSCs were carried out as decribed by Ying 
et al. (2003). Briefly, MD of ES cells was performed on 0.1% Gelatine pre-coated plates. 
Routinely, 0.5-1.5x104 cells/cm2 were plated in retinol-free N2B27 medium that consisted of 
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50% DMEM/F12 and 50% Neurobasal and was completed with 1:200 N2 and 1:100 B27 
supplements. Medium was changed every other day. According to their characteristic 
morphology, first neurons could be seen around day (d) 5 of differentiation. During the 
course of differentitiation the number of cells highly increases. Therefore, cells were replated 
between d5 and d8 of differentiation on poly-L-Lysine and Laminin coated dishes to obtain 
an optimal yield of neurons. Plates were incubated in 0.002% solution of poly-L-Lysine for 2 
hours at 37°C, rinsed twice with PBS and then covered with 10 µg/ml Laminin for 1 hour at 
37°C.  
For neural differentiation of EpiSCs, EpiSCs were plated on Fibronectin-coated plates and 
cultured in EpiSC media until cells reached a confluency of 60-80%. If the densitiy was too 
low, cells differentiated into non-neuronal cells with a big flat morphology which persisted 
and increased during the whole course of differentiation. Cells were rinsed twice with PBS 
and cultured in retinol-free N2B27. The day cells were switched to retinol-free N2B27 is 
designated as d0 MD. Due to the initial high number of EpiSCs at d0, half of the medium 
was replaced by fresh medium at d1. As a result of the high cell densitiy and continuing 
proliferation, cells formed a 3-dimensional layer by d2 of differentiation. At this stage, cells 
were gently rinsed and incubated for few seconds in PBS. Cells were mechanically 
dissociated in retinol-free N2B27 medium and seeded onto Fibronectin pre-coated plates at 
different dilutions from 1:3 to 1:6. The optimal plating densitiy for the generation of mDA 
neurons is 1:6 but this can slightly vary between cell lines. Medium was changed every other 
day, as with ESC differentiation. Cells were not further replated during differentiation as this 
might reduce the already existing neuronal cell population.  
Factors and chemicals used for MD as indicated elsewhere in the chapters can be found in 
Table 2.2.  
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2.3 Flow cytometry  
 
I used flow cytometry sorting to establish GFP profiles at different stages during neural 
differentiation. Cells were trypsinised and resuspended in PBS with 10% FCS. Cells were 
washed twice in PBS. Then, cells were immediately resuspended in 2% paraformaldehyde 
(PFA) and fixed for 15 min at 4°C. After washing with high volume of PBS, cells were 
resuspended in sorting buffer (1 mM EDTA, 25 mM HEPES pH7, 1% FCS in PBS without 
Ca2+ and Mg2+). To ensure that the cells are single cells, the cell suspension was transferred 
into tubes by passing through cell-strainer caps (BD Falcon). Cells were kept on ice and 
analysed with BD LSRII (Becton Dickison Biosciences), BD FACS Divaaria software (Becton 
Dickison Biosciences) and FlowJo v7.6.5 (TreeStar). The analysis was supervised by Phil 
Huxley in Flow Cytometry of MRC Clinical Sciences Centre, London. 
2.4 Electophysiological studies 
 
D14-16 MD cultures derived from Pitx3-GFP EpiSCs were placed on a recording chamber 
and viewed using an Olympus BX51WI microscope with a 40x water immersion lens and 
DIC optics. Cells were bathed in a solution containing: 140 mM NaCl, 3.5 mM KCl, 1.25 mM 
NaH2PO4, 2 mM CaCl2, 1 mM MgCl2, 10 mM Glucose, and 10 mM HEPES. For whole-cell 
electrophysiological recordings, low resistance recording pipettes (9-12 MΩ) were pulled 
from capillary glass (Harvard Apparatus Ltd.) and coated with ski wax to reduce pipette 
capacitance. Recording pipettes were filled with a solution containing: 140 mM K-gluconate, 
5 mM NaCl, 2 mM Mg-ATP, 0.5 mM LiGTP, 0.1 mM CaCl2, 1 mM MgCl2, 1 mM ethylene 
glycol-bis (b-aminoethyl ether) -N,N,N',N'-tetraacetic acid (EGTA), and 10 mM HEPES. 
Osmolarity and pH of both solutions were adjusted before experiments. Prior to recording, 
the GFP positive neurons were identified for recording using fluorescence via a GFP 
selective filter (X-Cite series 120, EXFO). Data were acquired at room temperature (20 - 
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22°C) using an Axon Multiclamp 700B amplifier and a Digidata 1440a acquisition system, 
with pClamp 10 software (Molecular Devices). Data analysis was carried out using Clampfit 
10.2 software (Axon Instruments), OriginPro 8.1 (OriginLab Corporation), and Spike2v5 
software (Cambridge Electronic Design). Data are presented as the mean ± sem (standard 
error of the mean). This work was performed and analysed by Dr. Jessica Risner-Janiczek 
from our group.  
2.5 Animal work 
 
The studies on mice were carried out by Andreas Heuer and Dr. Sophie Precious from the 
research group of Prof. Steve Dunnett at the Cardiff University. 
2.5.1 Animals 
Male adult mice of the C57/Black 6 strain (Charles River, UK) were used that were 20-25 g 
at the start of the experiment. All animals were housed in standard laboratory cages in 
groups of 4-6 with access to food and water ad libitum. All procedures were in accordance to 
the UK Scientific Procedures (1986) Act and to local ethical review. 
2.5.2 Lesion surgery 
Animals were placed into an induction box where anaesthesia was induced by 5% isoflurane 
using oxygen as carrier gas. Subsequently the head of the animal was shaved and cleaned 
and the mouse was placed into a sterotaxic frame (Kopf instruments) with the incisior bar set 
to 0.0mm on the intra-aural line. Anaesthesia was maintained via a nose mask delivering 1-
2% isoflurane in a 2:1 mixture of O2/NO. 
Lesions were performed by unilateral infusions of the neurotoxin 6-hydroxydopamine, also 
called 6-OHDA, at a concentration of 6 µg/µl calculated from free-base weight 
(hydrobromide salt, Sigma Chemicals, UK) in a solution of 0.9% sterile saline in 0.2 mg/ml 
Ascorbic acid. Lesions were aimed at the medial forebrain bundle at the sterotaxic 
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coordinates AP: -1.2, ML: -1.2, DV: -4.75. 1 µl of 6-OHDA was delivered via a 30-gauge 
stainless steel cannula connected via polyethylene tubing to a 10 µl Hamilton syringe which 
was mounted on a microdrive pump. The infusion rate of the toxin was 0.5 µl/min and the 
injection needle was left in place for an additional 3 min to allow for diffusion of the toxin 
before careful retraction of the needle. At the end of each surgical session the wound was 
cleaned and sutured and the animal was given a subcutaneous injection of 0.5 ml 0.9% 
sterile saline containing 4% glucose and 0.03 ml Metacam as analgesic.  
For 14 days post lesion the animals’ body weights were recorded and all lesioned animals 
received injections of glucose-saline (0.5 ml) three times daily in addition to wet palletable 
food during the post-lesion recovery period.  
2.5.3 Graft surgery 
Preparation for the surgery was as described above. Graft placement was performed at 
coordinates AP: +0.8, ML: -1.9, DV: -3.0 and -2.8. Cells were implanted via injection through 
a 10 µl Hamilton syringe at a density of 300.000 cells in 2 µl at a flow rate of 1 µl/min with an 
additional 3 min allowed for diffusion.  
For grafting of the primary fetal tissue, pregnant C57/Bl6 dams were sacrificed and the 
embryos (E12.5) removed from the amniotic sack. The ventral mesencephalic area was 
dissected and pooled from all pups that were dissected. Cells were ezymatically dissociated 
by incubation in trypsin for 10 min at 37°C followed by mechanical dissociation into a quasi-
single cell suspension. After inhibition of trypsin, the cells were centrifugated and 
resuspended to the required concentration of 150.000 cells per microliter.  
2.5.4 Drug-induced rotations 
Mice were injected with methamphetamine (2.5 mg/kg; Sigma) before they were placed into 
automated rotometer bowls, designed after the model by Ungerstedt (Ungerstedt and 
Arbuthnott, 1970). The machine recorded the rotations over a period of 60 min. Data were 
expressed as average net number of rotations per min.  
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2.6 Molecular biology methods  
 
Unless otherwise stated analytical grade chemicals were obtained from Sigma, Fisher or 
BDH Laboratory Supplies (Merck Ltd). Stock solutions were prepared with reverse osmosis 
purified water and filtered or autoclaved as necessary. Agarose for electrophoresis was 
supplied by Invitrogen. Synthetic oligonucleotides were synthesised by Sigma.  
2.6.1 Quantitative PCR 
Total RNA was extracted using TRIReagent (Sigma) and reverse transcribed using the 
Quantitect RT kit (Qiagen). Remaining RNA was removed afterwards by RNase H 
(2 units/µl, Invitrogen). qPCR was performed using iQ™SYBR®Green Supermix (Biorad) on 
a Chromo4-detection system (Biorad). To validate the primers, I included five serial dilutions 
(in steps of 2-fold) of a positive control cDNA from a whole mouse embryo at E12. Synthetic 
oligonucleotides were synthesised by Sigma (Genosys, Table 4). All PCR data were 
normalized to the average of the reference genes Cyclophillin and Hmbs. In addition to 
normalisation to reference genes, a reference sample was chosen as the calibrator. The 
relative expression of all samples in the assay was given in relation to the calibrator.  
Primers used to study neural differentiation can be found in Table 2.3.  
2.6.2 Protein extraction and quantification 
Cells were washed twice with PBS (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4 x7H2O, 
1.4 mM KH2PO4, pH 7.4) and lysed in lysis buffer containing 10 mM Tris-HCl (pH8.0, Fisher), 
50 mM EDTA (Fisher), 100 mM NaCl (BDH) and 0.5% sodium dodecyl sulfate (SDS, Fisher). 
RC DC Protein Assay kit from Biorad was used to measure the protein concentration. 
Albumin from bovine serum (BSA, Sigma) was used as protein standard.  
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2.6.3 Western Blot analysis 
The SDS PAGE was carried out using the Mini-PROTEAN®3 system from Biorad following 
manufacture’s instructions. 10% polyacrylamide separating gel and a 4.3% polyacrylamide 
stacking gel were used in a discontinuous buffer system. Protein was loaded into the well of 
a SDS-gel and ran for 45 min at 150 V in running buffer consisting of 0.025 M Tris, 0.25 M 
glycine, and 0.1% SDS. 
Separated proteins in SDS-gel were transferred using semidry transfer cell (Trans-Blot SD, 
Biorad) in transfer buffer (3.9 mM glycine, 4.8 mM Tris, 0,037% SDS, 20% methanol) to 
nitrocellulose membrane (GE healthcare) for 1 hour at 15 V and constant 0.27 A (for two 
gels á 9x6 cm). Then membrane was blocked in PBS (137 mM NaCl, 2.7 mM KCl, 4.3 mM 
Na2HPO4x7H2O, 1.4 mM KH2PO4, pH 7.4) containing 0.1% Tween 20 (hereafter called 
PBST) and 3% dried non-fat milk (blocking solution) for 1 hour at room temperature on a 
rotator. The membrane was incubated with primary antibody in the appropriate dilution in 
blocking solution at 4°C for over night. After washing with PBST, the membrane was 
incubated with horseradish peroxidase (HRP)-conjugated secondary antibody for 1 hour at 
room temperature. The signals were then detected with enhanced chemiluminescence 
(Roche) and Hyperfilm ECL (GE Healthcare). Primary antibodies used for Western Blot were 
rabbit anti-pERK (1:1000, Cell Signalling) and rabbit-anti ERK1/2 (1:500, Cell Signalling). 
Secondary antibodies were donkey anti-rb IgG-HRP (1:2000, Santa Crusz). 
2.6.4 Immunofluorescence staining 
Cells were washed twice with PBS (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4 x7H2O, 
1.4 mM KH2PO4, pH 7.4) and fixed in 4% PFA at room temperature for 10 min. Then, they 
were washed with PBS-0.3% TritonX-100 (PBST) three times for 5 min each. Fixed cells 
were blocked in blocking solution consisting of PBST and 5% normal serum for 10 till 20 min 
followed by incubation over night with primary antibodies. Cells were washed three times 
with PBST followed by incubation for 1 hour with fluorescence-labelled secondary antibodies 
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(1:200, Invitrogen). Again, cells were washed with PBST three times and counterstained with 
DAPI (1:1000, Molecular Probes).  
Primary antibodies used for immunochemical analysis can be found in Table 2.4.  
2.6.5 Quantitative analysis of immunocytochemistry 
Coverslips were examined using a Leica TCS SP5 confocal microscope equipped with 405 
Diode, Argon, DPSS 561, HeNe 594 and HeNe 633 lasers. To compare each set of 
experiment, pictures were taken with the same parameters on the confocal software. The 
number of positively stained cells was quantified by counting randomly selected fields from 
at least 3 independent experiments. To determine the number of TH positive, PITX3/TH 
double positive, and FOXA2/TH double positive cells, all positively stained cells were 
counted manually. To evaluate the proportion of OTX2, LMX1A, FOXA2 or DMRT5 positive 
cells, a custom written Image J macro was used (rsb.info.nih.gov/ij/download/). Tresholds 
were applied to each channel independently to select clearly labeled cells and to avoid 
detection of unspecific background staining. Binarised images were merged and the 
proportion of OTX2, LMX1A, FOXA2 or DMRT5 positive cells were determined by the total 
number of pixels of these positive labeled cells to the total pixel number of DAPI labeled 
cells. Statistical significance was determined using two tailed student t-test. The values of 
p<0.01 were considered significant. Analysis was performed using GraphPad software 
(www.graphpad.com, Dr. Harvey Motulsky, San Diego, California, USA)). Each set of values 
was expressed as means ± standard deviation.   
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Table 2.1 Pluripotent stem cell lines used for the investigations of this thesis. 
Cell lines  
E14TG2a (Hooper et al., 1987) 
Lmx1a-GFP (Dr. Johan Ericson and Dr. Thomas Perlmann lab) 
Pitx3-GFP (Zhao et al., 2004) 
Sox1-GFP (Ying et al., 2003b) 
NSAOK6 mouse iPSCs were reprogrammed by Oct4 and Klf4 from 
Neural Stem Cells as described by Jose Silva et al. (Silva et 
al., 2008a) 
 
 
Table 2.2 List of factors used for neural differentiation. 
Factors Supplier Final Concentration 
Ascorbic acid Sigma 200 µM 
BDNF Preprotech 10 ng/ml 
Cyclopamine Sigma 10 µM 
CHIR99021 Miltenyi Biotec 0.5 µM and 2 µM 
FGF8b, human Preprotech 100 ng/ml 
GDNF Preprotech 10 ng/ml 
LY294002 Cambridge Bioscience 2 µM 
PD173074 Sigma 50 ng/ml 
PD0325901 Axon 1 µM 
SHH (C25 II-N) R&D 200 ng/mL 
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Table 2.3 List of gene specific primers for qPCR. 
Gene Forward primer Reverse primer 
Cyclophilin GGCAAATGCTGGACCAAACAC TTCCTGGACCCAAAACGCTC 
Hmbs  ACTGGTGGAGTCTGGAGTCTAGATGGC GCCAGGCTGATGCCCAGGTT 
Axin2 GGTTGGCTTGTCCAGACAAAACT GCTGGTGGCTGGTGCAAAGAC 
Dmbx1 ACTCCCTGCACGCTATGAACT GGCCTCCAAGATGATGTCAGCTAG 
Dmrt5 GAGAGCCGAGGCGCGAGCCGAGCT GTCCCGTCGCTGTCGCTGCTGCTGT 
En1 CAAGACTGACTCACAGCAACC ACTCCGCCTTGAGTCTCTGC 
En2 ACTGCACGCGCTATTCTGAC TGTTGCCCGTGGCTTTCTTG 
Foxa2 CTGGGAGCCGTGAAGATGGA ATTCCAGCGCCCACATAGGA 
Foxg1 GACCCGTCGAGCGACGACG GGACAGGAAGGGCGACATGG 
Gad1 CGCAGGCACGACTGTTTACG CCAGGTGACTGAATTGGCCC 
Gata2 TCACCCCTAAGCAGAGAAGC CGCCATAAGGTGGTGGTTGTC 
Gbx2 AGAGAGAAGCTCTCCTCCTTG CGGCAACTTCGACAAAGCCG 
Gli1 TCAGGGTCCCAGGGTTATGG CGAGGCTGGCATCAGAAAGG 
Helt GGAGGGACCGAATTAACCGC CATGCACTCCGTGGTAACCGT 
Lmx1a GGACCATAAGCGACCCAAAC CCTGAACCACACGGACACTC 
Mash1 CCCTGAAACTGGGTTGATGT AAAGGCTGTCCGAGAACTGA 
Msx1 GCCTCTCGGCCATTTCTCAG CGGTTGGTCTTGTGCTTGCG 
Nanog CTTACAAGGGTCTGCTACTGAGATGC TGCTTCCTGGCAAGGACCTT 
Ncam TGAGCCTGAGAGTATCGACTG AGTTTGCCGTTCCTGAACC 
Nestin TGAGAACTCTCGCTTGCAGACAC GGTCCTCTGGTATCCCAAGGAAATG 
Ngn2 GCTGTGGGAATTTCACCTGT AAATTTCCACGCTTGCATTC 
Oct4 CACGAGTGGAAAGCAACTCA AGATGGTGGTCTGGCTGAAC 
Otx2 TCGAAGAGCTAAGTGCCGCC GGCAATGGTTGGGACTGAGG 
Shh AGCATCCCTGCAGCGCAATC GCTGGACTTGACCGCCATTC 
Six3 GGTTTAAGAACCGGCGACAG TACCGAGAGGATCGAAGTGC 
Sox1 GGGCGCCCTCGGATCTCTGGTCAA GCCCTGGTAGTGCTGTGGCAGCGAGT 
Tubb3 ATCAGCAAGGTGCGTGAGGAG ATGGACAGGGTGGCGTTGTAG 
Wnt1 TGAGCCGCAAGCAGCGGCGA TGGGGCCCCGGAGCAGTGGG 
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Table 2.4 List of primary antibodies for immunocytochemistry. 
Antigen Species Supplier dilution 
5HT mouse Abcam 1:50 
DMRT5 rabbit Custom-made antibody 1:1000 
FOXA2 goat Santa Cruz 1:200 
GAD67 mouse Millipore 5406 1:300 
GFP rabbit Invitrogen 1:500 
GFP mouse Invitrogen 1:500 
LMX1A ginuin pig Custom-made antibody 1:500 
Nestin chicken Neuromics 1:500 
Nestin mouse DSHB 1:200 
NEUN mouse Chemicon 1:200 
NURR1 rabbit Santa Cruz 1:200 
OCT4 goat Santa Cruz 1:500 
OTX2 rabbit Millipore 1:300 
OTX2 goat R&D 1:500 
PAX6 mouse DSHB 1:1000 
PITX3 rabbit gift of M.Smidt, University of Amsterdam 1:500 
SOX2 rabbit Chemicon 1:500 
TH rabbit Pelfreeze 1:500 
TH mouse Millipore 1:500 
TH sheep Pelfreeze 1:300 
TUBB3 rabbit Covance 1:1000 
TUBB3 mouse Covance 1:500 
TUBB3 mouse Sigma 1:1000 
VMAT2 rabbit Santa Cruz 1:500 
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3 Epiblast stem cells as an alternative model to 
study neural differentiation in vitro 
 
Pluripotent stem cells are capable of differentiating into cells from all three germ layers. 
Knowledge gained from in vivo studies about the mechanisms controlling the fate choice of 
stem cells during development has been used to design protocols directing differentiation of 
PSCs in vitro. Although efficient methods for directed differentiation of ESCs towards 
neuronal subtypes have been established (Eiraku et al., 2008; Gaspard et al., 2009; 
Gaspard et al., 2008; Lee et al., 2000b; Murashov et al., 2005; Salero and Hatten, 2007; Su 
et al., 2006; Wataya et al., 2008; Wichterle et al., 2002), ESC differentiation in vitro is 
asynchronised and heterogeneous in nature. During differentiation, progenitors of various 
spatial and temporal developmental stages co-exist and response differently to given 
inductive signals according to their distinct cellular properties.  
Furthermore, to study FGF signalling in neural differentiation, mouse EpiSCs may be a 
better cell source than ESCs for the following reasons: Firstly, the transition from ESCs to 
EpiSCs requires the activation of FGF signalling (Kunath et al., 2007). Secondly, EpiSCs are 
developmentally primed PSCs and may potentially offer a more accelerated and 
synchronised in vitro differentiation model than ESCs. Lastly, human ESCs seem to be more 
similar to mouse EpiSCs than mouse ESCs (Brons et al., 2007; Rossant, 2008; Tesar et al., 
2007; Vallier et al., 2009; Xu et al., 2008). 
To validate EpiSCs as an alternative in vitro differentiation model, I performed comparative 
neural differentiation from mouse ESCs and mouse EpiSCs. I used the monolayer 
differentiation (MD) protocol described by Ying et al. (2003), because it represents a well 
defined system ideally for studying the effect of molecular manipulations on cell lineage 
choice. I found that neural differentiation occurs more homogeneously and faster in EpiSCs 
than in ESCs. Furthermore, EpiSCs differentiated into multiple neuronal subtypes 
demonstrating their capacity of making neurons is not restricted to a specific subtype. 
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3.1 Comparison of neural induction in ESCs cell and EpiSCs 
 
To gain insight into the progress of in vitro neural differentiation in ESCs and EpiSCs, MD of 
ESCs and EpiSCs were analysed for pluripotent and neural lineage markers by 
immunocytochemistry and qPCR.  
Immunostaining for OCT4 demonstrated the pluripotent state of ESC and EpiSC cultures as 
the majority of the cells express OCT4 (Figure 3.1 B). In agreement with the published data, 
the expression level of Oct4 was similar in ESCs and EpiSCs whereas expression of Nanog 
was reduced in EpiSCs when compared to ESCs (Figure 3.1 A) (Greber et al., 2010; Han et 
al., 2010; Najm et al., 2011). In MD cultures of EpiSC, Nanog expression was already 
substantially decreased at day (d) 2 MD and extinguished at d4 MD. In contrast, the loss of 
Nanog mRNA was delayed in ESCs to d6 MD (Figure 3.1 A). Oct4 was significantly 
downregulated in EpiSC MD cultures by d2 whereas in ESC MD the expression level of Oct4 
decreased at d4 MD (Figure 3.1 A). Consistent with this gene expression analysis, an 
antibody against OCT4 detected few OCT4 positive cells at d4 in MD of EpiSCs whereas at 
the same time a high number of OCT4 positive cells were still present in MD cultures of 
ESCs. Furthermore, SOX2, which is expressed in both pluripotent stem cells and 
neuroepithelial stem cells, was detected in the majority of OCT4 negative cells at d4 in 
EpiSC MD, indicating neural lineage commitment.  
The neuroepithelial markers SOX1 and Nestin were used to analyse the kinetics of neural 
lineage conversion from the pluripotent stem cells, EpiSCs and ESCs. SOX1 is specifically 
expressed in the neuroectoderm at the headfold stage (Wood and Episkopou, 1999) and 
Nestin is an intermediate filament protein found to be expressed in neuroepithelial stem cells 
(Cattaneo and McKay, 1990; Lendahl et al., 1990). A robust upregulation of Sox1 was 
observed in MD of EpiSCs at d2, followed by a high increase of Nestin expression at d6 MD 
(Figure 3.1 A). In addition, the expression of the pro-neural genes, mammalian achaete-
scute homolog 1 (Mash1) (Guillemot and Joyner, 1993; Sommer et al., 1995; Verma-Kurvari 
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et al., 1996) and Neurogenin2 (Ngn2) (Sommer et al., 1996), started to increase at d2 and 
d4 MD respectively in EpiSC cultures. In comparison to the observation of neural lineage 
markers in EpiSC MD, upregulation of Sox1, Nestin, Mash1, and Ngn2 transcription was 
delayed by 2 days in MD of ESCs (Figure 3.1 A). An accelerated neural differentiation of 
EpiSCs was further confirmed by immunocytochemistry, EpiSC cultures at d4 contained 
numerous SOX1 and Nestin positive cells whereas there were significantly fewer in ESC 
MD. As a consequence of a more rapid neural differentiation in EpiSC MD, the neuronal 
marker genes Ncam and Tubb3 were markedly increased at d6 in MD of EpiSC compared to 
ESC MD (Figure 3.1 A,B). However, by d12 of MD, the mRNA levels of the neuronal marker 
genes in ESC MD were similar to those of EpiSCs (Figure 3.1 A), suggesting the efficiency 
of neural conversion is similar between the two protocols. Immunostaining for TUBB3 further 
confirmed that the quantitative conversion to a neuronal phenotype was comparable at d12 
MD in ESC and EpiSC cultures (Figure 3.1 B). It is worth noting that at d12 MD, SOX1 
positive neural progenitor cells were still present in MD cultures of ESCs and EpiSCs. I also 
observed a variety of neuronal subtypes in d14 MD cultures of EpiSCs verified by the 
expression of the serotonergic marker 5HT, the GABAergic marker GAD67 or the DA marker 
TH (Figure 3.1 C), as was previously demonstrated for MD of ESCs (Ying et al., 2003b), 
Interestingly, antibody for TUBB3 revealed neurons of mature morphology with long axons 
as well as cells with less pronounced neuronal morphology at d6 of ESC MD while in d6 
EpiSC MD all TUBB3 positive cells displayed an immature neuronal morphology indicating a 
more synchronised neuronal differentiation of EpiSCs. To strengthen this observation, I used 
the reporter cell line 46C in which GFP is inserted into the Sox1 locus (Ying et al., 2003b). 
EpiSCs were derived from 46C ESCs by culturing ESCs in N2B27 supplemented with 20 
ng/ml Activin A and 12 ng/ml FGF2 (Guo et al., 2009). 46C-ESCs and 46C-EpiSCs were 
subjected to MD and Sox1-GFP expression was detected by flow cytometry. Sox1-GFP was 
undetectable in 46C-ESCs and 46C-EpiSCs, but as cells differentiated, Sox1-GFP reporter 
expression was activated in both types of MD culture (Figure 3.2). In vivo data indicates that 
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as neural development progresses, Sox1 expression is switched off in most neurons and 
remains only expressed in the lens and subgranular layer of the hippocampus (Aubert et al., 
2003). In 46C-EpiSC MD the number of Sox1-GFP positive cells was dramatically increased 
by d4 of MD. In agreement with the in vivo data, I observed that most of the cells lost Sox1-
GFP by d6 of MD and only a small subset of cells maintained Sox1-GFP expression (Figure 
3.2). In contrast, MD of ESCs did not show a strong increase of Sox1-GFP positive cells until 
d6 of MD. Furthermore, although the neural differentiation of ESCs was successful which 
was observed by the presence of Sox1-GFP cells, the flow cytometry profile at d6 of ESC 
MD displayed the presence of a large Sox1-GFP negative cell population (Figure 3.2). These 
results indicate that EpiSCs progress more uniformly toward the neural lineage than ESCs. 
Taken together, the analysis of neural lineage markers by qPCR and immunocytochemistry 
as well as the detection of Sox1-GFP during differentiation revealed that EpiSCs commit to 
neuronal lineage more rapidly and in a more synchronised manner than ESCs. Furthermore, 
neural marker genes are upregulated at d2-4 in MD of EpiSCs, indicating the time window 
when neural induction is activated.   
49 
 
 
Figure 3.1 Accelerated neural differentiation potential of EpiSCs.  
(A) qPCR analysis for the expression of pluripotency and neural lineage genes over 12-days 
MD cultures of ESCs and EpiSCs. Data represent mean±s.e.m. from triplicate cultures of a 
single experiment. (B) Mouse ESC and EpiSC cultures at d0, d4, d6 and d12 MD 
immunostained for the pluripotent marker OCT4, the pluripotent and neuroepithelial marker 
SOX2, and the neural lineage marker proteins SOX2, SOX1, Nestin, and TUBB3. DAPI 
labeling is in blue. (C) At day 14 of neural differentiation from EpiSCs, cultures were stained 
for the serotonergic marker 5HT, GABAergic marker GAD67, dopaminergic marker TH, all 
labelled in green, and the neuronal markers, TUBB3 and NeuN, shown in red. DAPI labeling 
is in blue. Scale bars: 100 µm   
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Figure 3.2 Synchronised neuroectodermal differentiation from EpiSCs. 
Flow cytometry profiles of Sox1-GFP ESCs and EpiSCs MD cultures.  
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3.2 Discussion 
 
Realising the potential of human ESCs in regenerative medicine requires an in-depth 
understanding of the mechanisms that control the fate choice of stem cells during 
differentiation. Recent studies reported that hESCs appear to be functionally more akin to 
mouse EpiSCs than mouse ESCs (Brons et al., 2007; Rossant, 2008; Tesar et al., 2007; 
Vallier et al., 2009). Therefore, mouse EpiSCs are an attractive model system for studying 
neuroectodermal specification in vitro. Knowledge gained from neural differentiation of 
mouse EpiSCs may provide a better understanding of neural commitment in hESCs and 
improve techniques for the generation of particular neuronal subtypes from hESCs for 
biomedical applications. Mouse EpiSCs have been shown to be capable of multilineage 
differentiation in vitro (Bernemann et al., 2011; Brons et al., 2007; Tesar et al., 2007; Vallier 
et al., 2009) and to form teratomas when grafted into adult mice (Brons et al., 2007; Tesar et 
al., 2007). However, a direct comparison of mouse EpiSCs and mouse ESCs in neural 
differentiation has not been described.  
In this chapter, I report that EpiSCs are competent to commit efficiently to a neuronal fate. It 
was demonstrated that neuronal cells derived from ESCs are not restricted to a specific 
neuronal fate (Ying and Smith, 2003; Ying et al., 2003b) which was also the case for EpiSC-
derived neurons. I observed a more rapid loss of pluripotent markers in neural differentiation 
of EpiSCs when compared to ESC in MD (Figure 3.1). This observation might be explained 
by the developmentally advanced stage of EpiSCs (Brons et al., 2007; Tesar et al., 2007). 
EpiSCs are developmentally equivalent to cells from the postimplantation epiblast at E~6.5 
while ESCs are isolated from E3.5 embryos. Though EpiSCs express the pluripotent marker 
genes and readily form teratomas upon injection into immunocompromised mice, they make 
minimal contribute to the formation of chimeras (Brons et al., 2007; Tesar et al., 2007). In 
conclusion, ESCs represent a more immature stage of differentiation than EpiSCs which are 
poised to differentiate more readily.  
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The rapid exit of EpiSCs from a pluripotent stage was accompanied by an early, 
synchronised conversion into a neuroectodermal lineage whereas neural induction in ESC 
MD seemed to be a more heterogeneous progress (Figure 3.2). Consistent with this finding, 
it has been reported that ESC cultures are composed of cells with different pluripotency 
levels (Chambers et al., 2007; Furusawa et al., 2004; Hayashi et al., 2008; Toyooka et al., 
2008), consequently resembling different stages of development in vivo. Therefore, the 
asynchronous neural differentiation observed in ESCs might be due to the presence of 
distinct cell subpopulations within ESC cultures that when exposed to a given activation 
stimuli respond differently according their developmental stages. In this respect, MD of 
EpiSCs appeared as a more coordinated process, indicating that EpiSCs are more 
homogeneous in nature. The relative synchronous nature of EpiSCs during neural 
differentiation provides a more precise system to study the mechanisms of neural induction 
and specification than ESC MD.  
However, MD of ESCs and EpiSCs at d12 displayed comparable amounts of TUBB3 and 
Sox1-GFP positive cells (Figure 3.1). The Sox1-GFP positive cells are mostly seen in areas 
of high cell density concomitant with less TUBB3 positive cells. Since these areas seem to 
create a “niche” where neural precursors are maintained and neuronal differentiation is 
suppressed, dissociation of the cells might disrupt the niches with their cell-cell contacts and 
subsequently improve neuronal differentiation. It needs to be taken into consideration that 
replating of cells at this stage has a negative impact on the survival of the existing neuronal 
cell population.  
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4 Temporally controlled modulation of FGF/ERK 
signalling directs a midbrain dopaminergic fate  
 
Extrinsic signals, such as FGF, WNT, BMP, and SHH, are essential for governing stem cell 
fate decision and lineage specification. This chapter focuses on FGF signalling which plays 
multiple roles during development depending on the time and the tissue.  
During gastrulation, FGFs are involved in the posteriorisation of the neuroepithelium (Cox 
and Hemmati-Brivanlou, 1995; Doniach, 1995; Holowacz and Sokol, 1999; Kengaku and 
Okamoto, 1995; Lamb and Harland, 1995; Rentzsch et al., 2004; Ribisi et al., 2000; Wills et 
al., 2010). At E~6.5, loss of Fgf8 expression in mouse embryos results in an expansion of 
Otx2 and Six3 positive anterior tissue accompanied with the loss of posterior tissue marked 
by Gbx2 (Sun et al., 1999). Consistent with this finding, Oki et al (2010) demonstrated that 
potent FGFR inhibitors block posteriosation of mouse embryos during gastrulation. The 
same study further reported that MAPK/ERK inhibitor could mainly replace the FGFR 
inhibitor whereas antagonists of PLC-γ or PI3K pathway had no effect, implying FGF 
signalling acts via the MAPK/ERK pathway in this context.  
If in vitro differentiation of ESCs resembles the developmental process, inhibition of 
FGF/ERK pathway during early stages of in vitro neural differentiation should induce the 
production of cells with anterior characteristics (Otx2), including the cells from which mDA 
neurons arise, at the expense of posterior neuroepithelial cells (Gbx2). We proposed that a 
direct induction of early region-specific progenitors should improve the production of DA 
neurons. I therefore tested this hypothesis using EpiSCs in vitro differentiation model 
because they have already completed the transition from ESCs which involves the activation 
of FGF signalling (Kunath et al., 2007). Additionally, EpiSCs are more advantageous than 
ESCs because their in vitro differentiation towards neuroectoderm is more synchronously as 
shown in Chapter 3. In this chapter I show that regulating the level of FGF/ERK activity 
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during distinct phases of neural differentiation in vitro is crucial for efficient generation of 
mDA neurons. 
 
4.1 Blockade of FGF/ERK signalling upon exit of epiblast 
pluripotent state accelerates neural fate commitment 
 
Self-renewal of EpiSCs in vitro is maintained by FGF2 and Activin A. I proposed that, in the 
absence of Activin A, inhibition of FGF signalling promotes differentiation. To investigate 
whether early blockade of FGF/ERK promotes differentiation into neuroectoderm, MD of 
EpiSC was performed with either the FGFR inhibitor PD173074 (Stavridis et al., 2007) or the 
potent MEK (MAPKK) blocker PD0325901 (Ying et al., 2008), which prevents ERK activation 
and is referred as ERK inhibitor hereafter. As shown by Western Blot, phosphorylated ERK 
was diminished in cultures treated with PD173074 or PD0325901 (Figure 4.1 A).  
To determine whether FGF/ERK inhibition promotes the exit from the pluripotent stage, 
immunostaining for the pluripotent marker OCT4 was performed on MD cultures at d1-3 with 
and without PD0325901. As expected, less OCT4 positive cells were seen in cultures 
exposed to the FGF/ERK inhibitor when compared to control cultures from d2 MD and 
onward (Figure 4.1 B).  
The patterns of stage-specific gene expression observed in Chapter 3 suggest that neural 
induction in MD of EpiSCs occurred during the first 2-4 days of differentiation. In order to 
examine whether inhibition of FGF/ERK signalling further promotes the transition of EpiSCs 
into neuroectodermal cell fate, EpiSCs were cultured with PD0325901 and the expression of 
the pro-neural genes Ngn2 and Mash1 and the neuronal marker gene Tubb3 were analysed 
by qPCR (Figure 4.2 A). The levels of Mash1 were increased from d3 MD with or without 
PD0325901. However, Mash1 expression level was higher in cultures with PD0325901. 
Interestingly, the expression of the pro-neural gene Ngn2 was already highly upregulated at 
55 
 
d3 MD in PD0325901 treated cultures whereas in no-PD0325901 control cultures an 
increase of Ngn2 expression was not observed until d4 of differentiation. Moreover, in 
cultures that were exposed to PD0325901, the elevation of Tubb3 mRNA was shifted 
forward to d3 of differentiation when compared with no-PD0325901 controls.  
To strengthen the observation that inhibition of the FGF/ERK pathway causes a more rapid 
neuroectodermal differentiation, I used Sox1-GFP knock-in (46C) reporter EpiSCs (Ying et 
al., 2003b) to monitor differentiation. Sox1 is specifically expressed in the neuroectoderm 
from the headfold stage onwards (Wood and Episkopou, 1999), thus it is commonly used as 
a marker gene for neural progenitors. To gain insight into the kinetics of neural induction, 
Sox1-GFP positive cells were detected by flow cytometry and the percentage of Sox1-GFP 
positive cells was determined between d1 and d6 MD. As shown, Sox1-GFP was 
undetectable before differentiation (Figure 4.2 C, D). At d2 of differentiation, a high 
proportion of Sox1-GFP positive cells (44.15%±1.2) were already detected in cultures with 
PD0325901, compared to control cultures without PD0325901 (7.55%±0.64). Furthermore 
and consistent with the observation above, immunocytochemical staining of PLZF, a marker 
of neuroectodermal cells (Avantaggiato et al., 1995), indicated that PD0325901 treatment 
accelerated and enhanced the generation of PLZF positive cells compared to controls 
cultures (Figure 4.2 B).  
Taking together, the results from the analysis of the flow cytometry data, immunostaining 
and gene expression demonstrate that inactivation of FGF/ERK signalling accelerates the 
transition from a pluripotent epiblast stage toward neuroectoderm.  
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Figure 4.1 Inhibition of FGF/ERK activity accelerates the exit of EpiSCs from a 
pluripotent stage. 
(A) Western blot analysis for phosphorylated ERK in d2 mouse EpiSC differentiation cultures 
treated with PD0325901 (PD03) or PD173074 (PD17). Samples were loaded undiluted 
(1; 30 µg) or diluted 1:2 in loading buffer. (B) Antibody staining for the pluripotent marker 
OCT4, labelled with green, in d1, d2 and d3 MD cultures with or without PD0325901 (PD03). 
DAPI labelling is in blue. Scale bars: 100 µm. 
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Figure 4.2 Inhibition of FGF/ERK activity accelerates neural fate conversion of 
EpiSCs. 
(A) qPCR analysis for the expression of neural lineage marker genes over 4 days MD 
cultures of EpiSCs. Data represent mean±s.e.m. from triplicate cultures of a single 
experiment. (B) Immunostaining for the neural rosette marker PLZF, shown in green, at d2, 
d4 and d6 MD with or without PD0325901 (PD03). DAPI labelling is in blue. Scale bars: 100 
µm. (C) Antibody staining for a neuroepithelium marker SOX1, red, in d2-5 MD cultures with 
or without PD0325901 (PD03). DAPI labelling is in blue. Scale bars: 100 µm. (D) MD 
cultures of Sox1-GFP EpiSCs in the presence or absence of PD0325901 (PD03). Sox1-GFP 
reporter expression was analyzed by flow cytometry and the percentage of Sox1-GFP 
positive cells was determined from three independent cultures. Error bars indicate s.e.m.   
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4.2 Inhibition of FGF/ERK activity at the onset of EpiSC 
differentiation promotes mDA progenitor characteristics 
 
To investigate the effect of early FGF/ERK inhibition on the generation of mDA neurons from 
EpiSCs, cells were exposed for 2 days with either PD173074 or PD0325901 at the onset of 
neural differentiation and the expression of mDA regulatory genes, Foxa2, Lmx1a, and 
Dmrt5, were tested. Compared to no-factor controls, the expression levels of Lmx1a, Foxa2, 
and Dmrt5 were already upregulated at d2 MD in cultures that experienced FGF/ERK 
blockade. Moreover, the increase of Lmx1a, Foxa2, and Dmrt5 continued after withdrawal of 
FGF/ERK inhibitor (Figure 4.3 B, C).  
To determine whether longer exposure to the ERK inhibitor could further enhance the 
expression of mDA regulatory genes, I compared the effects of 5 days PD0325901 treatment 
(d0-5) to that of 2 days (d0-2) during MD. Contrary to short exposure of PD0325901, no 
increase of Foxa2 and Dmrt5 was observed after 5 days PD0325901 treatment. Moreover, 
the transcript level of Lmx1a was reduced in cultures continuously exposed to PD0325901 
when compared with the no-PD0325901 culture at d5. Notably, detection of p-ERK by 
Western Blot analysis demonstrated the presence of FGF/ERK signalling at d4 MD in 
cultures which had been treated with PD0325901 for 2 days (d0-2) (Figure 4.3 A). These 
results indicate that although FGF/ERK inhibition at early stages initiates EpiSC 
differentiation, endogenous FGF/ERK signalling is necessary from d3 to acquire mDA 
progenitor characteristics. 
To confirm the results of qPCR analysis, EpiSC cultures at d5 MD were stained for LMX1A, 
FOXA2, and DMRT5. The proportion of cells expressing either one of the mDA progenitor 
marker in the total cell population was determined by pixel-analysis. At d5, when the majority 
of cells are Nestin positive, the percentage of neural progenitors expressing LMX1A, 
FOXA2, or DMRT5 increased greatly in PD0325901 treated cultures (LMX1A: 12±4.3%; 
FOXA2: 59±10.82%; DMRT5: 35±7.65%) compared to cultures without PD0325901 
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treatment (LMX1A: 3±1.27%; FOXA2: 24±8.6%; DMRT5: 6±2.45%) (Figure 4.3 E). As 
treatment with either PD0325901 or PD173074 displayed similar results, PD0325901 was 
used for further studies unless stated otherwise. 
Gene expression analysis by qPCR further revealed an increased expression of Shh and 
Wnt1 in PD0325901 treated cultures when compared to control cultures. SHH and WNT1 
are signalling molecules which were shown to be required for the induction of mDA 
progenitor cells by forming regulatory loops with LMX1A and FOXA2 (Andersson et al., 
2006b; Chung et al., 2009; Echelard et al., 1993; Mavromatakis et al., 2010). At d2 MD, the 
expression level rose 1.5-fold and 4-fold in cultures with PD173074 and PD0325901, 
respectively, when compared to no-factor control. The expression of Shh was further 
upregulated between d3 and d5 after withdrawal of PD173074 and PD0325901. However, 
long exposure of PD0325901 displayed similar transcript levels of Shh as in cultures without 
PD0325901 (Figure 4.3 B). Wnt1 expression was already highly upregulated at d1 and d2 
MD in PD173074- or PD0325901-treated cultures whereas in control cultures the transcript 
levels of Wnt1 were low (Figure 4.3 B,C). In contrast to the observed Shh expression pattern 
during the first day of differentiation, Wnt1 expression decreased from d3 and onward even 
after withdrawal of the small molecule ERK inhibitor, implying the activation of a pathway 
negatively regulating Wnt1 expression. Consistent with a previous study (Chung et al., 
2009), I observed similar expression pattern of Wnt1 and Lmx1a at d1 and d2 MD. 
Furthermore, the kinetics of Shh expression correlates with the pattern of Foxa2 expression, 
supporting published results of a regulatory relationship between SHH and FOXA2 (Ang and 
Rossant, 1994; Mavromatakis et al., 2010).  
The FGF family can activate 3 different signalling pathways: Mitogen-activated protein 
kinase (MAPK/ERK), Phosphatidylinositol-3 kinase (PI3K) and Phospholipase C gamma 
(PLC-γ) (Figure 1.3 A). To address whether the induction of mDA regulators is specific to the 
blockade of FGF/ERK pathway, neural differentiation of EpiSC was carried out in the 
presence of the PI3K inhibitor LY294002 (2 µM) from d0-2 MD (Figure 4.4 A). RNA was 
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collected every day during d1-3 of MD, and the expression levels of Wnt1, Shh, Foxa2, 
Dmrt5, Lmx1a, and Msx1, a downstream target of LMX1A (Andersson et al., 2006b), were 
assessed by qPCR (Figure 4.4 B). I found similar level of mRNA for Wnt1, Shh, Dmrt5, and 
Msx1 between LY2949002 treated cultures and control cultures. The expression of Foxa2 
and Lmx1a dropped below control levels at d2-3. These findings indicate that early inhibition 
of FGF/PI3K signalling is not involved in mDA neural specification. 
Taking together, blockade of FGF/ERK activity at the onset of the epiblast pluripotent state 
induces the expression of Shh and Wnt1, signalling molecules essential for mDA generation, 
and enhances the generation of mDA progenitor cells marked by FOXA2, LMX1A, and 
DMRT5. However, these newly converted neural progenitors require endogenous FGF/ERK 
activity to maintain and stabilise mDA neural progenitor fate.   
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Figure 4.3 Inhibition of FGF/ERK on the exit of the epiblast pluripotent stage promotes 
the generation of mDA progenitor cells. 
(A) Western blot analysis for phosphorylated ERK (p-ERK) and total ERK in d4 mouse 
EpiSC differentiation cultures treated with PD0325901 (PD03) and FGF8 (15 µg protein). (B) 
E14tg2a mouse EpiSC MD cultures were exposed to PD0325901 from d0 MD for either 2 
days (PD03 d0-2) or 5 days (PD03 d0-5). Cultures were harvested at d1, d2, d3 and d5 MD 
for qPCR analysis. Gene expressions of Wnt1, Shh, Lmx1a, Foxa2, and Dmrt5 were tested. 
The value of the d1 MD control was set as 1. Error bars indicate s.e.m. of two sets of 
experiments performed in duplicate. (C) E14tg2a mouse EpiSC MD cultures were exposed 
to PD173074 from d0 MD for 2 days (PD17 d0-2) and cultures were harvested at d2, d4 and 
d6 MD. qPCR analysis of Wnt1, Shh, Lmx1a,Foxa2, and Dmrt5. The value of the d2 MD 
control was set as 1. Error bars indicate mean±s.e.m. of two sets of experiments performed 
in duplicate. (D) MD of EpiSCs exposed to PD0325901 (PD03) from d0 MD for 2 days were 
immunostained at d5 for LMX1A, FOXA2, and DMRT5 and counterstained with DAPI. Scale 
bar: 100 µm. (E) Quantification of immunostaining in D showing the percentage of cells 
expressing each mDA progenitor marker protein.   
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Figure 4.4 Blockade of FGF/PI3K signalling does not induce expression of mDA 
regulatory genes. 
(A) Experimental scheme of neural differentiation with E14tg2a mouse EpiSCs. MD cultures 
were exposed to PD0325901 (PD03) or LY294002 from d0 MD for 2 days. (B) Cultures were 
harvested at d1, d2, and d3 MD for qPCR analysis. Gene expressions of Shh, Wnt1, Lmx1a, 
Foxa2, Dmrt5 and Msx1 were tested. The value of the d1 MD control was set as 1. Error 
bars indicate s.e.m. of two sets of experiments performed in duplicate.   
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4.3 FGF/ERK inhibition affects anterior-posteriorisation and the 
maintenance of OTX2 in nascent neural progenitors 
 
It has been shown in mouse embryos that blockade of FGF signalling during gastrulation 
results in an expansion of anterior and a reduction of posterior tissue (Oki et al., 2010; Sun 
et al., 1999). Therefore, it is possible that inhibition of FGF/ERK promotes the generation of 
ventral midbrain progenitor cells via modulating anterior–posterior characteristics of neural 
progenitor cells. To verify whether early blockade of FGF/ERK signalling maintains anterior 
neural character during neural differentiation, EpiSC MD cultures were analysed for anterior-
posterior markers.  
In order to examine the anterior character of EpiSC MD, cultures were analysed by 
immunostaining for OTX2 which is an anteriorly expressed homeobox protein (Acampora et 
al., 1995; Ang et al., 1994; Millet et al., 1996; Simeone et al., 1992; Simeone et al., 1995). 
As expected, EpiSC cultures exposed to PD0325901 on exit of the pluripotent stage 
exhibited an enlarged OTX2 positive cell population when compared to control cultures at 
d3-5 MD (control, d5: 11.75±4.25%; PD0325901, d5: 69.48±17.89%) (Figure 4.5 A, B). 
Consistent with the immunostaining for OTX2, transcript levels of Gbx2, expressed in vivo in 
areas becoming the anterior hindbrain and spinal cord, increased from d1 until d3 of MD in 
cultures without PD0325901 whereas the expression decreased with PD0325901 (Figure 
4.5 C). Together, these data indicate that early FGF/ERK blockade promotes and/or 
maintains an anterior character of neural progenitor cells.  
However, FGFs are expressed in the anterior neural ridge where they are involved in the 
formation of the forebrain (Paek et al., 2009; Shimamura and Rubenstein, 1997). To 
investigate whether the generation of cells with forebrain characteristic is affected by 
inhibition of FGF/ERK activity, the expressions of the forebrain marker genes Six3 and 
Foxg1 were tested in MD cultures with or without PD0325901 at d0-2 (Figure 4.5 D) (Hebert 
and McConnell, 2000; Jeong et al., 2008; Lavado et al., 2008). The transcript level of Six3 
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and Foxg1 were similar at d2 MD in both conditions. Interestingly, in cultures exposed to 
PD0325901 the expression of Six3 and Foxg1 decreased after PD0325901 was withdrawn. 
Furthermore, their expression levels were reduced at d3-4 when compared to control MD, 
suggesting that early inhibition of FGF/ERK activity suppress the commitment of newly born 
neural progenitor cells toward anterior forebrain fate.  
The Otx2 positive domain in the neuroepithelium spans the prospective forebrain and 
midbrain. Following the observation on decreased forebrain marker gene expression in 
PD0325901-treated cultures, I examined the expression of midbrain marker genes En2 and 
Dmbx1 (Davidson et al., 1988; Davis et al., 1988; Gogoi et al., 2002; Ohtoshi and Behringer, 
2004). The transcript level of En2 increased steadily in both culture conditions from d2 until 
d5 of MD. However, a greater increase was observed in PD0325901-treated cultures 
compared to the control. An increase of Dmbx1 was already evident from d1 MD with 
PD0325901 treatment when compared to control, although its level in the control cultures 
catched up at d5 MD.  
To test whether FGF/PI3K pathway plays a role in anterior-posterior modulation of neural 
progenitor, EpiSC cultures at d5 MD treated with or without PD0325901 or LY294002 were 
assessed by immunocytochemistry for OTX2. An increase of the OTX2 positive cell 
population was only observed in PD0325901-treated cultures while LY294002-treated 
cultures had a similar proportion of OTX2 positive cells as those in the control.  
Taken together, these results suggest that early inhibition of FGF/ERK activity primes cells 
for a midbrain progenitor cell fate by blocking forebrain and hindbrain cell fate.   
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Figure 4.5 Early blockade of FGF/ERK activity modulates anterior –posterior 
characteristics of neural progenitor cells. 
(A) Antibody staining for the anterior marker OTX2 shown in red in d3, d4 and d5 MD 
cultures with or without PD0325901 (PD03). DAPI is labelled in blue. (B) Quantification of 
immunostaining in A illustrating the percentage of cells expressing OTX2. Mean±s.e.m. of 
ten fields from two independent experiments. *, P<0.01 relative to no-PD0325901 control 
(Student’s t-test). (C) Mouse E14tg2a EpiSC MD cultures were exposed to PD0325901 
(PD03) from d0 MD for 2 days. Cultures were harvested at d1, d2, d3 or d5 for qPCR 
analysis of Gbx2. (D) E14tg2a EpiSC MD cultures were treated with PD0325901 cultures 
were harvested at d2-4 for qPCR analysis of the forebrain marker genes Foxg1 and Six3. (E) 
EpiSCs were differentiated in the presence of PD0325901 from d0 MD for 2 days, collected 
as in C and tested for the midbrain marker genes En2 and Dmbx1 by qPCR. The value of 
the d3 MD control was set as 1. Error bars indicate s.e.m. of two sets of experiments 
performed in triplicates.   
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Figure 4.6 Early blockade of FGF/PI3K activity does not promote the generation of 
neural progenitors with anterior characteristics. 
(A) Antibody staining for the anterior marker OTX2 shown in red in d5 MD cultures with or 
without the small molecule inhibitors PD0325901 (PD03) or LY294002 (LY29). DAPI is 
labelled in blue. Scale bars: 100 µm. (B) Quantification of immunostaining in A illustrating 
the percentage of cells expressing OTX2. Mean±s.e.m. of ten fields from two independent 
experiments.   
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4.4 Highly reliable and efficient production of mDA neurons by 
ERK inhibitor-primed neural progenitors 
 
To investigate whether the primed mDA progenitor cells generated above can terminally 
differentiate into DA neurons (TH positive cells) with midbrain-specific identity, SHH and 
FGF8 were applied to induce DA differentiation in MD cultures at d5 when the majority of 
cells were Nestin positive as they are used in standard mDA differentiation protocols (Figure 
4.7 A) (Barberi et al., 2003; Kawasaki et al., 2000; Kim et al., 2002; Lee et al., 2000b; 
Parmar and Li, 2007; Perrier et al., 2004). D14 MD cultures were then analysed in detail for 
mDA neuronal markers by immunocytochemistry (Figure 4.7 B-D). I found that MD cultures 
exposed to PD0325901 at d0-2 followed by SHH and FGF8 at d5-9 contained 4-fold more 
TH positive neurons than no-PD0325901 cultures (PD, 52.3±8%; control, 13.5±9%) (Figure 
4.7 B, C). 
In order to examine the midbrain-specific characteristics of the derived DA neurons, EpiSC 
were derived from Pitx3-GFP knock-in ESCs (Maxwell et al., 2005; Zhao et al., 2004). 
During midbrain development, Pitx3 expression starts at E11.5 and is restricted to SN and 
VTA (Smidt et al., 1997). Therefore, co-expression of TH and PITX3 is used as a marker for 
mDA neurons. Pitx3-GFP EpiSCs were subjected to neural differentiation as illustrated in 
Figure 4.7 A. Cultures were assessed by immunstaining for TH and GFP at d14 MD. A high 
proportion (73.8±10.2%) of TH positive neurons co-expressed Pitx3-GFP in cultures 
received PD0325901 at d0-2 and SHH and FGF8 at d5-9 (Figure 4.7 B, C). In addition, 
these TH positive neurons also co-expressed midbrain transcription factors, LMX1A 
(88.5±3.9%) and FOXA2 (99.5±1.2%), and pan-dopaminergic-neuronal markers, NURR1 
(also known as NR4A2, 85.4±4%) and VMAT (known as SLC18A1, 85.6±12%). In contrast, 
37.1±9.5% of TH positive neurons co-expressed Pitx3-GFP in control cultures exposed to 
SHH and FGF8 only. In conclusion, midbrain progenitor cells induced by FGF/ERK inhibition 
can efficiently generate authentic mDA neurons.   
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Figure 4.7 Temporally controlled FGF/ERK activity promotes the production of 
functional, authentic mDA neurons. 
(A) Experimental scheme of neural differentiation with Pitx3-GFP EpiSCs. MD cultures were 
exposed to PD0325901 (PD03) from d0 MD for 2 days. SHH and FGF8 were applied from 
d5 until d9. Medium was then changed to N2B27 plus GDNF, BDNF and ascorbic acid and 
cultured for another 5 days. (B) MD cultures at d14 were double stained for (b1-4) TH, red, 
and TUBB3, blue, as well as (b5-8) TH, red, and Pitx3-GFP labelled in green. (C) 
Quantification of the immunostaining in B, showing the percentage of TH positive neurons 
and TH positive neurons co-expressing Pitx3-GFP. Mean±s.e.m. *, P<0.01 relative to no-
PD0325901 control (Student’s t-test). (D) Immunostaining of mouse d14 MD cultures for TH 
and mDA neural markers. Scale bars: 200 µm for B (b1,2,5,6) and 50 µm for B (b2,3,7,8), D. 
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4.5 Dopaminergic neuron differentiation of mouse iPSCs in 
response to ERK inhibition  
 
Next I wanted to test whether this protocol can be applied to mouse induced pluripotent stem 
cells. Considering that inhibition of FGF/ERK signalling maintains ESCs in the naïve 
pluripotent state (Silva et al., 2008a; Ying et al., 2008) and activation of FGF signalling is 
necessary to drive ESCs toward the primitive ectoderm/epiblast stage (Kunath et al., 2007), 
PD0325901 was applied for 2 days either during d1-3 or d2-4 of MD. To support the 
generation of mDA neurons, SHH and FGF8 were added from d6 until d10 of MD (see 
Figure 4.8 A). Immunostaining for TUBB3, TH and FOXA2 was carried out at d14 MD to 
observe the generation of mDA neurons. During development, the specification of mDA 
neurons, which are TH positive, starts in the medial domain of the Foxa2-expressing floor 
plate (Ferri et al., 2007). Consequently, co-expression of TH and FOXA2 can be used as a 
marker for mDA neurons. Consistent with the observation in EpiSC MD, mDA neurons (TH 
and FOXA2 double positive) neurons were also efficiently generated in MD cultures of iPSCs 
exposed to PD0325901 either at d1-3 or d2-4 MD when compared to control (Figure 4.8 B), 
supporting our hypothesis that early blockade of FGF signalling during neural induction 
primes a midbrain regional fate in derived neural progenitors, which subsequently 
differentiate into DA neurons exhibiting midbrain characteristics.   
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Figure 4.8 Efficient generation of mDA neurons from mouse iPSCs. 
(A) Experimental scheme of neural differentiation with mouse iPSCs. MD cultures were 
exposed to PD0325901 (PD03, green) at either d1-3 or d2-4 of MD. SHH and FGF8 (red) 
were applied from d6 until d10 of MD. Medium was then changed to N2B27 plus GDNF, 
BDNF and ascorbic acid and cultured for another 4 days. (B) MD cultures at d14 were 
double stained for TH shown in green, FOXA2, blue, and TUBB3, red. Scale bar: 200 µm.  
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4.6 Differential activity of SHH and FGF8 in mDA fate specification 
and differentiation 
 
Ye and colleagues reported (1998) that only the combinatorial treatment of SHH and FGF8 
can induce DA fate in E9 ventral caudal forebrain rat explants. In agreement with this study, I 
also observed a robust generation of TH positive neurons at d14 MD in PD0325901-treated 
cultures exposed to SHH and FGF8 from d5 until d9 whereas few TH positive cells were 
detected in cultures treated with PD0325901 alone (Figure 4.9). A large number of TH 
positive cells were also detected in MD cultures which received PD0325901 at d0-2 followed 
by SHH alone at d5-9. However, these DA neurons showed a low expression of TH with 
immature neuronal morphology. In contrast, TH positive neurons in d14 MD cultures treated 
with PD0325901 followed by FGF8 alone displayed a more mature morphology. The number 
of TH positive cells in this condition was comparable with control MD cultures exposed to 
SHH and FGF8 in the absence of PD0325901.  
I next analysed the expression of gene markers associated with GABAergic phenotype by 
qPCR. The RNA levels of Helt, Gata2, and Gad1 were determined at d5 and d8 and the data 
was presented as the fold change to the level of d5 in control MD cultures with no added 
factors. I detected the highest fold increase of these GABAergic marker genes in control 
cultures without exogenous stimuli (Gata2, 38-fold; Helt, 293-fold; Gad1, 401-fold) (Figure 
4.10) whereas in cultures with SHH the expression of these genes was substantially 
repressed. In cultures exposed to PD0325901 followed by SHH, the mRNA levels of Helt 
and Gad1 were only 10% of the level of MD cultures treated with SHH alone and were less 
than 1% of the level of no-factor controls.  
To further elucidate how SHH and FGF8 may shape neural progenitor cell fate, SHH and 
FGF8, either alone or in combination, were applied at d3-6 of EpiSCs, a stage when neural 
progenitor arise (Figure 3.1 and Figure 4.2), and changes in the expression levels of mDA 
regulator genes were monitored at d6 of differentiation when the majority of cells is Nestin 
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positive (Figure 4.3 D). The expression levels of Dmrt5, Foxa2, and Msx1 were upregulated 
in cultures exposed to SHH at d3-6 while the mRNA transcript levels of Lmx1a and Shh were 
not enhanced (Figure 4.11 B, C). In contrast, adding FGF8 alone or with SHH abolished the 
increased expression of Dmrt5, Foxa2, Msx1, Lmx1a, and Shh caused by PD0325901 or 
PD0325901-SHH. Moreover, activation of FGF signalling by FGF8 resulted in an increase of 
isthmus associated genes Wnt1, En1, and En2, in agreement with previously published data 
(Lee et al., 1997; Liu and Joyner, 2001; Liu et al., 1999).  
The results shown in chapter 4.2 indicated that a period of autocrine FGF/ERK signalling is 
essential for newly born neural progenitor cell to become specified into a ventral midbrain 
fate characterised by DMRT5, LMX1A, and FOXA2. However, enhancement of FGF 
signalling by FGF8 in newly born neural progenitors eliminated the PD0325901-mediated 
upregulation of mDA regulatory genes Dmrt5, Lmx1a, Foxa2, Shh and Msx1. These data 
demonstrate the importance of temporally controlled modulation of FGF/ERK signalling in 
the specification of neural progenitors towards a ventral midbrain fate. Furthermore, SHH 
and FGF8 co-operatively direct the conversion of PD0325901-generated d5 neural 
progenitors into mDA neurons where SHH signalling specifies a DA phenotype and FGF8 
facilitates progenitor differentiation.   
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Figure 4.9 Temporally controlled FGF/ERK activity in combination with SHH and FGF8 
promotes the production of DA neurons. 
(A) Experimental schemes for data in B. (B) MD cultures of EpiSCs at d14 were double 
stained for TH, shown in red, and TUBB3, labelled with green. Scale bar: 200 µm.   
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Figure 4.10 Activation of SHH signalling promotes the production of DA neurons by 
repressing the transcript level of genes for a GABAergic neuronal fate. 
(A) Gene expression analysis of Helt, Gata2, and Gad1 of d5 and d9 MD cultures by qPCR. 
Fold change analysis is used to determine the difference of gene expression between d5 
and d9 in control MD cultures with no added factors, control cultures treated with SHH, and 
cultures exposed to PD0325901 at d0-2 followed by SHH. Error bars indicate s.e.m. of 
triplicate cultures from one representative experiment.  
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Figure 4.11 Effect of SHH and/or FGF8 in EpiSC MD. 
(A) Experimental schemes for data in B. (B+C) Mouse E14tg2a EpiSC MD cultures were 
exposed to PD0325901 (PD03) from d0 MD for 2 days. Cultures were harvested at d4 and 
d6 for qPCR analysis of the mDA fate inducing signalling molecules Shh and Wnt1 (B) and 
the midbrain genes Lmx1a, Foxa2, Msx1, En1, and En2 (C). The value of the d6 MD control 
was set as 1. Error bars indicate s.e.m. of two sets of experiments performed in duplicate.  
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4.7 WNT alone or in combination with SHH cannot replace ERK 
inhibitor in inducing midbrain progenitor cell fate 
 
The induction of signalling molecules Shh and Wnt1 by either PD173074 or PD0325901 and 
the concomitant induction of their target genes Foxa2 and Lmx1a, respectively (Figure 4.3 B, 
C), prompted me to investigate whether SHH and WNT1 are the mediators of early 
FGF/ERK blockade that led to induced efficient mDA fate specification and differentiation.  
4.7.1 The effects of early SHH activation on mDA induction 
In order to investigate the contribution of an early activation of SHH signalling, MD 
differentiation was firstly carried out in the presence of SHH, PD0325901+SHH, or 
PD0325901 alone from d0. RNA was collected from d1-3 of MD and analysed for the 
expression of Shh, the SHH downstream targets Gli1 and Foxa2 and the mDA regulator 
genes Dmrt5, Lmx1a, and Msx1 (Figure 4.12). As expected, in MD cultures exposed to SHH 
alone (d0-2) showed an increased mRNA level of Gli1 and Foxa2 from d2 or d3 respectively 
when compared to control cultures. However, the transcript levels of the mDA regulator 
genes Lmx1a, Msx1, and Dmrt5 were similar to the expression levels in control cultures.  
Next I wanted to determine whether the observed induction of mDA marker gene expression 
is SHH dependent. To this end I performed an additional MD in the presence of the SHH 
inhibitor cyclopamine with or without PD0325901 (Figure 4.13). MD cultures exposed to 
cyclopamine (10 µM) in the presence or absence of PD0325901 displayed a reduction in the 
expression levels of the SHH downstream target genes Gli1 at d1-3 and Foxa2 at d2-3 to 
control cultures, confirming its SHH inhibitory activity. Cyclopamine had little effect on the 
expression of Shh, Msx1, and Dmrt5. Interestingly, PD0325901-induced expression of Dmrt5 
and Msx1 was further enhanced by cyclopamine, suggesting a SHH-independent 
mechanism. However, cyclopamine treatment attenuated PD0325901-mediated induction of 
Foxa2 and Lmx1a (Fig 4.7.2).  
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Because SHH treatment alone could increase the expression of Foxa2 and Lmx1a from d3 
onward, we asked whether an early addition of SHH is sufficient to direct MD cultures 
towards a midbrain neural progenitor fate. I first tested the expression of the hindbrain 
marker gene Gbx2 and midbrain marker genes En1 and Dmbx1 during 3 days of 
differentiation (Figure 4.14 A). The data revealed that, unlike PD0325901, SHH did not 
suppress the hindbrain marker gene Gbx2 and upregulated the midbrain marker genes En1 
and Dmbx1. Consistent with the qPCR data, I did not observe an increase of OTX2 positive 
cells at d5 and d9 in cultures exposed to early SHH (Figure 4.14 B). As shown in Figure 
4.14 C, only cultures exposed to PD0325901 had a significant proportion of OTX2 positive 
cells at d9 MD (PD0325901, 43.88±5.32%; SHH, 6.75±2.75%; control, 7.25±2.29%). 
Surprisingly, at d9, no obvious difference was seen in the number of FOXA2 and LMX1A 
positive neural progenitors in PD0325901-, SHH-treated and no-factor cultures. However, a 
high proportion of TH positive neurons were only obtained in PD0325901-treated cultures 
(Figure 4.15 B). Taken together, these results suggest that SHH is not sufficient to replace 
PD0325901 at d0-2 for complete mDA induction.  
4.7.2 The effects of GSK3ß inhibition on mDA induction 
Early inhibition of FGF/ERK activity also induced the expression of Wnt1. This factor is 
generally considered a canonical WNT because it co-localizes with β-catenin in the ventral 
midbrain and mutation of Wnt1 in vivo lead to a similar phenotype as ß-catenin mutations 
(Castelo-Branco et al., 2004; Castelo-Branco et al., 2003; Danielian and McMahon, 1996; 
Prakash et al., 2006; Tang et al., 2010). To test whether activation of WNT signalling can 
bring about similar effects to PD0325901, I used the small molecule CHIR99021, a selective 
inhibitor of the Glycogen synthase kinase-3 (GSK3ß) with an IC50 less than 10 nM (Bain et 
al., 2007; Murray et al., 2004; Ring et al., 2003). In the absence of WNT, ß-catenin is 
phosphorylated by a GSK3ß containing destruction protein complex inducing its 
degradation. In the presence of WNT, GSK3ß is physically displaced from the complex of 
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regulatory binding partners preventing the phosphorylation and degradation of ß-catenin. 
Thus, inhibition of GSK3ß by CHIR99021 results in the maintenance and accumulation of 
ß-catenin mimicking WNT signalling (Ring et al., 2003). As a transcriptional readout of active 
canonical WNT signalling, I analysed the expression of the downstream target Axin2 by 
qPCR (Jho et al., 2002). As expected, the expression level of Axin2 increased when 
CHIR99021 was added at d0-2 of MD confirming the stimulation of ß-catenin/TCF signalling 
(Figure 4.16 B). The effect of CHIR99021 on Axin2 expression was dose-dependent, as MD 
cultures exposed to 2 µM CHIR99021 showed an enhanced mRNA level of Axin2 when 
compared to cultures that experienced only 0.5 µM. The expression level of Axin2 dropped 
to the transcript level of control cultures at d3 MD after withdrawal of CHIR99021. 
PD0325901 treatment resulted in upregulation of Axin2 (2.5 to 3.7x fold compared to control 
cultures), suggesting that activation of canonical WNT signalling may be involved (Figure 
4.16 B).  
It has been reported that LMX1A is in a autoregulatory loop with the WNT pathway in the 
context of mDA neurogenesis (Chung et al., 2009). I therefore asked whether CHIR99021 
could mimic PD0325901 in upregulating of Lmx1a. The expression of Lmx1a in cultures 
exposed to CHIR99021 was similar to control cultures at d1 whereas Lmx1a induction was 
already evident in PD0325901-treated cultures (Figure 4.16 B). However, at d2 MD, the 
mRNA level of Lmx1a visibly increased in CHIR99021-treated cultures compared to cultures 
without factor. Furthermore, expression of Dmrt5 was not affected by CHIR99021. These 
findings suggest that other pathway(s) may contribute to the induction of the mDA neural 
progenitor fate. 
It has been reported that in the developing midbrain OTX2 and WNT1 are in a positive 
regulatory feedback loop (Chung et al., 2009; Prakash et al., 2006). To investigate whether 
the observed Otx2 upregulation is mediated by WNT1, I examined OTX2 and Gbx2 by 
immunocytochemistry and qPCR (Figure 4.16 C-E). No increase of OTX2 positive cells was 
observed at d5 MD with any concentrations of CHIR990221 (0.5 µM: 6±2.02%; 2.0 µM: 
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16±6.02%) when compared to control cultures (16±3.57%), whereas in PD0325901-treated 
sister cultures the majority of cells were OTX2 positive neural progenitors (64±13.64%) 
(Figure 4.16 C, D). In addition, no reduction of Gbx2 expression was seen in cultures 
experienced early inhibition of GSK3ß (Figure 4.16 E).  
4.7.3 The effects of combined treatment of SHH and CHIR99021 on mDA 
induction 
Because SHH and CHIR99021 only partially induced mDA neural progenitor characteristics 
(↑Foxa2, ↑Lmx1a), I next studied their combination in mDA induction. In the presence of both 
CHIR99021 and SHH at d0-2 MD, the expression of Lmx1a and Foxa2 at d2 MD increased 
up to ~3 times compared to control cultures, similar to that observed in cultures exposed to 
PD0325901 (Figure 4.17 B). However, unlike PD0325901 treatment, no upregulation of 
Dmrt5 was observed (Figure 4.17 B). Furthermore, the proportion of OTX2 positive cells in 
cultures with SHH and CHIR99021 (SHH & 0.5 µM CHIR99021: 5.56±2.5%; SHH & 2µM 
CHIR99021: 0.35±0.22%) was even below the percentage observed in control cultures at d5 
MD (16±3.57%) (Figure 4.17 C, D). In keeping with this observation, a downregulation of 
Gbx2, as in PD0325901 treated cultures, was not detected in cultures exposed to SHH and 
CHIR99021 (Figure 4.17 E). Nonetheless, I performed terminal neural differentiation with 
PD0325901, CHIR99021 alone or with SHH and no-factor, as illustrated in Figure 4.18 A, 
and tested whether robust induction of the mDA regulators Lmx1a and Foxa2 potentiate 
mDA neuronal production. I applied immunofluorescent staining at d14 MD to examine the 
generation of DA neurons with midbrain character, marked by TH and FOXA2 double 
positive cells. As anticipated, most of FOXA2 and TH double positive cells were detected in 
cultures treated with PD0325901 at d0-2 (Figure 4.18 B). Only few TH positive cells were 
observed in MD cultures with CHIR99021, CHIR99021-SHH or without factors. Most of these 
TH positive cells did not co-express FOXA2, suggesting that they might be a different 
subpopulation of DA cells. On the other hand, the cell population of FOXA2 positive cells 
was slightly but consistently increased in cultures exposed to CHIR99021 alone or its 
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combination with SHH. It is possible that CHIR99021 treated cells respond more efficiently to 
secreted SHH. 
Taken together, neither SHH, canonical WNT signalling nor their combination can replace 
early inhibition of FGF/ERK activity in the generation of mDA neurons, indicating that other 
pathways are involved in this process.  
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Figure 4.12 Activation of SHH pathway is not sufficient for complete mDA induction. 
(A) Experimental schemes for data in B. (B) Mouse E14tg2a EpiSC MD cultures were 
exposed to PD0325901 (PD03) and/or SHH from d0 MD for 2 days. Cultures were harvested 
at d1-3 for qPCR analysis of the mDA fate inducing signalling molecule Shh and its 
downstream target genes Gli1 and Foxa2 as well as the midbrain genes Lmx1a, Msx1, and 
Dmrt5. The value of the d1 MD control was set as 1. Error bars indicate s.e.m. of two sets of 
experiments performed in triplicate.   
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Figure 4.13 Early inhibition of FGF/ERK acts partly via the SHH pathway. 
(A) Experimental schemes for data in B. (B) Mouse E14tg2a EpiSC MD cultures were 
treated with PD0325901 (PD03), the SHH antagonist cyclopamine or a combination of the 
two as indicated. Cultures were harvested at d1, d2, and d3 for qPCR analysis of the mDA 
fate inducing signalling molecule Shh and its downstream target genes Gli1 and Foxa2 as 
well as the midbrain progenitor genes Lmx1a, Msx1, and Dmrt5. The value of the d1 MD 
control was set as 1. Error bars indicate s.e.m. of two sets of experiments performed in 
triplicate.   
87 
 
 
  
88 
 
Figure 4.14 SHH treatment cannot induce midbrain neural progenitor fate. 
(A) Mouse E14tg2a EpiSC MD cultures were exposed to PD0325901 (PD03), SHH or to no-
factor control from d0 MD for 2 days. Cultures were harvested at d1, d2, and d3 for qPCR 
analysis of the hindbrain marker gene Gbx2 and the midbrain genes En1 and Dmbx1. The 
value of the d1 MD control was set as 1. Error bars indicate mean±s.e.m. of two sets of 
experiments performed in triplicate. (B) EpiSC MD cultures were treated with PD0325901 
(PD03), SHH, or without a factor (Control) at d0-2 and exposed to SHH and FGF8 from d5 
for 4 days. MD cultures were fixed at d5 and d9 for analysis by immuncytochemistry. 
Immunostaining of d5 and d9 MD E14tg2a EpiSCs (top two rows) and Lmx1a-GFP EpiSCs 
(bottom two rows). Antibodies against OTX2, red, and Nestin, green, or OTX2 alone, red, 
were used in E14tg2a EpiSCs. FOXA2 and GFP, green, and Nestin, red, were used in the 
Lmx1a-GFP panels. Scale bar: 100 µm. (C) Quantification of OTX2 immunostaining at d9 in 
E illustrating the percentage of cells expressing OTX2. Mean±s.e.m. of ten fields from two 
independent experiments. *, P<0.01 relative to no-PD0325901 control (Student’s t-test).   
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Figure 4.15 Activation of SHH alone cannot replace early blockade of FGF/ERK 
pathway in the generation of DA neurons. 
(A) Experimental schemes for data in B. (B) MD cultures of EpiSCs at d14 were double 
stained for TH, red, and TUBB3, green. Scale bar: 200 µm.  
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Figure 4.16 Activation of the WNT pathway does not mirror the effects of early ERK 
inhibition in neural differentiation.  
(A) Experimental schemes for data in B-E. (B) EpiSCs were differentiated in the presence of 
PD0325901 (PD03), 0.5µM or 2.0µM CHIR99021 from d0 MD for 2 days. RNA was collected 
at d1-3 and tested for Axin2, Lmx1a, and Dmrt5 by qPCR. The value of the d1 MD control 
was set as 1. Error bars indicate mean±s.e.m. of two sets of experiments performed in 
duplicates. (C) Antibody staining for the anterior marker OTX2 labelled with red in d5 MD 
cultures with or without PD0325901 or CHIR99021. DAPI is labelled in blue (top row) and 
Nestin is coloured in green (bottom row). Scale bars: 100 µm. (D) Quantification of 
immunostaining in C illustrating the percentage of cells expressing OTX2. Mean±s.e.m. of 
ten fields from two independent experiments. *, P<0.01 relative to no-PD0325901 control 
(Student’s t-test). (E) Mouse E14tg2a EpiSC MD cultures were exposed to PD0325901 
(PD03), 0.5 µM or 2.0 µM CHIR99021 or no-factor control from d0 MD for 2 days. Cultures 
were harvested and analysed as in B for qPCR analysis of Gbx2.   
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Figure 4.17 SHH and CHIR99021 treatment partly mimics early ERK inhibition. 
(A) Experimental schemes for data in B-E. (B) EpiSCs were differentiated in the presence of 
no factors, PD0325901 (PD03), and CHIR99021 together with SHH from d0 until d2 of MD. 
RNA was collected at d2 and tested for Axin2, Lmx1a, Foxa2, and Dmrt5 by qPCR. The 
value of control was set as 1. Error bars indicate s.e.m. of two sets of experiments 
performed in duplicates. (C) Antibody staining for the anterior marker OTX2 labelled with red 
in d5 MD cultures without or with factors as indicated. DAPI is labelled in blue (top row) and 
Nestin is coloured in green (bottom row). Scale bars: 100 µm. (D) Quantification of 
immunostaining in C illustrating the percentage of cells expressing OTX2. Mean±s.e.m. of 
ten fields from two independent experiments. *, P<0.01 relative to no-PD0325901 control 
(Student’s t-test). (E) EpiSCs were differentiated in the presence of no factors, PD0325901 
(PD03), and CHIR99021 together with SHH at d0-2 MD RNA was collected at d1, d2 and d3 
MD and analysed for Gbx2 by qPCR. The value of the d1 MD control was set as 1. Error 
bars indicate mean±s.e.m. of two sets of experiments performed in duplicates.   
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Figure 4.18 Early stimulation of SHH and WNT pathway cannot substitute ERK 
inhibition in the generation of DA neurons. 
(A) Experimental scheme of neural differentiation with mouse EpiSCs. MD cultures were 
exposed to PD0325901 (PD03), CHIR99021 and SHH or to no-factor control at d0-2 MD. 
SHH and FGF8 were applied from d5 until d9 of MD. Medium was then changed to N2B27 
plus GDNF, BDNF and ascorbic acid and cultured for another 4 days. (B) MD cultures at d14 
were double stained for TH, red, and FOXA2, green. DAPI is labelled in blue. Scale bar: 
200 µm.  
A 
B 
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4.8 Discussion 
 
Midbrain characteristic DA neurons derived from stem cells provides a unique opportunity in 
cell therapy and drug discovery for developing novel strategies for brain repair in PD. 
However, the generation of ‘authentic’ mDA neurons in a robust and reproducible manner 
requires an in-depth understanding of the mechanisms that control the fate choice of stem 
cells during differentiation. The data of the present chapter revealed that a stepwise control 
of FGF/ERK activity during specific stages of neural differentiation can effectively promote 
the generation of authentic mDA neurons from mouse PSCs.  
Regulation of mDA differentiation by controlling FGF signalling  
Compared to ESCs, EpiSCs, the in vitro counterpart of postimplantation epiblast stem cells, 
have already completed the transition from a naive pluripotent stage toward a primed stage 
of lineage commitment which involves the activation of FGF signalling (Kunath et al., 2007; 
Ying et al., 2008). As described in chapter 3, EpiSCs are more synchronised in the process 
of neural induction than ESCs. I found that inactivation of FGF/ERK pathway by either FGFR 
or ERK inhibitor upon the exit of the epiblast pluripotent stage specifies nascent neural 
progenitor cells towards mDA progenitor fate. Notable, our strategy appears to induce 
region-specific gene expression almost at the same time when neural induction occurs, 
implying that coupling neural induction and regionalisation may be crucial for generating 
specific neuronal cell types in vitro.  
To maintain the mDA neural progenitor characteristics, these cells require endogeneous 
FGF signalling (Figure 4.3 A). Addition of FGF8 or continued PD0325901-treatment after the 
onset of a ventral midbrain fate abolished the early increased expression levels of mDA key 
regulator genes (Foxa2, Lmx1a, Dmrt5) caused by early FGF/ERK blockade (Figure 4.3 B 
and 4.11), suggesting that the level of FGF signalling is important. Previous in vivo studies 
revealed that high levels of FGF8 specify cells of the presumptive midbrain to a hindbrain 
fate (Liu and Joyner, 2001; Liu et al., 2003; Sato et al., 2001) whereas reduction of FGF 
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signalling in the midbrain instructs cells toward anterior cell fates (Basson et al., 2008; Lahti 
et al., 2012). In keeping with these findings, an increase or decrease of FGF8 in the 
prospective diencephalon or hindbrain respectively induce a midbrain identity (Crossley et 
al., 1996; Lee et al., 1997; Liu et al., 1999; Martinez et al., 1999; Sato et al., 2001; Sato and 
Nakamura, 2004; Shamim et al., 1999). I also found that increase of FGF signalling resulted 
in an upregulation of the isthmus organizer related genes, Wnt1, En1, and En2 (Figure 
4.11), supporting previously reported cross-regulatory network between these molecules 
(Wurst and Bally-Cuif, 2001; Ye et al., 2001). Furthermore, these genes have been shown to 
be essential for the differentiation and survival of DA neurons (Prakash et al., 2006; Simon 
et al., 2001; Tang et al., 2009). However, it has been reported that SHH and canonical WNT 
signalling have opposing roles in mDA neurogenesis (Joksimovic et al., 2009; Tang et al., 
2010). Thus, for an efficient generation of mDA neurons, it might be crucial to allow SHH-
dependent progenitor specification and expansion before activating FGF signalling by FGF8 
which indirectly stimulates WNT signalling (Andersson et al., 2006b; Hynes et al., 1997; 
Sasaki et al., 1997). These findings point out the importance of precise temporal control of 
FGF signalling to orchestrate mDA midbrain induction and neurogenesis. 
Early inhibition of FGF/ERK signalling promotes acquisition of a midbrain 
neural progenitor identity 
I found that blocking specifically FGF/ERK signalling at the onset of EpiSC MD directs a 
midbrain fate in the anterior-posterior axis by suppressing both hindbrain (Gbx2 expression) 
and the forebrain fates (Foxg1 and Six3 expression) (Figure 4.5) whereas blockade of 
FGF/PI3K did not modulate anterior-posterior characteristics (Figure 4.6). However, it is 
unclear whether blockade of the FGF/PLC-γ pathway instruct cells toward a midbrain fate. 
Recent reports demonstrated that forced expression of any of the mDA regulator genes 
(Lmx1a, Otx2, Dmrt5, Foxa2) lead to an increased production of DA neurons (Chung et al., 
2009; Friling et al., 2009; Gennet et al., 2011; Kittappa et al., 2007) and combined 
overexpression of Oxt2, Lmx1a, and Foxa2 significantly improved the generation of mDA 
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neurons (Chung et al., 2009). My results showed that a complete set of the key mDA 
progenitor transcription factors (FOXA2, LMX1A, DMRT5 and OTX2) was already induced at 
d5 MD in PD0325901-treated neural progenitor cells (Figure 4.3 and 4.5). These cells 
exposed to SHH and FGF8 differentiated efficiently into mDA neurons. Although, untreated 
neural progenitors exposed to SHH and FGF8 for 4 days (d5-9) showed an increase in the 
number of FOXA2 and LMX1A positive cells at d9 MD (Figure 4.14 B), their efficiency to 
convert into mDA neurons was low compared to PD0325901-treated MD cultures (Figure 4.7 
and 4.9). These data suggest that an early induction of Lmx1a and Foxa2 is required for 
highly efficient production of mDA neurons.  
Implications of SHH and WNT1 
SHH and WNT1 are required for the expression of Otx2 (Chung et al., 2009; Prakash et al., 
2006; Puelles et al., 2004), Lmx1a (Andersson et al., 2006b; Chung et al., 2009) and Foxa2 
(Hynes et al., 1997; Sasaki et al., 1997). These factors form a network that coordinates mDA 
differentiation (Chung et al., 2009; Lin et al., 2009; Nakatani et al., 2010; Prakash et al., 
2006; Tang et al., 2010). The results of this chapter revealed a robust induction of Shh and 
Wnt when exposed to FGF/ERK inhibitor (Figure 4.3). One might ask whether the effect of 
early FGF/ERK inhibition is based on the initiation of these signalling molecules. However, 
MD of EpiSCs in the presence of either SHH or canonical Wnt pathway or both only partially 
mimicked PD0325901 effect on nascent neural progenitors (↑Foxa2, ↑Lmx1, ↓Dmrt5, ↓Otx2) 
and failed to produce a high number of DA neurons (Figures 4.12 and 4.16-17), suggesting 
that a fully correct region-specific identity is essential for efficient generation of mDA 
neurons. 
It was demonstrated that SHH establishes the dorso-ventral axis and subsequently 
controlling the positioning and generation of DA neurons in the ventral midbrain (Andersson 
et al., 2006b; Ye et al., 1998). The same studies showed that SHH has no effect on the 
formation of the anteror-posterior axis. Our results also revealed that SHH applied at d0-2 
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had no effect on anterior-posterior identity (Gbx2, Otx2) (Figure 4.14). Thus, other factors 
are needed to synchronise and modulate the cell fate of distinct anteror-posterior identities 
during differentiation of EpiSC. Chung et al. (2009) demonstrated that WNT1 positively 
regulates expression of Otx2 via the canonical pathway, making it a good candidate to shift 
the cell fate toward an anterior character during neural in vitro differentiation. However, 
mimicking the canonical WNT signalling via the GSK3ß inhibitor at d0-2 did neither increase 
the percentage of OTX2 positive cells. In addition, expression of Dmrt5 was neither induced 
by activation of canonical WNT or SHH signalling indicating the involvement of other 
unknown pathways/factors.  
Although activation of canonical WNT pathway resulted in an upregulation of Lmx1a 
expression (Chung et al., 2009), in PD0325901-treated neural differentiation the expression 
of Lmx1a steadily increased even after Wnt1 expression dropped below the levels observed 
in control EpiSC MD cultures (Figure 4.3 B, C). A previous study indicated that Lmx1a is 
induced by SHH (Andersson et al., 2006b) as midbrain explants from chick embryos 
displayed LMX1A positive cells only after SHH treatment. In PD0325901 treated MD 
cultures, Shh expression increased continuously until d5 of differentiation as seen for Lmx1a 
expression (Figure 4.3 B, C), which was enhanced by the addition of SHH to PD0325901 at 
d0-2 and when SHH signalling was blocked by cyclopamine Lmx1a expression dropped at 
d3 after an initial burst of upregulation, implying a role of SHH in the regulation of Lmx1a 
expression. These findings lead to an interesting question whether Lmx1a is initially induced 
by canonical WNT pathway and later on maintained and stabilised by SHH signalling.  
Efficient generation of mDA neurons from PD0325901-treated EpiSCs  
Differentiation protocols using growth factors to control the process have so far been highly 
variable and limited in the generation of DA neurons (Kawasaki et al., 2000; Lee et al., 
2000b; Ying and Smith, 2003). Cells derived by these strategies represented a mixed 
population containing neural cells at different developmental stages, or other embryonic 
germ layer lineages and undifferentiated ESCs which used in cell replacement therapy can 
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cause the formation of tumour or transplant-induced diseases such as dyskinesia. Although 
overexpression of mDA transcription factors increases markedly the efficacy of ESC-derived 
DA neurons (Chung et al., 2009; Chung et al., 2002; Friling et al., 2009; Kittappa et al., 
2007; Maxwell et al., 2005), the genetic manipulations are a burden for the production of DA 
neurons for clinical trials. Therefore, there is a pressing need to develop a robust chemically 
defined condition that can rapidly convert stem cells into DA neurons of midbrain identity in a 
synchronised manner. In this chapter, I have presented a novel strategy of highly reliable 
nature that allows producing mDA neurons in high yield and fully chemical defined condition 
free from genetic manipulation. The presence of the FGF/ERK inhibitor at the onset of EpiSC 
MD resulted in a remarkably increase of TH positive cells. A common problem of DA 
differentiation protocols is the sub-specification into distinct DA cell phenotype. The majority 
of DA neurons generated by my new method are mDA specific as confirmed by co-
expression of the marker genes LMX1A, FOXA2, NURR1, TH, PITX3, and VMAT.  
It is worth to note that, even without FGF/ERK inhibitor treatment, nearly 40% of TH positive 
neurons were immunopositive for PITX3 in MD of EpiSCs which is much higher than that 
from ESCs (Andersson et al., 2006b; Friling et al., 2009; Parmar and Li, 2007). This 
suggests that using the more synchronised nature of EpiSC differentiation is important for 
the effective enrichment of mDA-competent progenitors.   
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5 Functional analysis of in vitro derived midbrain 
dopaminergic neurons 
 
A major goal of in vitro derived mDA neurons will be their use for disease modeling and cell 
therapy. Thus, it is essential to test the functional properties of these cells and their 
functional integration to the surrounding host tissue. I therefore set up collaborations to 
investigate whether the cells I generated and described in Chapter 4 exhibit 
electrophysiological properties similar to those of mDA neurons in vivo as well as their ability 
to integrate into the striatum of a 6-hydroxy-dopamine-lesioned mouse model PD. 
 
5.1 In vitro generated mDA neurons exhibit functional neuronal 
characteristics 
 
Electrophysiological characterisation of mDA neurons was carried out in collaboration with 
Dr. Jessica Risner-Janiczek in our laboratory, using facilities of Dr. Mark Ungless at the 
MRC Clinical Sciences Centre in London. For this study, I employed a reporter cell line in 
which GFP is inserted into the Pitx3 locus allowing specific labelling of mDA neurons (Zhao 
et al., 2004). Pitx3-GFP EpiSCs were first cultured for two days with or without PD0325901. 
From d5 until d9 of MD the cultures were treated with SHH and FGF8 and were then further 
differentiated in the presence of BDNF, GDNF, and ascorbic acid. GFP positive neurons 
were analysed by whole-cell recordings at d14-16 MD. Neurons derived from EpiSC-MD 
cultures with or without PD0325901 exhibited a negative resting membrane potential which 
is a characteristic feature of neurons (control, –67±1.3 mV, n=6; PD0325901, –45±4.7, n=13; 
P<0.05). Neurons generated with PD0325901 treatment showed a slightly more depolarized 
resting membrane potential when compared to those in no-PD0325901 control cultures. The 
input resistance was similar for neurons generated under both conditions (control, 422±198 
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MΩ, n=8; PD0325901, 558±79 MΩ, n=15; P>0.05). Furthermore, no difference was seen 
between the groups in whole-cell capacitance (control, 9.6±1 pF, n=8; PD0325901, 12±5 pF, 
n=15; P>0.05). As we did not observe any changes in the input resistance and whole-cell 
capacitance in neurons from PD0325901-treated MD cultures, we assume that PD0325901 
treatment had no affect on the cell size. 14% of Pitx3-GFP positive neurons showed multiple 
spontaneous potentials (n=14) (Figure 5.1 B). Stimulation with a depolarizing current pulse 
resulted in an overshooting action potential in all cells (n=14) of which 19% (3/14) responded 
by firing multiple action potentials with a low frequency (0.95±0.14 Hz; n=3) and in an 
irregular pattern (CV-ISI, 1.19±0.24; n=3). When cells were cultured in medium containing 
BDNF, GDNF, and ascorbic acid until d40, we observed 67% (PD0325901, 6/9) of cells firing 
spontaneous action potentials (3.54±0.8 Hz; CV-ISI, 0.49±0.08; n=6). These cells displayed 
a pacemaker-like activity typical of mDA neurons (Figure 5.1 E). Moreover, all Pitx3-GFP 
positive neurons demonstrated a large outward current in voltage–clamp mode, typical of a 
delayed-rectifier K+ current (2.19±0.28 nA, n=15; P>0.05) (Figure 5.1 D, left panel). The 
cells exhibited fast activating, fast-inactivating inward currents that is a typical feature of Na+ 
currents (1.69±0.25 nA, n=15; P>0.05) (Figure 5.1 D, right panel).  
In summary, these results provide evidence that the mouse EpiSC-derived Pitx3-GFP 
positive neurons acquired functional, neuron-like properties that were similar to those of 
mDA neurons in vivo. 
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Figure 5.1 Pitx3-GFP positive cells exhibit functional neuron-like electrophysiological 
properties. (kindly provided by Dr. Jessica Risner-Janiczek). 
(A) DIC and GFP image showing a recording pipette patched onto a mouse Pitx3-GFP 
positive cell. (B) Spontaneous action potentials fired by a d14 neuron. Vertical scale bar, 20 
mV; horizontal scale bar, 5 ms. (C) A single spontaneous action potential (left). A single 
action potential fired in response to a 50 pA depolarizing current pulse (middle). Multiple 
action potentials fired in response to a 50 pA depolarizing current pulse (right). Vertical bars, 
20 mV; horizontal bars, 50, 100, and 100 ms, respectively. (D) Outward current evoked by a 
serious of voltage steps (left). Fast inward current evoked by a series of voltage steps (right). 
Vertical bars, 1 nA; horizontal bars, 50 ms. (E) Pacemaker-like spontaneous firing a d41 
neuron. Vertical bar, 20 mV; horizontal bar, 1 second.  
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5.2 Transplantation of in vitro generated mDA progenitors in a 
mouse model of Parkinson’s disease  
 
I then investigated whether DA neurons generated by the present protocol can functionally 
integrate in the brain of a mouse PD model. This part of the work was carried out in 
collaboration with Prof. Steve Dunnett’s laboratory at Cardiff University.  
5.2.1 Modification of differentiation protocol 
Many lines of previous studies demonstrated that the developmental stage of the donor cells 
is pivotal for survival and efficient functional integration in animal models of PD0325901. The 
most suitable donor cells appear to be those that are mDA specified and yet to leave the cell 
cycle (Brundin et al., 1988; Das et al., 1980; Finger and Dunnett, 1989; Torres et al., 2007). 
From a practical standpoint, a shorter differentiation time prior to transplantation may benefit 
cell survival during transportation of the cells. Therefore, I sought to modify the protocol to 
accelerate and possibly enhance mDA lineage commitment. SHH is a well known 
ventralising factor that induces the generation of floorplate cells including cells from which 
mDA neurons derive (Bayly et al., 2007; Blaess et al., 2006; Fedtsova and Turner, 2001; 
Hynes et al., 1995; Ye et al., 1998). I therefore proposed that SHH added at d2-5 straight 
after PD0325901 treatment would enhance the induction of ventral midbrain progenitor cells 
and subsequently the conversion into mDA neurons. MD cultures were stained at d5 MD for 
OTX2, LMX1A, FOXA2, and DMRT5, and the percentage of cells expressing one of these 
markers were quantified by pixel analysis (Figure 5.2 B, C). I found that early SHH 
treatment, either alone or following PD0325901 treatment, significantly increased the 
number of FOXA2 positive cells (control: 24±9%; SHH: 77±6%; PD0325901-SHH: 40±18%) 
by d5 MD (Figure 5.2 C). Furthermore, early SHH following PD0325901 also resulted in an 
increase of LMX1A positive cells compared to with PD0325901 alone cultures (PD0325901: 
12±4%; PD0325901-SHH: 17±4%) (Figure 5.2 C). However, SHH had no effect on the 
generation of DMRT5 and OTX2 positive cells (Figure 5.2 C).  
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To see how above changes might impact on the generation of DA cells, progenitors in all 
four MD cultures were allowed to differentiate till d14 of MD (Figure 5.3 A). Immunostaining 
for TH revealed that cultures with the earlier SHH treatment following PD0325901 generated 
the most numbers of TH positive cells (Figure 5.3 B). Interestingly, no-PD0325901 MD 
cultures treated with SHH at d3-5 also generated more TH positive cells compared to the 
basal control condition. This number is still lower than those original plus PD0325901 
condition. This data indicates that enhanced induction of FOXA2 alone by SHH at d5 is not 
sufficient for DA commitment. 
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Figure 5.2 Early blockade of FGF signalling and postliminary enhancement of SHH 
signalling support generation of ventral midbrain progenitor cells. 
(A) Experimental schemes for data in B. (B) Mouse E14tg2a EpiSC MD cultures were 
treated with PD0325901 (PD03) at d0-2 or SHH at d2-5 or a combination of the two as 
indicated in A. At d5, cultures were analysed by immunocytochemistry for the anterior 
marker OTX2, red, and the midbrain progenitor markers LMX1A, FOXA2, and DMRT5, all 
shown in green. DAPI is labelled in blue. Scale bars: 200 µm. (C) Quantification of 
immunostaining in B illustrating the percentage of cells expressing OTX2, FOXA2, LMX1A, 
or DMRT5. Mean±s.e.m. of ten fields from two independent experiments. *, P<0.05 relative 
to no-PD0325901 control (Student’s t-test).   
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Figure 5.3 ERK inhibition followed by stimulation of the SHH signalling promotes the 
generation of DA neurons. 
(A) Experimental schemes for data in B. (B) Mouse E14tg2a EpiSC MD cultures were 
treated with PD0325901 (PD03) at d0-2 or SHH at d2-5 or a combination of the two as 
indicated in A. From d5 until d9 of MD, all cultures were exposed to SHH and FGF8. 
Cultures were stained for the DA marker TH labelled with at d14 MD. DAPI is labelled in 
blue. Scale bars: 100 µm.    
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5.2.2 Transplantation of EpiSC-derived mDA progenitors; pilot study 
The pathophysiology of PD is the preferential loss of a specific DA neuronal subpopulation, 
those in the Substantia Nigra (SN). These cells project to the striatum and form the 
dopaminergic nigrostriatal pathway which controls motor functions. Embryonic midbrain cells 
transplanted into the striatum has been shown to differentiate into DA neurons, survive 
longterm, re-innervate the striatum and improve motor control (Bjorklund et al., 1980; Bolam 
et al., 1987; Doucet et al., 1989; Dunnett et al., 1983; Dunnett et al., 1987; Lindvall and 
Bjorklund, 1989; Madrazo et al., 1988; Mendez et al., 2005; Schmidt et al., 1983). These 
findings demonstrate the functionality of cell derived from embryonic midbrain tissue. To test 
whether the cells generated by the present protocol have the potential to replace the loss of 
mDA neurons, we have used 6-hydroxydopamine (6-OHDA) treated mouse models of PD. 
Injection of the catecholaminergic neurotoxin 6-OHDA into the area where the ascending DA 
fibres is at its most compact, the medial forebrain bundle, results in a robust degeneration of 
the dopaminergic nigrostriatal pathway. In order to reduce health problems of the animals, 
unilateral depletion was carried out which in addition allows a variety of behavioural tests 
(Heuer et al., 2012). Cells transplanted into the SN do not reconnect with the striatum 
(Collier et al., 2002; Mukhida et al., 2001; Nikkhah et al., 1994; Starr et al., 1999). Therefore, 
cells are generally placed within the striatal target region.  
Previous transplantation studies demonstrate that maximum functional integration is 
achieved with ventral midbrain progenitors prior to neurogenesis (Brundin et al., 1988; Das 
et al., 1980; Finger and Dunnett, 1989; Torres et al., 2007). In my culture system, active 
neuronal differentiation occurs from d7 MD. We therefore transplanted cells of d5 and d7 MD 
into striatum of mice that had been lesioned with 6-OHDA. Both d5 and d7 cultures were 
exposed to PD0325901 at d0-2 followed by SHH treatment from d2 till transplantation. D7 
cultures received two days exposure of FGF8. At the time of transplantation most of the cells 
were Nestin positive (Figure 5.4 A). Immunostaining and pixel analysis revealed a similar 
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proportion of cells positive for OTX2, FOXA2, LMX1, and DMRT5 in d5 and d7 MD cultures 
(Figure 5.4 A, B).  
To investigate the integration, differentiation, and neuronal function, drug-induced behavioral 
rotation tests were performed. Here we used the DA agonist amphetamine which induces 
typical body rotations in unilateral 6-OHDA lesioned mice to the side of the DA-depletion. 
Consequently, any recovery by the transplanted cells will be observed by a significant 
reduction in rotational behaviour. In vivo DA neurons of the SN are part of the Basal Ganglia 
which forms a circuit that controls their activity in the striatum. Grafts that are transplanted 
within the target side, the striatum, are not under the control of this regulatory network. 
Therefore, grafts that are enriched with DA neurons display an overcompensatory response 
which correlates with the induced Dopamine level.  
Eight weeks after transplantation, animals grafted with d7 MD cultures showed a significant 
reduction in amphetamine-induced rotation scores and over-compensatory response in 
6-OHDA lesioned mice (Figure 5.5). However, mice that received d5 MD cultures showed no 
recovery compared to lesion control group. (Figure 5.5).  
To verify whether the observed difference in recovery correlates with DA neuronal 
differentiation and survival after transplantation, immunostaing for TH was carried out on 
brain sections with grafted cells of d5 and d7 MD cultures after 8 weeks of transplantation. 
The loss of DA fibres in the striatum was clearly visible in these sections, demonstrating the 
unilateral depletion of the DA nigrostial pathway by 6-OHDA (Figure 5.6 A). TH positive 
neurons were observed in both d5 and d7 MD grafts, demonstrating their potential for DA 
lineage commitment in vivo. However, d7 MD grafts had significantly more TH positive 
neurons than d5 MD grafts (Figure 5.6 B-E), which could explain the difference of the 
amphetamine-induced rotation behavioural test (Figure 5.5).  
One of the concerns for cell replacement therapy in PD is the formation of tumours and 
neural overgrowth. Strikingly, none of the animals exhibited tumour formation or extensive 
overgrowths in the surviving grafts.  
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Figure 5.4 EpiSC-derived cells display robust induction of ventral midbrain progenitor 
fate at the day of transplantation. 
(A) Mouse Pitx3-GFP EpiSC MD cultures were treated with PD0325901 at d0-2 and SHH at 
d2-5. D7 cultures were exposed to FGF8 and SHH from d5 for 2 days of differentiation. At 
the day of transplantation, cells were fixed and analysed by immunocytochemistry for 
anterior marker OTX2 and the midbrain progenitor markers FOXA2, LMX1A, and DMRT5. 
DAPI is labelled in blue and Nestin is shown in green. (B) Quantification of immunostaining 
in B illustrating the percentage of cells expressing OTX2, FOXA2, LMX1A, or DMRT5. 
Mean±s.e.m. of ten fields from two independent experiments.  
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Figure 5.5 Bar graph of amphetamine-induced rotational behaviour 8 weeks after 
transplantation of lesioned, d5 and d7 MD cultures mice (kindly provided by Dr. 
Sophie Precious and Andreas Heuer). 
Eight weeks after transplantation, amphetamine-induced rotations in unilateral 6-OHDA 
lesioned mice with or without grafts were determined by the number of rotations per minute. 
The black line displays the rotational behaviour of control mice without any lesion. Recovery 
by d7 MD grafts was observed by a significant reduction in the number of rotations to the the 
side of DA-depletion, an overcompensatory response which correlates with the induced 
Dopamine level. The bar graphs represent 11 mice for lesion control group, 16 mice for d5 
MD cell group and 15 mice that received cells of d7 MD cultures. Data represent mean ± 
SEM.  
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Figure 5.6 Substantial graft-derived reinnervation of the lesioned striatum 8 weeks 
after transplantation of d5 and d7 MD cultures (kindly provided by Dr. Sophie 
Precious and Andreas Heuer). 
(A) Immunohistochemistry for TH illustrates the typical dense staining of DA fibers in the 
intact striatum (left) and almost complete loss of TH fibers is seen in 6-OHDA lesioned 
striatum (right). (B+C) Graft-derived re-innervation of the lesioned striatum 8 weeks after 
transplantation (boxed area, graft core). The graft cores in B+C contain stained TH positive 
neurons. (D+E) The boxed area in B+C is shown at larger magnification.   
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5.2.3 Head to head comparison of EpiSC-derived mDA grafts with 
ventral midbrain tissue in 6-OHDA-lesioned mouse models of PD 
Transplantation of embryonic ventral midbrain (VM) tissue into dopamine-depleted animals 
has been studied in detail. In summary, embryonic VM cells have been demonstrated to 
survive, reinnervate into the host striatum, make synaptic connections onto the appropriate 
neuronal populations, and reduce many of the motor deficits caused by dopamine depleting 
lesions (Bjorklund et al., 1980; Bjorklund and Stenevi, 1979; Bjorklund et al., 1983; Dunnett 
et al., 1981; Dunnett et al., 1988; Freed et al., 1980; Perlow et al., 1979; Schmidt et al., 
1983; Schmidt et al., 1982; Schultz, 1982; Schultzberg et al., 1984; Stromberg et al., 1985; 
Wuerthele et al., 1981). These very promising results led to clinical trials started in 1987 
where cells of the human fetal mesencephalic tissue were transplanted to the striatum of PD 
patients. However, the use of fetal tissue involves ethical concerns. Pluripotent stem cells 
(PSC) offer a promising alternative to obtain mDA neurons in vitro but to date it has been a 
challenge to generate PSC-derived mDA neurons that functionally engraft in vivo as 
successfully as embryonic VM cells. 
In the section above (5.2.2), I showed that d7 MD cultures were able to reduce drug-induced 
rotational behaviour in 6-OHDA lesioned mice after 8 weeks of tranplantation. To valuate d7 
MD cultures for cell replacement in PD, we transplanted the d7 MD cells side-by-side with 
ventral E12.5 foetal ventral midbrain cells. Amphetamine-induced rotational test was 
performed before transplantation and at 4, 8, and 16 weeks after transplantation. As 
expected, VM graft goups displayed a decrease in rotations and an over-compensated 
rotational response by 4 weeks post-grafting which was maintained until 16 weeks after 
transplantation (the latest time point examined) (Figure 5.7). The group of mice that received 
d7 MD cultures also showed a decrease in the rotational behaviour but the score was less 
when compared to VM grafts (Figure 5.7). However, the level of over-compensatory 
response increased over the time in d7 MD grafted animals, indicating an increased level of 
Dopamine.  
115 
 
Following the functional assessment, graft survival and neuron cell differentiation was 
evaluated by immunostaining. Both groups displayed good TH positive cell survival within 
the transplanted striatum after 16 weeks of transplantation (Figure 5.8 A). Counting analysis 
of immunohistochemistry data further revealed large numbers of TH positive cells within the 
grafts wich received VM or d7 MD cells (Figure 5.8 A, C), indicating therapeutical potential of 
d7 MD cultures in the treatment of PD.  
A negative side effect of cell replacement in PD is the appearance of graft-induced 
dyskineasia, showing abnormal involuntary movements and postures. The presence of 
serotonergic neurons within grafts is thought to play an important role in graft-induced 
dyskinesia (Braak and Del Tredici, 2008; Carta et al., 2007). Therefore, we performed an 
immunostaing for 5HT to detect serotonergic neurons. As shown in Figure 5.8 B, both the 
VM and d7 MD grafts contained 5HT positive neurons. It has been suggested that the ratio 
of DA neurons to serotonergic neurons may be inversely correlated to the development of 
graft-induced dyskineasia. In this study, the TH/5HT ratio of d7 MD grafts was higher than 
the one of VM grafts (Figure 5.8 C), suggesting that animals which received d7 MD grafts 
might be less likely to develop graft-induced dyskineasia.  
 
In summary, these data demonstrate that the cells produced by the present protocol may 
potentially provide a useful therapeutic source for cell replacement therapy in PD. 
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Figure 5.7 Behavioural analysis in E12.5 VM- versus d7 MD-grafted mice (kindly 
provided by Dr. Sophie Precious and Andreas Heuer). 
Amphetamine-induced rotational test of no-lesion control (12 mice), lesioned (12 mice), VM- 
(29 mice) and d7 MD grafted mice (12 mice) in response to amphaetamine. Bars underlain 
by a grey background show drug induced rotations after 6-OHDA treatment (post lesion). 
Test was performed 4, 8 (control: n=12; lesion: n=12; VM: n=29; d7 MD EpiSC: n=28) and 
16 weeks after transplantation (control: n=12; lesion: n=12; VM: n=21; d7 MD EpiSC: n=20).  
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Figure 5.8 Characterisation of neurons in 6-OHDA lesioned mouse models of PD 
grafted with either d7 MD or VM cells (kindly provided by Dr. Sophie Precious and 
Andreas Heuer). 
(A) Immunohistochemistry for TH on coronal sections illustrating TH positive cell survival 
and striatal reinnervation on the lesioned and grafted striatum with cells of d7 MD cultures or 
VM (E12.5) after 8 and 16 weeks of Transplantation. (B) Immunohistochemistry for the 
serotonergic marker 5HT in 6-OHDA lesioned mice 8 weeks posttransplantation. (C) The 
total number of TH positive and 5HT positive neurons oin the lesioned and grafted striatum 
shown in A and B.   
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5.3 Discussion 
 
In this chapter, I show that EpiSC-derived mDA neurons exhibit electrophysiological 
properties typical of primary mDA neurons. Moreover, after transplantation into 6-OHDA 
lesioned mouse striatum, the mDA progenitor cells survived and differentiated into DA 
neurons, and mediated behavioural improvements. Thus, neural progenitors with ventral 
midbrain characteristics may represent a valuable source for functional and transplantable 
mDA neurons in clinical applications for the treatment of PD.  
Although cells of d5 and d7 MD display the same profile for the molecular markers examined 
(Figure 5.4), only d7 MD cells markedly restored amphetamine-induced behaviour which 
correlates with the observed increase of TH positive cells in the grafts. D7 MD cultures 
received 2 days of FGF8 whereas d5 MD cultures did not, suggesting that the activation of 
FGF signalling is essential for the acquisition of DA properties. These results point towards 
an important point for FGF8 in mDA neural progenitor cells.  
During development of the midbrain and hindbrain region, FGF8 has been reported to be 
involved in patterning (Basson et al., 2008; Crossley et al., 1996; Sato and Joyner, 2009), 
proliferation (Lahti et al., 2011; Xu et al., 2000), and cell survival (Basson et al., 2008; Chi et 
al., 2003). I found that when FGF8 was added during differentiation, the expression of the 
En1/2 was highly increased (Figure 4.11). EN1/2 are implicated in regionalisation of the 
midbrain and hindbrain (Crossley et al., 1996; Liu and Joyner, 2001; Simon et al., 2001) and 
in the survival of mDA neurons (Alberi et al., 2004; Alvarez-Fischer et al., 2011; Sgado et al., 
2006; Simon et al., 2001). Thus, the increase of TH positive cells in grafts with d7 MD 
cultures may be a result of FGF-induced upregulation of En expression, which in turn result 
in decreased cell death and/or proper induction of DA neuronal phenotype.  
To reinforce the importance of FGF8 for the specification of mDA neurons (Ye et al., 1998), 
only EpiSC MD cultures exposed to SHH and FGF8 efficiently produced DA neurons (Figure 
4.7 and 4.9). In addition, I observed that DA neurons exposed to FGF8 displayed a 
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morphologically more mature phenotype compared to cultures with SHH alone (Figure 4.9). 
These data suggest an integral role for FGF8 in the maturation of functional mDA neurons. 
Torres et al (2007) reported that the developmental age of the donor cells has a significant 
impact in cell replacement of DA neurons. Cells derived from ventral midbrain of rat embryos 
(E~12) at a stage, when no DA neurons are present, differentiated into DA neurons after 
transplantation. These cells survived and integrated into the host striatum of 6-OHDA-
lesioned rat PD models. However, foetal ventral midbrain cells taken from E~11 rat embryos 
failed to generate DA neurons post-implantation. Therefore, the possibility cannot be 
excluded that the stage of maturation might also be a reason for the difference in TH positive 
cells in d5 and d7 MD grafts.  
Taken together, temporally controlled modulation of FGF signalling during MD of pluirpotent 
stem cells is crucial for obtaining functional authentic mDA neurons. Furthermore, it provides 
a fully chemically defined system that resembles an attractive tool for biomedical 
applications.   
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6 Concluding remarks and future directions 
 
The characteristics of pluripotent stem cells in broad differentiation potential and self-renewal 
represent a remarkable model to study development in vitro and further offer an attractive 
tool for biomedical application such as cell therapy, disease modelling and drug screening. 
Several studies have demonstrated that ESC-derived mDA neurons transplanted into animal 
PD models can survive and alleviate behaviour deficits (Bjorklund et al., 2002; Cho et al., 
2008; Friling et al., 2009; Hargus et al., 2010; Kim et al., 2002; Kriks et al., 2011; Rodriguez-
Gomez et al., 2007; Roy et al., 2006; Sanchez-Pernaute et al., 2008; Tabar et al., 2008; 
Takagi et al., 2005). However, due to pluripotent nature of ESCs, the generation of a desired 
cell type is often accompanied by other cells that may negatively interfere with the benefits of 
biomedical applications. In order to achieve a pure mDA cell population, it is essential to 
understand the molecular mechanisms responsible for the generation of mDA neurons that 
in turn enable us to commad stem cell fate specification and differentiation.  
The work presented in this thesis is focused on the role of FGF signalling in mDA neuronal 
differentiation using mouse pluripotent stem cells. In summary (Figure 6.1), the findings 
demonstrate a previously unrecognized inhibitory role of FGF/ERK in the institution of a 
midbrain progenitor cell fate and the induction of Wnt and Shh. I show that a period of 
endogenous FGF activity is essential to confer a ventral midbrain progenitor fate and that 
later in differentiation activation of FGF signalling is required to generate mDA neurons. 
EpiSC-derived mDA neurons exhibit functional, neuron-like properties and when implanted 
into the striatum of mouse PD model strongly restored amphetamine-induced rotation 
behaviour without any signs of overgrowth. Thus, a stepwise control of FGF/ERK activation 
during specific stages of neural differentiation from mouse stem cells is crucial for generation 
of authentic, functional mDA neurons. Importantly, this small-molecular-based protocol is 
fully chemically defined, free from genetic manipulation and represents a method for 
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significantly improved efficiency and high reproducibility compared to previously reported 
transgene-free protocols. 
In collaboration with the group of Steve Dunnett we have begun detailed analysis of the 
potential of the mDA precursor cells generated by the current protocol. These studies will 
involve the validation of a midbrain specific DA phenotype in grafts and the precise 
characterisation of grafted non-DA neuronal cells. It cannot be excluded that the observed 
reduced rotation behaviour was caused by cells releasing neurotrophic factors which have 
the ability to regulate the survival of specific neuronal populations in the central nervous 
system. One potential candidate is the glial cell line-derived neurotrophic factor (GDNF) 
which has been demonstrated to protect and restore mDA neurons (Behrstock et al., 2006; 
Dezawa et al., 2004; Redmond et al., 2007). Moreover, by using behaviour tests, we will 
further investigate the consequences of the presence of serotonergic neurons in grafts which 
are assumed to be in causative relationship with graft induced dyskinesia (Carlsson et al., 
2007; Politis et al., 2011; Politis et al., 2010). However, for future therapies of PD, the results 
obtained on mouse cells have to be confirmed on human ESCs.  
Charlie Arber in our group has addressed this point and has obtained encouraging results. 
Briefly, human ESCs were exposed to PD0325901 at d3 MD, a time point when the primitive 
ectoderm/epiblast marker FGF5 was peaked. Indeed, blockade of FGF/ERK signalling after 
initial neurectodermal induction resulted in a direct and early induction of the midbrain 
characteristics at the expense of forebrain and caudal neural fates. Exposure of these cells 
to SHH and FGF8 led to the robust production of DA neurons expressing marker genes for 
correct, ventral midbrain-specific identity. We are currently in the process of validating the 
potential of these hESC-derived ventral midbrain neuronal cells to restore parkinsonian 
symptoms in a rat model of PD.  
Given the similarities in the response to early Erk inhibition during differentiation, cell fate 
decisions of human ESC and mouse EpiSC may be instructed by the same signalling 
pathways. Yet, Kriks et al. (2011) recently reported that early stimulation of SHH and FGF 
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signalling followed by activation of WNT signalling, using the GSK3ß inhibitor CHIR99021, 
can direct human ESC toward an mDA specific fate (↑FOXA2, ↑LMX1A, ↑OTX2). It is worth 
noting that FGF signalling activates the expression of the FGF signalling inhibitors MPK3, 
SPRY and SEF (Eblaghie et al., 2003; Kawakami et al., 2003; Kovalenko et al., 2006; 
Kovalenko et al., 2003; Urness et al., 2008; Vieira and Martinez, 2005). It might be therefore 
possible that such a negative feedback regulation of FGF signalling results in a reduction of 
FGF activity at a time when regional specification occurs. However, this controversy raises 
the need for more direct in vitro analysis of FGF regulation during differentiation toward mDA 
neurons.  
The results of this thesis also revealed that neither stimulation of SHH pathway nor 
activation of canonical WNT signalling or their combination could replace early inhibition of 
FGF/ERK activity in the specification of mouse EpiSCs toward a ventral midbrain progenitor 
cell fate. This observation opens up the possibility that early FGF/ERK inhibition allows the 
activation of other pathways that promote midbrain induction. For example, although 
expression of Lmx1a and Foxa2 were increased by SHH treatment and/or activation of 
canonical WNT signalling, the number of OTX2 positive cells and the expression of Dmrt5 
were not altered. In order to identify pathways that are activated or blocked in a FGF/ERK 
deficient environment, I have recently performed a microarray gene expression assay of d3 
MD EpiSC cultures with and without PD0325901. The outcome of this study would widen our 
knowledge in the molecular interactions between signalling pathways during the process of 
regional specification. Furthermore, the microarray might identify novel surface markers 
specific for ventral midbrain progenitor fate which in turn allows the purification of mDA 
progenitors by fluorescence-activated cell sorting. 
Previous studies indicated that Msx1 is directly induced by LMX1A (Andersson et al., 2006a; 
Chung et al., 2009). In the developing midbrain Msx1 is expressed in the ventral and dorsal 
midline as Lmx1a (Andersson et al., 2006b; Bach et al., 2003; Mishima et al., 2009; Yan et 
al., 2011) strentghten that Msx1 is a downstream target of LMX1A. Andersson et al. (2006) 
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recently reported that SHH can induce the expression of Lmx1a and Msx1 in neural tube 
explants of chick embryos. However, my findings presented in chapter 4.7 show that 
expression of Msx1 was not increased by SHH (Figure 4.12) and treatment with the SHH 
antagonist cyclopamine did not reduce PD0325901-induced Msx1 mRNA level (Figure 4.13), 
implying a SHH-independent activation of Msx1 expression. Interstingly, induction of Lmx1a 
by PD0325901 was abolished at d3 of MD in cultures with cyclopamine. Another study 
demonstrated that WNT1 and LMX1A form a regulatory loop in the gerenation of mDA 
neurons (Chung et al., 2009). However the same study showed that overexpression of Wnt1 
during neural differentiation did not significantly alter the expression of Msx1 while the level 
of Lmx1 expression was highly induced. These observations raise the question of which 
other extrinsic or intrinsic factors regulate Msx1. In other tissues, Msx1 was demonstrated to 
be a downstream target of BMP (Furuta et al., 1997; Liu et al., 2004; Suzuki et al., 1997; 
Timmer et al., 2002) which, in the developing midbrain, is expressed in the roofplate (Bach 
et al., 2003). Therefore, for detailed analysis of the molecular mechanisms during mDA 
neural differentiation, further anaylsis should be carried out to elucidate whether EpiSC-
derived midbrain cell population by early ERK inhibition contain cells of a dorsal midbrain 
progenitor identity.  
The results of chapter 4 pointed out further an important role of DMRT5 in the generation of 
mDA neurons. Dmrt5 is one of the genes upregulated by Erk inhibition, implying a crucial 
role of DMRT5 in the differentiation of mDA neurons as previously suggested (Gennet et al., 
2011). Our lab has recently generated a conditional Dmrt5 KO allele in mouse ES cells for 
elucidating the role of DMRT5 in this process. This model should facilitate the identification 
of factors that are regulated by DMRT5 and to unreveal the precise mechanism in which this 
factor is involved.  
Here, we have focused on the inhibition of FGF signaling via ERK. It would be of importance 
to verify whether FGF/ERK inhibition has an effect on the other two FGF mediated 
pathways, FGF/PI3K and FGF/PLC-γ. I would also like to investigate whether modulation of 
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FGF/PLC-γ has any role in the promotion of mDA neurons by using the PLC-γ inhibitor 
U73122.  
Previous studies demonstrated that dopaminergic neurons of the midbrain targeting the 
striatum are implicated in drug addiction (Reading et al., 1991; Robbins et al., 1990; White, 
1989). In this context, electophysiological studies on Pitx3-GFP positive cells revealed 
features similar to adult dopamine neurons observed in vivo midbrain DA system; even more 
than ex vivo brainslices (unpublished observation by Dr. Jessica Risner-Janiczek). Thus, 
EpiSC-derived mDA neurons represent an attractive model to study in detail the impacts of 
drug exposure: firstly, the desired neurons are easily accessible in vitro for 
electrophysiological studies and, secondly, this strategy allows a powerful high-throughput 
screening of mDA neurons.  
Finally, using the knowledge obtained from in vivo developmental studies, it might be 
interesting to test whether the strategy of early specification can be applied for the 
generation towards other disease-relevant neurons such as medium spiny GABAergic 
neurons lost in Huntington’s disease, basal forebrain cholinergic neurons implicated in 
Alzheimer’s disease or motor neurons affected in spinal cord injury, amyotrophic lateral 
sclerosis, and spinal muscular atrophy. 
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Figure 6.1 Proposed model of FGF signalling in mDA neural differentiation. 
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8 Appendix 
1DEVELOPMENT AND STEM CELLS RESEARCH ARTICLE
INTRODUCTION
The midbrain dopaminergic (mDA) neuron has been a prime target
in stem cell research and developmental neurobiology owing to its
association with Parkinson’s disease. Recent years have witnessed
a rapid advancement in understanding the regulatory cascade that
governs ventral midbrain neuroepithelial cell fate specification and
the differentiation and maintenance of mDA neurons (Andersson
et al., 2006; Ferri et al., 2007; Nakatani et al., 2009).
Overexpression of mDA transcription factors offers a valid strategy
for generating DA neurons from embryonic stem cells (ESCs)
(Andersson et al., 2006; Chung et al., 2005; Kittappa et al., 2007;
Konstantoulas et al., 2010; Maxwell et al., 2005). However, mDA
specification via genetic manipulation is limited and context
dependent (Andersson et al., 2006; Friling et al., 2009; Parmar and
Li, 2007; Roybon et al., 2008). This could be attributed to the fact
that, during development, the transcription factors employed act
only on regionally specified mDA-competent ventral midbrain
progenitors, but the extent to which such progenitor populations
can be generated from pluripotent stem cells using currently
available paradigms remains unclear. Several studies indicate that
ESCs give rise to forebrain-like identity under defined conditions
or to heterogeneous progenitor phenotypes, which exhibit a broad
range of anterior-posterior domain-specific expression profiles,
when differentiated under the influence of stromal feeders and/or
patterning cues (Bouhon et al., 2005; Gaspard et al., 2008;
Kawasaki et al., 2000; Watanabe et al., 2005).
During development, mDA neurons are generated from the
ventral midbrain floor plate cells under the cooperative action of
the homeobox transcription factor Lmx1a and the forkhead
transcription factor Foxa2 (Andersson et al., 2006; Chung et al.,
2009; Lin et al., 2009; Nakatani et al., 2009). A recent gain-of-
function study in ESCs reported that the early expression of an
Lmx1a transgene in ESC-derived neural progenitors is crucial for
its mDA neuron-inducing activity (Friling et al., 2009), suggesting
that temporally restricted characteristics essential for the mDA-
competent state become limited in ESC-derived neural cultures
soon after neural induction. This change in progenitor competency
might explain why sonic hedgehog (Shh), which plays a pivotal
role in ventral midbrain patterning and mDA neuron fate
specification during development (Ye et al., 1998), is reported to
have a widely varying ability to promote mDA neuron production
from mouse or human ESCs (Andersson et al., 2006; Friling et al.,
2009; Kim et al., 2002; Parmar and Li, 2007; Perrier et al., 2004;
Yan et al., 2005). Thus, there is a pressing need to elucidate the
essential attributes of mDA-competent neural progenitors and the
regulators that are capable of inducing this state.
Molecular signaling is essential for shaping cell fate choice
during development. FGF signaling plays multiple roles during the
induction and maintenance of the telencephalon (Paek et al., 2009)
and, together with Wnt, participates in the formation of the isthmus
organizer (IsO) at the midbrain and hindbrain boundary (Olander
et al., 2006). However, prior to IsO induction, phosphorylated
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SUMMARY
Effective induction of midbrain-specific dopamine (mDA) neurons from stem cells is fundamental for realizing their potential in
biomedical applications relevant to Parkinson’s disease. During early development, the Otx2-positive neural tissues are patterned
anterior-posteriorly to form the forebrain and midbrain under the influence of extracellular signaling such as FGF and Wnt. In the
mesencephalon, sonic hedgehog (Shh) specifies a ventral progenitor fate in the floor plate region that later gives rise to mDA
neurons. In this study, we systematically investigated the temporal actions of FGF signaling in mDA neuron fate specification of
mouse and human pluripotent stem cells and mouse induced pluripotent stem cells. We show that a brief blockade of FGF
signaling on exit of the lineage-primed epiblast pluripotent state initiates an early induction of Lmx1a and Foxa2 in nascent
neural progenitors. In addition to inducing ventral midbrain characteristics, the FGF signaling blockade during neural induction
also directs a midbrain fate in the anterior-posterior axis by suppressing caudalization as well as forebrain induction, leading to
the maintenance of midbrain Otx2. Following a period of endogenous FGF signaling, subsequent enhancement of FGF signaling
by Fgf8, in combination with Shh, promotes mDA neurogenesis and restricts alternative fates. Thus, a stepwise control of FGF
signaling during distinct stages of stem cell neural fate conversion is crucial for reliable and highly efficient production of
functional, authentic midbrain-specific dopaminergic neurons. Importantly, we provide evidence that this novel, small-molecule-
based strategy applies to both mouse and human pluripotent stem cells.
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Temporally controlled modulation of FGF/ERK signaling
directs midbrain dopaminergic neural progenitor fate in
mouse and human pluripotent stem cells
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2ERK1/2, which marks regions of FGF signaling, is scarcely
detectable in the epiblast of pre-streak vertebrate embryos (Lunn et
al., 2007) and in the prospective ventral midbrain of early
gastrulating embryos (Corson et al., 2003; Lunn et al., 2007). This
temporospatial restriction of FGF/ERK signaling might be
necessary for initiating the regulatory cascade that induces
competency and cell fate potentials of prospective midbrain neural
progenitors.
Using mouse and human pluripotent stem cells and mouse
induced pluripotent stem cells (iPSCs), we report here for the first
time that a pharmacological blockade of FGF/ERK signaling upon
neural induction induces midbrain-specific characteristics, whereas
a subsequent activation of FGF signaling consolidates and
maintains dopaminergic traits. Combinatorial stimulation with Shh
in this experimental paradigm leads to robust production of
‘authentic’ mDA neurons from mouse and human pluripotent stem
cells.
MATERIALS AND METHODS
Cell culture and neural differentiation
Mouse ESCs, mouse iPSCs and mouse epiblast stem cells (EpiSCs) were
maintained feeder-free as previously described (Guo et al., 2009; Parmar
and Li, 2007; Ying et al., 2003). Mouse EpiSCs were established from
E14tg2a, Sox1-GFP (also referred to as 46C), Pitx3-GFP and Lmx1a-GFP
mouse ESCs as described (Guo et al., 2009). Human ESCs (hESCs; H1
and H7) were cultured on mitomycin C-inactivated feeder cells in knockout
DMEM supplemented with 20% knockout serum replacement (KSR) and
8 ng/ml FGF2. Neural differentiation of hESCs was induced with a 3-day
treatment with Smad inhibitor, but otherwise similar to that described by
Chambers et al. (Chambers et al., 2009). Monolayer differentiation of
EpiSCs was developed based on the method by Ying et al. (Ying et al.,
2003). Briefly, EpiSCs were plated on fibronectin-coated plastics and
cultured in EpiSC media until 50% confluency. Cells were then rinsed
twice with PBS and cultured in retinol-free N2B27. Medium was refreshed
every other day, as with ESC differentiation, where the day cells are
switched to N2B27 is designated as d0 MD. Where indicated, PD0325901
(1 M, Axon), PD173074 (50 ng/ml, Sigma), FGF8b (100 ng/ml,
Peprotech), Shh (200 ng/ml, C25 II-N, R&D) or cyclopamine (2 M,
Sigma) were added to the cultures.
Immunocytochemistry
Cultures were washed twice in PBS then fixed in 4% paraformaldehyde
for 20 minutes. Fixed cultures were washed three times in PBS
containing 0.3% Triton X-100 followed by incubation in blocking
solution containing the above plus 1% BSA and 10% serum compatible
with the secondary antibodies. Cells were then incubated overnight at
4°C with the appropriate primary antibody diluted in blocking solution.
Cells were washed three times in PBS followed by incubation for 1-2
hours with fluorescently labeled secondary antibodies and DAPI
(Molecular Probes). Primary antibodies used were: TH (rabbit, Pel-
Freez), TH (sheep, Pel-Freez), 3-tubulin (mouse, Babco), Pitx3 (rabbit,
gift of M. Smidt, University of Amsterdam), Foxa2 (goat, Santa Cruz),
Lmx1a (rabbit, gift of M. German, University of California, San
Francisco), nestin (DSHB), GFP (mouse, Roche), Otx2 (rabbit,
Millipore) and Nurr1 (rabbit, Santa Cruz).
Images were captured using a Leica TCS SP5 confocal microscope. The
number of Otx2+ cells was determined using ImageJ macro (NIH), based
on the total number of pixels of Otx2-labeled and DAPI-labeled nuclei.
Quantification of other markers was carried out manually by examining
randomly selected fields from at least three independent experiments and
data are presented as mean ± s.e.m. Statistical significance was determined
using a two-tailed Student’s t-test.
Quantitative (q) PCR
Total RNA was extracted using TRI Reagent (Sigma) and processed for
RT-PCR on a Chromo4 real-time PCR detection system according to the
manufacturer’s protocols (Bio-Rad). All PCR data were normalized to the
average of two reference genes: Hmbs and cyclophilin (peptidylprolyl
isomerase A). For PCR primers, see Table S1 in the supplementary
material. All qPCR data are presented as mean ± s.e.m. of at least three
biological replicates.
Electrophysiology
Day 14-16 MD cultures derived from Pitx3-GFP EpiSCs were placed in a
recording chamber and viewed using an Olympus BX51WI microscope
with a 40 water-immersion lens and DIC optics. Cells were bathed in 140
mM NaCl, 3.5 mM KCl, 1.25 mM NaH2PO4, 2 mM CaCl2, 1 mM MgCl2,
10 mM glucose, 10 mM HEPES pH 7.4. For whole-cell recordings, low-
resistance recording pipettes (9-12 M) were pulled from capillary glass
(Harvard Apparatus) and coated with ski wax to reduce pipette capacitance.
Recording pipettes were filled with 140 mM potassium gluconate, 5 mM
NaCl, 2 mM MgATP, 0.5 mM LiGTP, 0.1 mM CaCl2, 1 mM MgCl2, 1 mM
EGTA, 10 mM HEPES pH 7.4. The osmolarity and pH of both solutions
were adjusted before experiments. Prior to recording, the GFP+ neurons
were identified and targeted for recording using fluorescence via a GFP-
selective filter (X-Cite series 120, EXFO). For analysis of action potential
frequency and the coefficient of variation of the interspike interval (CV-
ISI), the first 30 seconds of recording time were used to avoid potential
effects of washout. Data were acquired at room temperature (20-22°C)
using an Axon Multiclamp 700B amplifier and a Digidata 1440a
acquisition system, with pClamp 10 software (Molecular Devices). Data
analysis was carried out using Clampfit 10.2 (Axon), OriginPro 8.1
(OriginLab) and Spike2v5 (Cambridge Electronic Design) software. Data
are presented as mean ± s.e.m.
RESULTS
EpiSCs offer an alternative model for efficient
neural induction in vitro
In vitro differentiation of ESCs is asynchronous, generating
scenarios in which intermediate progenitors of distinct
developmental stages and/or positional identity co-exist and elicit
heterogeneous responses to a given inductive signal. Mouse ESCs
differentiate into somatic cells via the primitive ectoderm/epiblast
stage, when lines of EpiSCs can be established (Brons et al., 2007;
Guo et al., 2009; Tesar et al., 2007). Thus, EpiSCs are
developmentally primed pluripotent stem cells, which might offer
a better in vitro differentiation model than mouse ESCs. We
therefore subjected EpiSCs to a monolayer differentiation (MD)
protocol previously developed in ESCs (Ying et al., 2003). We
found that EpiSCs convert to neuroectoderm cells more quickly
than ESCs (Fig. 1). At day 4 (d4) MD, when Oct4+ cells were still
abundant in ESC MD cultures, few were detected in EpiSC
cultures. However, Sox2, which is expressed in both pluripotent
stem cells and neuroepithelial stem cells, was detected in the Oct4–
d4 EpiSC derivatives (Fig. 1A). At d6, EpiSC cultures contained
numerous nestin+ neural progenitors, whereas significantly fewer
were found in ESC progeny.
Consistent with the above observation, qPCR analysis showed a
more rapid reduction of Oct4 (Pou5f1 – Mouse Genome
Informatics) and Nanog transcripts in EpiSC than in ESC MD
cultures. By contrast, we observed a greater rate of upregulation of
the neuroepithelial genes Sox1 and nestin in EpiSC cultures. This
was followed by an earlier upregulation of the pro-neural genes
Ngn2 and Mash1 (Neurog2 and Ascl1 – Mouse Genome
Informatics) and, subsequently, of the neuronal marker genes
Ncam1 and 3-tubulin (Tubb3) in EpiSC cultures (Fig. 1B).
Taken together, this survey of marker expression indicates that
EpiSCs offer a more rapid neural differentiation system than ESCs.
Furthermore, the pattern of stage-specific gene expression observed
indicates that neural induction occurs during the first 2-3 days of
MD using the EpiSC system.
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FGF/ERK signaling blockade accelerates the
conversion from the epiblast pluripotent state
toward neuroectoderm
FGF/ERK signaling promotes the conversion of ESCs toward
neural progenitors and this signal may be required at multiple
points during neural differentiation (Kunath et al., 2007; Stavridis
et al., 2007). Kunath et al. (Kunath et al., 2007) suggest that ERK-
dependent FGF signaling is required for the exit from an inner cell
mass-like state toward epiblast ectoderm, whereas Stavridis et al.
(Stavridis et al., 2007) argue that this signaling acts in the transition
of epiblast-like cells to neural progenitors. To distinguish between
these possibilities, we performed EpiSC MD in the presence of the
specific FGF receptor inhibitor PD173074 or the potent MEK
blocker PD0325901 (Stavridis et al., 2007; Ying et al., 2008). Both
compounds prevented the phosphorylation of ERK1/2 (Mapk3/1 –
Mouse Genome Informatics) (Fig. 2A). Using EpiSCs derived
from the 46C ESCs, which harbor a knock-in GFP reporter in the
Sox1 locus (Ying et al., 2003), we observed an early appearance of
Sox1-GFP+ neural progenitors (Fig. 2B). This was supported by
immunocytochemical analysis for another neuroepithelial marker,
PLZF (Zbtb16 – Mouse Genome Informatics) (Fig. 2C). This
finding indicates that FGF/ERK signaling blockade accelerates
neural induction of EpiSCs.
Blockade of FGF/ERK signaling at the onset of
EpiSC differentiation induces mDA neural
progenitor characteristics
Isthmus-derived Fgf8 plays an important role in midbrain-rostral
hindbrain patterning and mDA development and has been used as
a standard inductive cue in all ESC differentiation protocols
targeting dopamine neurons (Barberi et al., 2003; Kawasaki et al.,
2000; Kim et al., 2002; Lee et al., 2000; Perrier et al., 2004; Ye et
al., 1998). Surprisingly, we found that treatment with either
PD173074 or PD0325901 at the onset of MD led to early induction
of Lmx1a and Foxa2 (Fig. 3A,B, see Fig. S1 in the supplementary
material). Moreover, cultures that experienced FGF/ERK blockade
for the first 2 days continued to show elevated levels of Lmx1a and
Foxa2 between d3 and d5, as compared with no-PD controls. By
contrast, MD cultures exposed to PD0325901 continuously for 5
days showed a similar level of Foxa2 and a reduced level of Lmx1a
transcript compared with the no-PD culture at d3 and d5 (Fig.
3A,B). Consistent with the RNA analysis, at d5 MD, we observed
a pronounced increase of neural progenitors expressing Foxa2
protein or a knock-in Lmx1a-GFP reporter in cultures exposed to
2 days of PD173074 or PD0325901 (Fig. 3C). These results
demonstrate that blocking FGF/ERK activity on exit of the epiblast
pluripotent state induces appropriate gene markers for the
presumptive ventral midbrain in newly converted neural
progenitors, which then require FGF/ERK signaling to maintain
and consolidate this progenitor trait.
We obtained similar results with PD0325901 and PD173074 for
the gene markers described above (Fig. 3) and the additional
markers presented in Fig. S1A in the supplementary material. The
studies described below were therefore performed with PD0325901
(hereafter referred to as PD) unless stated otherwise.
Temporally controlled modulation of FGF/ERK
signaling leads to highly reliable and efficient
production of mDA neurons
To investigate whether the observed induction of the mDA
progenitor phenotype translates to mDA neuron production either
quantitatively [the number of tyrosine hydroxylase-positive (Th+)
neurons] or qualitatively (the midbrain-specific identity of Th+
neurons), we assessed a panel of markers by immunocytochemistry
at d14 MD. We employed a scheme that is analogous to most DA
differentiation protocols in which Shh is applied to nestin+ cells
(Fig. 4A, see Fig. S2 in the supplementary material) (Barberi et al.,
2003; Kawasaki et al., 2000; Kim et al., 2002; Lee et al., 2000;
Parmar and Li, 2007; Perrier et al., 2004). We found that, despite
the robust induction of Foxa2+ Lmx1a+ neural progenitors at d5,
cultures treated with PD alone did not produce more Th+ neurons
than the standard control culture treated with Shh and FGF8 (SF
control, see Fig. S2A,B in the supplementary material). This might
indicate that the d5 Foxa2+ Lmx1a+ neural progenitors were not
sufficiently specified toward an mDA fate. However, when further
stimulated with Shh and FGF8 for 4 days, PD-treated cultures had
an almost 4-fold increase in Th+ neurons as compared with the SF
control (PD, 52.3±8%; control, 13.5±9%) (Fig. 4B,C). Consistent
with the increase of Th+ neurons, we detected a near 3-fold
increase in extracellular dopamine levels in PD-treated culture
supernatant compared with the SF controls (see Fig. S2D in the
supplementary material). Using another line of EpiSCs, which
carrys a GFP reporter knocked into the Pitx3 locus and drives
mDA-specific GFP expression (Maxwell et al., 2005; Zhao et al.,
2004), we found a substantial increase of Pitx3-GFP+ cells in PD-
treated cultures as compared with the SF controls (40±6.6% versus
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Fig. 1. EpiSCs enter the neuroectoderm
lineage faster than ESCs. (A)Mouse ESC
and EpiSC MD cultures immunostained for
Oct4 and Sox2 at day 4 (top) and nestin at
day 6 (bottom). DAPI labeling is in blue.
(B)qPCR analysis for the expression of
pluripotency and neural lineage genes over
12-day MD cultures of ESCs and EpiSCs.
Data represent mean±s.e.m. from triplicate
cultures of a single experiment.
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45±3.2%; P<0.01) (Fig. 4Be-h). Furthermore, the majority of Th+
neurons in PD-treated cultures were Pitx3-GFP+ (73.8±10.2%).
This was also the case for other mDA and pan-DA neuronal
markers such as Lmx1a (88.5±3.9%), Foxa2 (99.5±1.2%), Nurr1
(Nr4a2 – Mouse Genome Informatics) (85.4±4%) and VMAT
(Slc18a1 – Mouse Genome Informatics) (85.6±12%) (Fig. 4D, see
Fig. S2C in the supplementary material).
We next tested the efficacy of this experimental scheme on
mouse iPSCs. Consistent with the report that FGF/ERK signaling
is required for the progression from the naïve to the primed
pluripotent state (Kunath et al., 2007), we found that PD treatment
from d0 MD inhibited neural induction (data not shown). However,
PD treatment for 2 days either at d1-3 or d2-4 MD significantly
enhanced the production of Th+ neurons compared with controls
without PD (see Fig. S3 in the supplementary material). Similar to
EpiSCs, iPSC-derived Th+ neurons co-expressed Foxa2. Together,
these data demonstrate that FGF signaling blockade during neural
induction primes a midbrain regional fate in derived neural
progenitors that is necessary for their terminal differentiation into
DA neurons exhibiting midbrain characteristics.
Blockade of FGF signaling upon exit from the
epiblast pluripotent state induces Shh and Wnt1
We next investigated how FGF inhibition confers mDA competence.
Wnt1 and Shh are two essential signaling molecules that govern
mDA progenitor fate specification and neurogenesis by forming
regulatory loops with Lmx1a and Foxa2 (Andersson et al., 2006;
Chung et al., 2009; Echelard et al., 1993). We examined Wnt1 and
Shh expression by qPCR in MD cultures treated with PD at d0-2. PD
treatment resulted in a sharp increase in Wnt1 transcript at d1, with
a further increase at d2 (Fig. 5A, see Fig. S2B in the supplementary
material). This effect was also observed with PD173074 (see Fig.
S1A in the supplementary material). Intriguingly, Wnt1 transcript
returned to, or dropped below, control levels at d3-5 irrespective of
the continued presence or absence of PD, indicating that early
FGF/ERK blockade in EpiSCs initiates downstream molecular
events that negatively regulate Wnt1 expression. For Shh, similar
(low) levels of transcript were detected at d1 in PD173074- or
PD0325901-treated culture and in non-treated cultures. However,
1.5-fold and 4-fold increases of Shh transcript were observed at d2
in PD173074 and PD0325901, respectively. The level of Shh
continued to increase (up to 8-fold) post-PD exposure between d3
and d5 (Fig. 5A, see Fig. S1A in the supplementary material). The
kinetics of PD-mediated Wnt1 induction at d1 and d2 MD is similar
to that of Lmx1a, whereas the pattern of Shh upregulation is similar
to that of Foxa2 (Fig. 3, see Fig. S1B in the supplementary material),
indicating a regulatory relationship.
We then investigated the contribution of Shh signaling to the
upregulation of Lmx1a and Foxa2, as these genes are known to be
induced by Shh (Andersson et al., 2006; Chung et al., 2009). We
performed additional MD in the presence of the Shh inhibitor
cyclopamine. This treatment abolished the induction of Foxa2 by
PD, suggesting that PD-mediated Foxa2 regulation is strictly
dependent on Shh signaling (Fig. 5B). Interestingly, cyclopamine did
not affect PD-induced Lmx1a expression at d1-2, but did exhibit an
effect at d3 and d5 (Fig. 5B). Because the Lmx1a transcript was
already induced at d1 MD after 24 hours of FGF/ERK inhibition,
and because Shh was not induced until d2 (Fig. 5A,B, see Fig. S1B
in the supplementary material), our data suggest that the early
induction of Lmx1a by PD might be elicited by Wnt1 in an Shh-
independent feed-forward fashion. However, sustained expression of
Lmx1a between d3 and d5 MD requires Shh signaling.
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Fig. 2. FGF/ERK inhibition accelerates neural fate
conversion of EpiSCs. (A)Western blot analysis for
phospho-ERK in day-2 mouse EpiSC differentiation
cultures treated with PD0325901 (PD) or PD173074.
Samples were loaded undiluted (1) or diluted 1:2 in
loading buffer. (B)MD cultures of Sox1-GFP EpiSCs in
the presence or absence of PD. Sox1-GFP reporter
expression was analyzed by flow cytometry and the
percentage of Sox1-GFP+ cells was determined from
three independent cultures. Error bars indicate s.e.m. 
(C) Antibody staining for a neural rosette marker PLZF
(green) in d2, d4 and d6 MD cultures with or without
PD. DAPI labeling is in blue. Scale bars: 100m.
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FGF/ERK inhibition promotes mDA characteristics
via modulation of anterior-posteriorization and
the maintenance of Otx2
Although PD induces Shh, we found that replacing PD with Shh at
d0-2 did not recapitulate the highly efficient production of mDA
neurons at d14 MD (see Fig. S2A-C in the supplementary
material). This could be due to the relatively late and weaker
stimulation of Lmx1a and Foxa2 by Shh compared with PD (see
Fig. S4A in the supplementary material). However, it is also
possible that FGF/ERK inhibition induces other properties that are
necessary for mDA fate specification.
An attractive hypothesis is that blocking FGF/ERK maintains
anterior neural character, as FGF is known to promote caudal
attributes (for a review, see Wilson and Rubenstein, 2000).
Consistent with this, we found using qPCR analysis that cultures
exposed to PD for 2 days consistently exhibited reduced levels
of Gbx2 (Fig. 5C), which encodes a homeobox protein that is
expressed in the anterior hindbrain and prospective spinal cord.
By contrast, 2 days of stimulation by Shh had no effect on Gbx2
expression. Also consistent with this hypothesis, neural
progenitors co-expressing Otx2, an anteriorly expressed
homeobox protein that forms a mutually repressive circuit with
Gbx2, were significantly more abundant in PD-treated cultures
than in control cultures (Fig. 5E, see Fig. S4B in the
supplementary material) (Millet et al., 1999). Again, Shh in
place of PD at d0-2 MD did not increase the number of Otx2+
neural progenitors at d5 MD (Fig. 5E,F). Furthermore, PD-
treated and non-treated cultures exposed to Shh and FGF8 for a
further 4 days at d5-9 maintained the differential expression of
Otx2 at d9 MD (Fig. 5D-F). These findings suggest that
FGF/ERK blockade promotes the generation of anterior neural
progenitors by suppressing posteriorization.
FGF signaling from the anterior neural ridge plays an important
role in the formation of forebrain (Paek et al., 2009). We therefore
determined the effect of FGF/ERK inhibition on the expression of
the telencephalic gene markers Six3 and Foxg1. As expected,
increases of Six3 and Foxg1 transcripts were readily detected from
d2 and d3 MD, respectively, in the control cultures without PD
(Fig. 5G). By contrast, PD-treated cultures did not upregulate either
of the telencephalic marker genes. Furthermore, we detected a
sharp increase in the mesencephalic transcription factor genes
engrailed 1 (En1) at d1 and En2 from d2 MD in PD-treated, but not
Shh-treated, cultures (Fig. 5C). Taken together with the finding that
PD induces Wnt1, these data suggest that FGF/ERK inhibition
confers a midbrain bias within the Otx2+ anterior neural progenitor
population. Otx2 has been shown to play a regulatory role in
Lmx1a transcription and in the proliferation and differentiation of
mDA progenitors (Brodski et al., 2003; Chung et al., 2009; Omodei
et al., 2008; Ono et al., 2007). Thus, the retention of Otx2 in neural
progenitors, and the early induction of isthmus-patterning
molecules by FGF/ERK inhibition, are likely to serve as additional
attributes essential for the observed efficient production of mDA
neurons.
It is worth noting that, at d9 MD following 4 days exposure to
Shh/FGF8, PD-treated and untreated control cultures had similar
proportions of Foxa2+/Lmx1a+ neural progenitors (Fig. 5E),
indicating that either Foxa2/Lmx1a neural progenitor expression at
later stage of MD, or Foxa2/Lmx1a expression alone, is not
sufficient for mDA commitment, at least in pluripotent stem cell
cultures in vitro.
Shh and Fgf8 participate in distinct regulatory
pathways governing mDA fate specification and
differentiation
Our study shows that both Shh and Fgf8 are necessary during the
period d5-9 for achieving the highest number of mDA neurons:
those co-expressing Th, Pitx3, Lmx1a and Foxa2. Cultures treated
with PD followed by Shh alone contained a large number of faintly
stained Th+ cells with immature neuronal morphology. In addition,
few of these Th+ neurons co-expressed Pitx3-GFP (see Fig. S2 in
the supplementary material). By contrast, Th+ neurons present in
cultures treated with PD, followed by FGF8 alone, were mature in
appearance and mostly Pitx3-GFP+. However, the number of Th+
neurons was similar to that found in the no-PD control cultures.
These observations suggest that PD-generated d5 neural
progenitors require sustained Shh signaling to specify a
dopaminergic phenotype, whereas FGF8 facilitates progenitor
differentiation involving Pitx3 expression.
Day 5-9 MD spans the peak of neurogenesis during which the
expression of neuronal subtype determination factors rapidly
increases (Fig. 1; data not shown). To further elucidate how Shh
and FGF affect neural progenitor behavior, we examined their
effect on the expression of a number of genes that encode mDA
and non-dopaminergic neural progenitor domains by RT-PCR (Fig.
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Fig. 3. FGF/ERK blockade at the onset of neural fate conversion
induces mDA regulatory genes. (A)Experimental schemes. E14tg2a
mouse EpiSC monolayer cultures were exposed to PD0325901 (PD)
from d0 MD for either 2 days (PD0-2) or 5 days (PD0-5). Cultures were
harvested at d1, d2, d3 and d5 MD. (B)qPCR analysis of Lmx1a and
Foxa2. The value of the d1 MD control (Cont) was set as 1. Error bars
indicate mean±s.e.m. of two sets of experiments performed in
duplicate. (C) d5 MD of Lmx1a-GFP EpiSCs exposed to PD from d0 MD
for 2 days were immunostained for Foxa2 and GFP (both green) and
counterstained with DAPI (red). Scale bar: 100m.
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66). We found that Shh added either at d3-6 MD or d5-9 MD
induced a further increase in Foxa2 and Msx1 expression, although
it had no effect on either Lmx1a or Shh (Fig. 6B). FGF8
stimulation, by contrast, led to significant upregulation of Wnt1,
En1 and En2, which are all known to participate in mDA
differentiation and survival (Alberi et al., 2004; Joksimovic et al.,
2009) (Fig. 6B,C).
We also found that cultures without any exogenous stimuli
experienced a sharp increase of gene transcripts controlling
GABAergic fate, such as Gata2 (38-fold), Helt (293-fold) and
Gad1 (401-fold) (Fig. 6D), consistent with the suggestion that in
vitro-derived neurons are mostly GABAergic (Kala et al., 2009;
Nakatani et al., 2007). However, Shh stimulation at d5-9
suppressed the expression of these genes, and progenitors exposed
to sequential PD and Shh treatment showed a further reduction in
these non-DA markers. Thus, the fold increases in Helt and Gad1
transcripts in the PD-Shh cultures were only 10% of the level of
Shh alone cultures and were less than 1% of the level of no factor
controls. Together, our data demonstrate that Shh and Fgf8
participate in distinct regulatory pathways that contribute to
efficient mDA fate specification and differentiation.
Interestingly, FGF8 treatment, with or without Shh, from d3 MD
immediately after PD treatment eliminated the PD-mediated
upregulation of Lmx1a, Foxa2, Shh and Msx1 (Fig. 6B).
Consequently, we observed little increase in the number of Th+
neurons in these cultures at d14 MD compared with the untreated
control (data not shown). Together with the finding that persistent
FGF/ERK blockade after neural induction abolishes PD-mediated
induction of mDA regulators (Fig. 3B, Fig. 5B), our data indicate
that a period of autocrine FGF/ERK signaling is crucial for newly
converted neural progenitors to process the patterning information
that leads to the eventual commitment of the dopaminergic neuron
fate.
In vitro-generated mDA neurons exhibit
functional neuronal characteristics
We examined whether dopamine neurons generated using these
protocols had functional neuron-like properties. We took advantage
of the Pitx3-GFP reporter system (Zhao et al., 2004), in which we
could target dopamine neurons by their GFP signal (Fig. 7A). We
conducted whole-cell recordings at d14-16 MD, from GFP+ cells
differentiated with or without PD. First we examined the passive
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Fig. 4. Stepwise inactivation and
activation of FGF/ERK signaling leads
to the highly efficient production of
dopamine neurons exhibiting mDA
components. (A)Outline of the
experiment using the Pitx3-GFP EpiSCs.
(B)Immunostaining of mouse d14 MD
cultures for (a-d) Th (red) and Tuj1 (blue)
as well as (e-h) Th (red) and Pitx3-GFP
(green). (C)Quantification of the
immunostaining in B, illustrating the
percentage of Th+ neurons and Th+
neurons co-expressing Pitx3.
Mean±s.e.m. *, P<0.01 relative to no-PD
control (Student’s t-test). (D)
Immunostaining of d14 MD cultures for
various midbrain and pan-DA markers.
Scale bars: 200m for Ba,b,e,f; 50m
for Bc,d,g,h,D.
D
E
V
E
LO
P
M
E
N
T
membrane properties of the differentiated cells. All cells exhibited
a negative resting membrane potential typical of neurons (control,
–67±1.3 mV, n6; PD, –37±4.6, n13; P<0.05). Interestingly, cells
treated with PD had a resting membrane potential that was
significantly more depolarized than that of control cells. Both
groups had similar input resistance (control, 422±198 M, n8;
PD, 558±79 M, n15; P>0.05) and whole-cell capacitance
(control, 9.6±1 pF, n8; PD, 12±5 pF, n15; P>0.05) values,
suggesting that PD treatment did not affect cell size.
At d14-16 MD, 14% of these cells (control, 1/7 cells; PD, 2/14
cells) exhibited multiple spontaneous action potentials (Fig. 7B).
In all cells, application of a depolarizing current pulse evoked an
overshooting action potential (n21), and 19% of cells (control, 1/7
cells; PD, 3/14 cells) fired multiple action potentials in response to
the stimulus (Fig. 7C). The cells that were spontaneously active
fired at a low frequency (0.95±0.14 Hz; n3) and in an irregular
pattern (CV-ISI, 1.19±0.24; n3). However, 67% (6/9) of cells in
MD cultures at d40 or later fired spontaneous action potentials.
Importantly, these older cells exhibited the pacemaker-like
spontaneous activity (Fig. 7E) that is characteristic of mDA
neurons (3.54±0.8 Hz; CV-ISI, 0.49±0.08; n6). In voltage-clamp
mode, all differentiated cells exhibited a large outward current,
typical of a delayed-rectifier K+ current (control, 2.91±0.39 nA,
n7; PD, 2.19±0.28 nA, n15; P>0.05) (Fig. 7D, left panel). Fast-
activating, fast-inactivating inward currents were also observed that
were typical of Na+ currents (control, 1.38±0.14 nA, n7; PD,
1.69±0.25 nA, n15; P>0.05) (Fig. 7D, right panel). Taken
together, these recordings show that dopaminergic cells generated
using our differentiation protocol exhibit functional, neuron-like
properties.
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Fig. 5. FGF inhibition directs a midbrain neural progenitor fate. (A)Mouse E14tg2a EpiSC monolayer cultures were exposed to PD0325901
(PD) from d0 MD for 2 (PD0-2) or 5 (PD0-5) days. Cultures were harvested at day 1, 2, 3 or 5 for qPCR analysis of Shh and Wnt1. (B)E14tg2a EpiSC
MD cultures were treated with PD or cyclopamine (Cycl) or a combination of the two as indicated. Cultures were harvested at day 1, 2, 3 or 5 for
qPCR analysis of Lmx1a and Foxa2. (C)EpiSCs were differentiated in the presence of PD or Shh for 2 days from d0 MD, as in B, and analyzed for
Gbx2, En1 and En2 by qPCR at d1-3 and d5 MD. (D)Experimental schemes for E-G. (E)Immunostaining of d5 and d9 MD E14tg2a (top two rows)
and Lmx1a-GFP (bottom two rows) EpiSCs. Antibodies against Otx2 (red) and nestin (green), or Otx2 alone (red), were used in E14tg2a EpiSCs.
Foxa2 (green), nestin (red) and GFP (green) were used in the Lmx1a-GFP panels. Scale bar: 100m. (F)Quantification of immunostaining in E
illustrating the percentage of cells expressing Otx2. Mean±s.e.m. of ten fields from two independent experiments. *, P<0.01 relative to no-PD
control (Student’s t-test). (G)qPCR analysis of the telencephalic markers Six3 and Foxg1 in d2-4 MD cultures with or without PD. Data in A-C,G are
mean±s.e.m. of three replicate cultures.
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fate specification of hESCs
Finally, we asked whether the modulation of FGF/ERK signaling
could also promote mDA neuron differentiation of hESCs. H1 and
H7 hESCs were induced to differentiate by a 3-day exposure to
Smad inhibitors. Under this condition, the primitive ectoderm
marker FGF5 peaked at d3 MD and the majority of the cells
became NES+ neural precursors at d11 for H1 and d20 for H7. To
mimic the condition experienced by the mouse cells, we applied
PD for 4 days from d3 MD (Fig. 8A). Similar to the finding in
mouse cells, PD treatment in hESCs also resulted in an increase in
OTX2, WNT1, EN1/2 and in the suppression of SIX3, FOXG1 and
GBX2 (Fig. 8B), indicating the induction of a midbrain fate and the
suppression of caudalization as well as forebrain induction. We also
observed similar induction of ventral fate regulators such as SHH,
LMX1A, FOXA2 and MSX1. Interestingly, PD treatment led to
robust induction of DMRT5, a newly identified midbrain floor plate
marker that confers mDA progenitor identity following forced
expression in ESC-derived neural progenitors (Fig. 8B) (Gennet et
al., 2011).
Consistent with the transcript analysis, the major population of
NES+ progenitors in PD-treated cultures co-expressed OTX2,
FOXA2 and DMRT5 (Fig. 8C). Of the PD-treated cells, 47.5±7.1%
were FOXA2+ OTX2+, a molecular profile characteristic of mDA
neural progenitors (see Fig. S5 in the supplementary material). By
contrast, this cellular phenotype only constituted 6.8±1.5% of the
control population. As cultures progressed toward neuronal
differentiation at d35 MD, we detected numerous TH+ neurons co-
expressing FOXA2, LMX1A and PITX3 in PD-treated cultures
(Fig. 8D,E), which was in dramatic contrast to the no-PD controls,
in which LMX1A+ and PITX3+ cells were rarely detected (data not
shown). Furthermore, we found that, although FOXA2+ cells were
present in the no-PD cultures, they were mostly mutually exclusive
with TH+ neurons (Fig. 8D). Thus, PD treatment resulted in a near
7-fold increase of FOXA2+ TH+ neurons when compared with no-
PD controls (Fig. 8D-F). Together, the above data demonstrate that
FGF/ERK signaling plays a conserved role in mouse and human
pluripotent stem cells.
DISCUSSION
Dopamine neurons derived from pluripotent stem cells constitute a
powerful resource in neurobiological research. In the context of
patient-specific iPS cells, in vitro-derived dopamine neurons also
provide a valuable tool for drug discovery, modeling of Parkinson’s
disease and as a potential alternative cell source for transplantation-
based therapy.
Here, we demonstrate a functional impact of the FGF/ERK
signaling level on the course of mDA neuron differentiation of
mouse and human pluripotent stem cells. Pharmacological
inactivation of FGF/ERK activity upon exit of the lineage-primed
epiblast pluripotent state initiates transcription activities that
govern early mesencephalic patterning of both the anterior-
posterior and dorsal-ventral axes, leading to the induction of
mDA neural progenitor characteristics and maintenance of
dopaminergic competence. The consolidation of these
characteristics, however, requires a period of autocrine/paracrine
FGF/ERK signaling immediately after neural induction. Either
continued FGF/ERK blockade in newly derived neural
progenitors, or enhancing FGF signaling activity by exogenous
FGF8 in these cells, abolishes the effects of PD. These findings
demonstrate a previously unrecognized inhibitory role of
FGF/ERK in the induction of ventral midbrain neural progenitors
and offer a novel strategy for mDA neuron production from
mouse and human pluripotent stem cells and iPSCs. Furthermore,
the current method represents a simple, small-molecule-based
paradigm for significantly improved efficiency and high
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Fig. 6. Shh and FGF8 act on distinct aspects of
mDA neuron differentiation. (A)Experimental
scheme for data in B and C. (B)qPCR analysis of mouse
d6 MD cultures for the ventral mesencephalic regulator
genes Lmx1a, Foxa2, Msx1 and Shh and the isthmus-
expressed midbrain patterning genes Wnt1, En1 and
En2. (C)qPCR analysis at d9 MD for Wnt1, En1 and
En2. PD0325901 (PD) was added for 2 days from d0-2,
whereas Shh and/or FGF8 were added from d5.
(D)qPCR analysis of Helt, Gata2 and Gad1 in d5 and
d9 MD cultures. Expression levels were examined in
control MD cultures with no added factors, control
cultures treated with Shh between d5 and d9 alone, as
well as in cultures treated with PD at d0-2 followed by
Shh between d5 and d9 MD. Data in B and C are
mean±s.e.m. of two experiments performed in
duplicate, whereas data in D are mean± s.e.m. of
triplicate cultures from one representative experiment.
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reproducibility compared with previously reported transgene-free
protocols. Importantly, our strategy directs a midbrain regional
identity in the derived dopamine neurons, a property that is
essential for functional integration of transplanted dopamine
neurons in the Parkinsonian brain (Hudson et al., 1994).
Stimulation of ESC-derived neural progenitors with Shh and
FGF8 is used by almost all dopamine differentiation protocols
(Barberi et al., 2003; Kim et al., 2002; Lee et al., 2000; Perrier et
al., 2004; Yan et al., 2005). However, unless combined with genetic
manipulation of mDA transcription factors, such as Pitx3 or Lmx1a
(Andersson et al., 2006; Chung et al., 2002; Konstantoulas et al.,
2010; Maxwell et al., 2005), the midbrain regional identity of the
dopamine neurons generated has remained uncertain. Furthermore,
the yield of Th+ neurons has often proved unreliable between
experiments and even highly variable between different
microscopic fields within a single culture. A major limiting factor
is the temporal and spatial heterogeneity of ESC-derived neural
progenitors. Our findings demonstrate that the above issues can be
addressed using EpiSCs. We found that, in the absence of
FGF/ERK signaling manipulation, nearly 40% of Th+ neurons
generated by EpiSCs already co-expressed Pitx3. This represents a
significant improvement over ESC-derived monolayer cultures,
where Pitx3+ neurons are rarely observed (Andersson et al., 2006;
Friling et al., 2009; Parmar and Li, 2007). This improvement is
likely to be due to the more synchronous conversion of EpiSCs to
the neuroepithelial fate, which would allow for the effective
capture of mDA-competent progenitors.
However, without additional FGF/ERK inhibitor treatment at the
neural induction phase, the total numbers of Th+ Pitx3+ cells
remained low due to the overall poor efficiency in producing Th+
cells. The early induction of both Lmx1a and Foxa2 by inhibiting
FGF receptor or ERK is likely to be a key factor in the observed
high efficiency in our experiments. This hypothesis is based on the
following observations: (1) d5 PD-treated (EpiSC) MD cultures are
highly enriched for Foxa2+ Lmx1a+ neural progenitors compared
with untreated controls; (2) although Shh treatment in d5-9 MD
results in comparable numbers of Foxa2+ Lmx1a+ cells in PD-
primed and no-PD cultures, mDA neuron production was not
enhanced in the manner observed with PD treatment; (3) replacing
PD with Shh, which turned out to be a slower and less effective
inducer of Lmx1a and Foxa2, also led to poor mDA production;
and (4) previous reports have credited the dopaminergic-promoting
activity of Lmx1a to its early transgene expression in ESC-derived
neural progenitors (Friling et al., 2009) and indicated that Lmx1a
functions by cooperating with Foxa2 in specifying mDA fate
during midbrain development (Lin et al., 2009; Nakatani et al.,
2009).
The robust induction of Wnt1 and its targets in naïve neural
progenitors is likely to be a key downstream mediator that confers
the observed early induction of Lmx1a, in light of the recent finding
that it can be directly regulated by Wnt1/-catenin signaling
(Chung et al., 2009). The same study also showed that, although
Otx2 itself had no effect in promoting the expression of terminal
mDA neuronal marker genes such as Th, Pitx3 and Nurr1, it
significantly enhanced the regulatory effect of Lmx1a and Foxa2
on the expression of these genes. Thus, Otx2 plays a permissive
role in Lmx1a/Foxa2-mediated mDA neuronal production. It is
worth noting that a significant effect of FGF/ERK blockade is the
maintenance of Otx2 in derived neural progenitors.
Our study also shows that, in addition to inducing a regulatory
cascade for ventralizing nascent neural progenitors, FGF/ERK
inhibition suppresses forebrain specification while promoting
anterior neural induction, as demonstrated by the strong and
consistent repression of the forebrain regulator genes Six3 and
Foxg1 and the hindbrain marker Gbx2. Thus, blocking FGF/ERK
at the onset of neural induction leads to a direct and early induction
of the midbrain fate at the expense of forebrain and caudal neural
fates. Our finding is consistent with the developmental role of FGF
signaling in regionalization of the forebrain (Corson et al., 2003;
Shimamura and Rubenstein, 1997).
Furthermore, we demonstrate the importance of precise temporal
control of cell signaling and its cross-regulation with other signaling
pathways in mDA neuronal fate specification. During development,
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Fig. 7. Pitx3-GFP+ cells exhibit functional neuron-like
electrophysiological properties. (A)DIC and GFP image showing a
recording pipette patched onto a mouse Pitx3-GFP+ cell.
(B)Spontaneous action potentials fired by a day-14 neuron. Vertical
scale bar, 20 mV; horizontal scale bar, 5 mseconds. (C)A single
spontaneous action potential (left). A single action potential fired in
response to a 50 pA depolarizing current pulse (middle). Multiple action
potentials fired in response to a 50 pA depolarizing current pulse
(right). Vertical bars, 20 mV; horizontal bars, 50, 100 and 100
mseconds, respectively. (D)Outward current evoked by a serious of
voltage steps (left). Fast inward current evoked by a series of voltage
steps (right). Vertical bars, 1 nA; horizontal bars, 50 mseconds.
(E)Pacemaker-like spontaneous firing a day-41 neuron. Vertical bar, 20
mV; horizontal bar, 1 second.
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Fgf8-mediated signaling can induce the patterned expression of
many midbrain/rostral hindbrain genes and is required for normal
development of the midbrain and cerebellum (Chi et al., 2003; Liu
et al., 1999; Meyers et al., 1998). Fgf8-induced Wnt1 and engrailed
are key regulators of midbrain and cerebellum patterning, as well as
of the differentiation and survival of dopamine neurons (Prakash et
al., 2006; Simon et al., 2001; Tang et al., 2009). In EpiSC-derived
neural cultures, after an initial burst of upregulation induced by PD
exposure, Wnt1 expression was subsequently reduced to a level
below the no-PD control by unknown factors in the newly generated
neural progenitors in d3-5 MD. This is the period when Shh, Lmx1a
and Foxa2 expression levels continued to rise. Given that Shh and
Wnt1 play opposing roles with regard to mDA neurogenesis
(Joksimovic et al., 2009), our findings suggest that the delay in FGF
reactivation, which suppresses Wnt1 levels, might be crucial for
achieving high numbers of Th+ neurons by consolidating Lmx1a and
Foxa2 expression via Shh signaling.
From a technological standpoint, we describe a novel method of
mDA neuron differentiation that employs temporally controlled
exposure of human and mouse pluripotent stem cells to an
FGF/ERK-deficient environment. The highly reliable nature of this
method was demonstrated using five independent mouse EpiSC
lines, a mouse iPS cell line and two human ESC lines. This protocol
offers several advantages over current methods of generating
midbrain-specific DA neurons in that it is adherent culture-based and
free from genetic manipulation and thus could be readily applied to
other cell lines of interest. Furthermore, because it is fully chemically
defined, this paradigm could be readily adapted for use in a clinical
setting or scaled up for toxicity and drug screening relevant to
developing new therapeutics for Parkinson’s disease.
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Fig. 8. Generation of mDA neurons from human
ESCs. (A)Experimental schemes. (B)qPCR analysis of
regional markers in d7 and d11 H7 MD cultures with
or without PD0325901 (PD). Data are mean±s.e.m. of
three replicate cultures. (C)Double immunostaining of
d13 H1 MD cultures for nestin (green) plus OTX2,
FOXA2 or DMRT5 (all in red). (D)Triple antibody
staining of d35 H7 cultures for FOXA2 (red), TH
(green) and 3-tubulin (TUJ1, blue).
(E)Immunostaining of PD-treated d32 H7 MD cultures
for PITX3 (red) and TH (green), and for LMX1Aa (red)
and TH (green). (F)Quantification of the
immunostaining in E, illustrating the percentage of
TH+ neurons and TH+ neurons co-expressing FOXA2.
Error bars indicate s.e.m. Scale bars: 75m.
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